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G neral introduction
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Introduction
Acute and chronic respiratory problems are the most common reasons for
parents to visit a physician. Apart from upper and lower airway infections
especially recurrent wheezing and asthma are important differential diag-
noses in children with respiratory complaints. Serious respiratory disease
accounts for 30% of paediatric mortality and thirty percent of hospital
admissions is caused by serious respiratory illnesses1. In infants it is the most
common cause of death2. Several studies report an increasing incidence and
prevalence of asthma and asthma-like diseases, especially in young chil-
dren3,4.
Additionally, recent advances in neonatal medicine have improved the out-
come of very premature and small children5,6 and better treatment of chil-
dren with congenital respiratory malformations and cystic fibrosis has
prolonged survival as well as quality of life for these patients7,8. However, a
considerable part of these children will develop chronic lung disease in
childhood, adolescence and adulthood.
Asthma and asthmatic symptoms
Within Europe the prevalence of asthma has been reported to vary between
5 and 10%9-11, but the incidence of asthma and atopy is rising in all coun-
tries that have improved standards of living. Some studies report a preva-
lence of 30-40% in many developed countries3. Part of this is certainly due
to better recognition, but there has been a real increase in incidence4.
Several reasons have been reported for this increase and recent studies indi-
cate that probably environmental changes more than genetic drifts are
major determinants. Probably there is not only a real increase in the inci-
dence of atopy and asthma (e.g. caused by lower incidence of early child-
hood respiratory infections) but also an increased incidence of pulmonary
symptoms in children with atopy and asthma (e.g. caused by external air
pollution)12.
During early childhood many children experience recurrent asthmatic symp-
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toms such as wheezing, cough or breathlessness. Silverman et al13 found a
prevalence of 40%. Although up to 60% of these children are symptom free
around the age of 6 years14, a substantial proportion remains symptomatic
during later childhood and adulthood. Specifically the latter group is even-
tually labelled as asthma, especially when further diagnostic work up is
indicative of asthma and atopy (pulmonary function tests, reaction to thera-
py, bronchial hyperresponsiveness, skin prick tests or specific IgE, etc.).
The treatment of asthma with inhaled corticosteroids has shown to be effec-
tive and relatively safe in adults and older children15,16. In the younger age
group there is a tendency to treat recurrent asthmatic symptoms in a similar
way, although there is uncertainty about the diagnosis and thus uncertainty
about the most appropriate treatment. Recent studies indicate that anti-
inflammatory treatment for asthma should start as early as possible to prevent
the development of irreversible, structural airway remodelling17-19.
Paediatric pulmonology, from pregnancy to adulthood?
Chronic lung disease in childhood and adulthood is determined partially by
upper and lower respiratory illnesses during early childhood. Apart from
infectious or chemical agents, increasing evidence indicates that significant
events in foetal life predispose to abnormal lung function during infancy,
predisposing to early childhood respiratory illnesses and chronic airway dis-
ease in later life20. Probably not only childhood asthma, chronic lung dis-
ease, cystic fibrosis or congenital malformations, but many other respiratory
problems, encountered during early life have consequences for pulmonary
well being during later life. It is important to recognise the child that is at
risk for later respiratory disease as early as possible during infancy or child-
hood. Only in this way adequate treatment (e.g. inhaled corticosteroids)
and prophylaxis (e.g. smoking prevention) might prevent long term mor-
bidity and possibly mortality21.
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Pulmonary function measurement in young children.
The diagnosis of respiratory disease in children is based on medical history
and physical examination. In most cases one must rely on clinical assess-
ment without the benefit of objective measures of respiratory function.
Sometimes further diagnostic work up contains laboratory and radiological
investigation.
The evaluation of pulmonary function is helpful to enable clinicians to
objectively measure functional abnormalities in children with (or without)
respiratory symptoms (Table 1).
Although lung function studies are increasingly used for the diagnosis and
assessment of severity and follow up of asthma and other respiratory prob-
lems, objective pulmonary function testing is often only possible for older
children. Currently, forced expiratory volume in 1 second (FEV1) is the
most widely used parameter of airway obstruction. This parameter cannot
be used in children younger than 4 years old. That’s why other lung func-
tion methods are needed in this age group.
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Table 1. Contribution of pulmonary function testing to diagnosis and treatment in
paediatric pulmonology
Pulmonary function tests can be used to:
1. detect the presence of pulmonary functional abnormalities
2. quantify the degree of abnormality
3. differentiate between obstructive, restrictive and mixed obstructive/restrictive
pathology
4. differentiate between fixed from variable airway obstruction
5. differentiate between central (intra- or extrathoracic) and peripheral obstruction
6. follow the time course of disease
7. evaluate the effect of therapy
8. evaluate the presence and degree of increased airway responsiveness
9. evaluate the risk of therapeutic or diagnostic interventions
10. monitor pulmonary side effects of therapy (chemotherapy/radiation)
11. enable prognosis of disease and disability
12. evaluate effects of disease or intervention on lung growth
For infants and pre school children several alternative methods to measure
pulmonary function have been developed. However, most cannot be
implemented for use in daily clinical practice. Standardisation of these tech-
niques is a developing science in paediatric pulmonary medicine21. Many of
these tests are currently available only in specialised centres and develop-
ment of these methods is a growing area of interest and will add greatly to
understanding the growth and development of the respiratory system22.
Pulmonary function testing is not only useful in clinical diagnosis and
assessment of disease severity, but may also help to monitor progression of
disease and evaluate response to therapeutic intervention.
Lung volumes can be measured by body plethysmography or gas dilution
techniques. Whole body plethysmography has been used to determine tho-
racic gas volume since 195623 and is also possible in infants. With the
infant’s body in a sealed box and breathing through a shutter which is
closed at a predetermined point in the respiratory cycle, changes in alveolar
pressure can be measured at the mouth piece and related to the simultane-
ous change in pulmonary volume of gas in the lungs. Airway conductance
can be measured simultaneously24. However, several technical difficulties
and the necessity of sedation impairs widespread application.
During the gas dilution method the patient breathes a known concentration
of helium from a reservoir. After some time a new equilibrium of helium
concentration is reached and the functional residual volume can be calculat-
ed from the additional volume into which the helium has diffused25.
In the evaluation of bronchus obstructive disease, especially asthma, the
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Table 2. Requirements for pulmonary function tests in infants and young children
1. Easy performance for children of all ages
2. Not burdensome or long lasting procedure
3. Repeatable/reproducible
4. Cheap
5. Distinguishing healthy from diseased children
6. Not invasive
7. Applicable during spontaneous breathing, not requiring sedation
8. Quickly available results
9. Responsive to therapeutic influences
10. Useful for follow up
most widely accepted and best standardised method to quantify airway
obstruction is the maximal expiratory flow-volume measurement26. The
“gold standard” parameter derived from this test is the forced expiratory
volume in the first second of expiration (FEV1). This parameter is obtained
from flow-volume measurements during forced expiratory manoeuvres.
The technique, necessary to perform these manoeuvres requires optimal
co-ordination and co-operation and these premises impair the applicability,
not only in infants, pre school children and geriatric patients but even in
older children and adults.
Compliance and resistance of the lung can be measured during active
breathing using an oesophageal balloon or a weighted spirometer method27.
Respiratory system mechanics can also be measured using passive deflation
by applying single28 or multiple occlusions29. The static compliance of the
respiratory system Crs is calculated from the exhaled volume, related to
mouth pressure at end-inspiration. Forced expiratory flow-volume meas-
urements can be obtained from partial expiratory flow-volume loops by
applying rapid thoracic compression with an inflatable plastic jacket30.
However all these tests require difficult technical procedures, allowing only
application in well equipped research laboratories. Most techniques are only
useful at specific ages. Also in many children sedation is required to per-
form reliable tests.
Clinical application of new or alternative pulmonary function tests in
young children is only possible for techniques that show characteristics as
described in Table 2. Indeed no co-operation can be expected from todd-
lers and infants and non invasive methods are of paramount importance to
avoid disturbing the physiology being studied and to ensure patient and
parent acceptance21.
Scope and outline of this thesis.
During the past decades several new alternatives for measurement of pul-
monary function in pre-school children have been developed. The studies
described in this thesis addressed several aspects, both methodological and
clinical, of pulmonary function tests in school and pre-school children.
An overview of literature on relevant anatomy and physiology, followed by
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an overview of currently available methods to measure airway mechanics in
non-sedated, spontaneously breathing children is presented in Chapter 2.
One of the pulmonary function techniques that has been subject of several
studies in the University Medical Centre Utrecht is the tidal breathing
analysis. In Chapter 3 a short overview of this technique is presented.
The gold standard of pulmonary function testing at all ages is the maximal
expiratory flow volume (MEFV) curve. Prior to attempting to interpret any
MEFV curve (or whatever other pulmonary function test) result in physio-
logic terms the quality of the tests should be assessed. Patient effort, co-
ordination, co-operation, artefacts and reproducibility should be evaluated
and less than optimal procedures should be judged with caution. General
standards for pulmonary function technicians, equipment and recommen-
dations for testing procedure were published and subsequently adapted by
both the American Thoracic Society (ATS)31-33 and European Respiratory
Society (ERS)34,35. Specific guidelines for children were published by
Taussig in 198036. An adaptation and overview of these guidelines are pre-
sented in Chapter 4.1.
The performance of a maximal effort expiratory manoeuvre is not easy, as
was discussed before. Especially young children lack the co-ordination and
co-operation to perform the difficult breathing techniques necessary for
acceptable and reproducible measurements. The American Thoracic
Society and the European Respiratory Society have developed specific cri-
teria for this procedure, especially concerning acceptability and repro-
ducibility of performance and results33,37. In a retrospective study the flow
volume curves, performed by children of all ages were evaluated for their
capability to meet these international criteria. The results are described in
Chapter 4.2.
Recently an old technique, the interrupter technique, for assessment of air-
way resistance showed a revival after introduction of a small handheld
device, the MicroRint. In Chapter 5.1 the feasibility of this method is
described in both healthy children and children with asthmatic symptoms.
Values in healthy children in Utrecht were combined with the findings in
healthy children in a study, performed in the Sophia Children’s Hospital in
Rotterdam. These enabled the publication of reference values for children
of 3-13 years old, presented in Chapter 5.2.
One of the methods to measure resistance and reactance of the respiratory
system which is applicable in young children is the impulse oscillation tech-
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nique (IOS). To study the clinical applicability of this method to measure
airway responsiveness a study was performed in school children in whom
results of IOS and MEFV were compared (Chapter 6).
The maintenance treatment of asthmatic children with inhaled corticos-
teroids has evolved during the last decennia. There is a tendency to treat
not only severely affected subjects, but also children with less frequent and
(mild to) moderate symptoms. The availability of preparations for inhala-
tion, with few important side effects, the increasing knowledge of airway
remodelling and the presence of asthma-like airway inflammation in chil-
dren during early childhood has supported this concept. The effect of ICS
in children with infrequent symptoms, quite normal lung function and less
specific symptoms is difficult to measure.
The effect of prophylactic treatment with inhaled corticosteroids in 5-10
year old children with mild to moderate asthma was studied in a prospec-
tive, randomised, placebo controlled, double blind, multi-centre study.
This study was called the SJOKOLA 1 study, short for “Steroiden bij
JOnge Kinderen als OnderhoudsbehandeLing van Astma” (Chapter 7.1).
The effect of ICS in children with mild asthma was evaluated using both
subjective and objective effect parameters.
As in older children and adults, there is a tendency to treat recurrent asth-
matic symptoms in the younger age group in a similar way, although there
is uncertainty about the diagnosis and thus uncertainty about the best ways
of treatment. There is no consensus on this treatment modality and there
are no studies on the effect of ICS on tidal breathing parameters, impulse
oscillometry and interrupter resistance in pre school asthmatic children. In a
prospective study the effect of ICS in this age group was evaluated with
both subjective and objective parameters (Chapter 7.2). Also the possibili-
ties of these and other parameters to predict a possible beneficial effect of
ICS and the correlation of changes in lung function parameters and subjec-
tive parameters are described.
Conclusions from these studies and suggestions for further research are pre-
sented in Chapter 8, followed by a summary of the thesis in English and
Dutch (Chapter 9).
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Introduction
Measurement of pulmonary function is an important tool for the diagnosis
and monitoring of respiratory diseases. The gold standard of pulmonary
function testing (PFT) is the maximal expiratory flow volume (MEFV)
curve. However, only children aged 6-8 years and older can be expected to
perform reproducible forced respiratory manoeuvres1,2. In younger chil-
dren MEFV measurements are rarely performed, because these children
lack co-operation, but also show diminished reproducibility and reliability
of results3.
There are little alternatives in this age group. The clinical evaluation of
lung function by auscultation appears to be an extremely insensitive indica-
tor of bronchial obstruction4-6. For instance a fall in oxygen tension of 33%
may occur in young asthmatic children without audible wheeze4. Probably
at least 30% fall in FEV1 is necessary before wheezing is heard5.
Between infancy and school age only methods that do not require sedation
(unlike e.g. baby body plethysmography, V’maxFRC measurement by the
squeeze jacket method) and are not invasive (unlike airway pressure meas-
urement using pitot static probe7 or oesophageal balloons8) are widespread
applicable. In small children they should only require passive co-operation.
Tidal breathing analysis and resistance measurement by the interrupter
technique or (impulse) oscillation technique all appear to fulfil these
requirements. The accuracy of these methods, i.e. their relationship to true
airway resistance is not well known. These measures may be considered as
indices of lung function3.
In this chapter general principles of pulmonary and especially airway anato-
my, development and physiology are discussed, followed by an overview of
the different available methods to measure airway mechanics. The tidal
breathing technique is comprehensively discussed in the next chapter.
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1. General principles of respiratory mechanics
Modelling of the respiratory system
The respiratory system can be considered as a physical model, i.e. a collec-
tion of physical components interacting with one another and with the
environment. Most real life systems, such as the respiratory system are non
linear, but they can be simplified to linear models under certain conditions.
A linear model has useful properties that makes analysis easier.
The most simple model of the complex respiratory system is that of a single
balloon on a pipe. The relationship between the pressure applied at the
opening of the model (P(t)) and the volume in the model (V(t)) during
emptying of this balloon can be described as a first order model:
P(t) = E.V(t) + R.V’(t)
where E = elastance of the balloon, R = resistance of the pipe and V’ =
flow through the opening. Using regression analysis one can calculate E and
R from P(t), V(t) and V’(t).
If this model is applied to the respiratory system, the values of R and E
reflect the R of the airways and the E of the respiratory system, whereas
V(t) is the volume increase from functional residual capacity (FRC), i.e.
where P(t) at mouth opening is zero.
In other words the passive deflation of the respiratory system is charac-
terised by a volume-time profile determined by E and R.
In vivo measurements show that the lungs can not be seen as a single com-
partment and when one reports a single airway resistance or elastance value,
the underlying assumption that this is the one and only value for these
parameters is never satisfied in real life, especially in non healthy subjects.
Nevertheless, the majority of respiratory mechanics are represented by this
simple linear, single compartment model.
Using this model there are three important components:
1. time constant (τ)
2. compliance or elastance
3. resistance
2
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The relationship of these parameters is given by the equation:
τ = C X R, τ = R/E
Time constant of lung emptying
The time constant (τ) describes the expiratory airflow generated by the
elastic properties of the respiratory system (balloon)9.
During passive emptying the time to reduce by 63% is known as the time
constant of the respiratory system (Figure 1). In healthy adults τ = approxi-
mately 0.5 sec. This allows the lung to empty to FRC at each expiration. In
infants with normal lungs τ = 0.3 sec and in infants with stiff ‘hyaline mem-
brane’ lungs 0,1 sec10. In obstructive airway disease increasing R (with or
without decreasing E) increases τ, leading to a need for longer expiration
time.
Elastance and compliance
When forces are applied to elastic structures such as the lungs, these struc-
tures will resist deformation by an opposing force in order to return to their
relaxed state. This opposing force is called elastic recoil. The pressure need-
ed to overcome elastic recoil, the elastic recoil pressure (Pel), depends on
the lung volume above or below the equilibrium volume. The Pel divided
14
Figure 1. Time constant (τ) of lung emptying. V = lung volume,
τ = resistance/elastance
by the lung volume gives a measure of the elastic properties of the lung tis-
sue and is called elastance (E):
E=Pel/V
The slope of the volume (V) versus pressure (Pel) gives the reciprocal of
elastance, i.e. compliance ( C ).
C = V/P C = 1/R
The phenomenon that elastance and compliance depend on the volume
history of the lung is called hysteresis. Expiration and inspiration are repre-
sented by different pressure-volume curves. Actually this is the failure of
tissue to follow identical paths of response during in- and expiration as
shown in Figure 2. Hysteresis depends on visco-elasticity and plasticity of
the lung. It is important to know that during tidal breathing hysteresis is
negligible, which is functionally desirable because the area of the hysteresis
loop represents energy loss from the system. This also means that in all
PFTs during tidal breathing hysteresis will hardly influence results.
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Figure 2. Hysteresis in the pressure volume curve of the lung. The area contained within the curve represents
the energy lost in the system. V = volume, P = pulmonary pressure, d = change.
expiration
inspiration
Resistance
Resistance is expressed as changes in pressure divided by changes in flow:
R = dP /dV’
In other words, the flow (V’) measured at the mouth depends on the driv-
ing pressure (i.e. the pressure difference between alveoli (Palv) and mouth
Pmo)) and the airway resistance (Raw):
V’ = (Pmo-Palv)/ Raw
If mouth pressure is 0 (i.e. atmospheric pressure), driving pressure is alveo-
lar pressure.
Alveolar pressure is determined by two components: elastic lung recoil
pressure (Pel) and intrathoracic or pleural pressure (Pith or Ppl).
Pel is the pressure caused by the elastic properties of the lung, resulting in
volume reduction of the lungs. Ppl results from the influence of breathing
muscles on the thorax. During inspiration these forces counteract (Palv =
Ppl - Pel) during expiration they work together (Palv = Ppl + Pel)
Airway resistance (Raw) can be considered the sum of peripheral airway
resistance (peripheral intrathoracic airways < 2 mm diameter; Rawp), central
airway resistance (large intrathoracic airways > 2 mm diameter; Rawc) and
extrathoracic airway resistance (especially glottis; Rext).
Raw = Rawp + Rawc + Rext
In healthy persons Rext accounts for 50% of total Raw and Rawp accounts
for about 15% of Raw. Rawp and Rawc are influenced by lung volume, i.e.
by Pel. Higher lung volumes give higher Pel and therefore increase airway
diameter. With increasing volumes during inspiration the increased Pel is
counteracted by Ppl, resulting in increased radial distending force. This dis-
tending force is the transmural pressure and is the difference between pres-
sure in (Pin) and outside (Pout) the airway.
During breathing arrest the pressure inside the airways (Pin) equals atmos-
pheric pressure and transmural pressure (Ptm) equals  Pel:
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Pin = Pmo
Ptm = Pel
Airway diameter is sigmoidally related to Ptm of the intrathoracic airways.
This results in volume dependency of Raw. At higher lung volumes Rawp
decreases. The specific relation between Rawp (or its reciprocal conduc-
tance Gaw (=1/Raw) and volume is mirrored by the specific Raw (sRaw) and
specific Gaw (sGaw).
Raw = Raw / V and sGaw = Gaw / V
Dynamics of breathing
The forces produced by respiratory muscles should overcome the elastic,
flow resistive and inertial properties of the lungs and chest wall to produce
ventilation.
The inertance is the “resistance of the respiratory system to acceleration”.
During tidal ventilation inertance is negligible. 90% of pressure is required
to overcome the elastic forces, only 10% to overcome flow resistant forces.
The elastic properties, compliance and resistance, are the main determi-
nants. Frictional resistance to airflow acceleration to airflow accounts for
1/3 of the work during quiet breathing. The magnitude of pressure loss,
due to friction depends on the pattern of flow, which can be laminar
(streamlined) and turbulent. This depends on the properties of the gas (vis-
cosity, density), velocity of airflow and the radius of the airway. In general
there is laminar flow in small peripheral airways and turbulent flow in larger
central airways.
The pressure gradient required to maintain laminar flow through a tube is
given by Poiseuille’s law:
P = V’ (8lη/πr4)
P = pressure, V’ = flow, l = length, r = radius of the tube, η = viscosity
of the gas.
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Viscosity of air is low (0.000181 poise).
Because resistance = pressure/flow, it is clear that the most important deter-
minant of resistance in small airways is the radius raised to the fourth power
in the denominator of the equation.
Flow limitation
Expiratory flows are limited throughout most of the forced expiratory
manoeuvre11-13. Above a certain expiratory effort expiratory flow is inde-
pendent of the applied pleural pressure.
During forced expiration, the driving pressure for air flow is determined by
the sum of elastic lung recoil pressure and actively applied pleural pressure.
As the actively applied pressure is also applied to the airway walls it is only
the elastic recoil pressure at any lung volume that allows pressure inside the
airways to be higher than that outside the airways. During forced expiration
flow-related frictional and convective accelerative intrabronchial pressure
losses occur. At some point along the airways from the alveoli to the
mouth, the flow-related pressure losses will equal the lung elastic recoil
pressure and the difference between the intrabronchial and extrabronchial
pressures will be zero. This point is called the equal pressure point
(EPP)(Figure 3). Downstream, i.e. mouthward from this point airways are
compressed by the pressure surrounding the airway wall which will be
greater than the decreasing intrabronchial pressure, thus leading to dynamic
compression of the airway lumen.
Following this theory, MEFV measurements can be considered the blue
print of the mechanical properties of the lung parenchyma and airways and
explains the high reproducibility within one subject of the MEFV curve.
The shape of the MEFV curve is determined by the variable site of the flow
limiting segment. This site is normally located in the central intrathoracic
airways14-16, especially the lobar and segmental airways17,18 during forced
expiration and does not move beyond the subsegmental airways19.
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2. The influence of anatomy on airway mechanics
The force generated by the respiratory muscles must overcome the total
respiratory resistance (Rrs), consisting of resistances of the lung (RL) and
chest wall (Rcw) and the resistance to gas flow through the airways (Raw).
Rrs = Rcw + RL + Raw .
The contribution of Rcw and RL to Rrs is not completely clear. In adults
and older children Rcw and RL represent only 10-20% of Rrs
20. Polgar and
String reported that in newborns RL averaged 24% of Rrs, almost twice that
in adults21, but other investigators found almost identical values for Raw and
Rrs, so only small contributions of Rcw and RL
22,23. Largely because of dif-
ferent techniques of measurement, absolute values for resistance in infants
and children remain unsettled and values in different age groups can hardly
be compared.
The upper airway
The upper airway consists of the passages between airway opening and lar-
ynx. Normally this is the nasal passage (from nostrils to the posterior ending
of the nasal septum), the nasopharynx (from end of nasal septum to lower
border of the palatum mollle) and the pharynx (from soft palate to glottis).
When breathing orally, it also includes the mouth. Breathing through the
nose causes much greater resistance than breathing through the mouth.
There are important anatomic features that have to be considered in the
phase of gas transport through the upper airways. The axis of the nose to
that of the trachea is 90%. Cross sectional area of the airways increase from
anterior nares, containing hairs to large turbinated airways, than decreases
again in the nasopharynx and the rest of the airways. The nose accounts for
50% of total respiratory resistance, although there is marked variation
among subjects and the contribution is less in children than in adults. Most
of this is accounted for by the first 2 cm of the nasal passage.
Under normal conditions 15-50% of airway resistance is accounted for by
oral cavity, pharynx and larynx24-26. The individual contribution of these
three elements was studied by Schiratzky in 1965. She found that the larynx
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accounts for 25% of the total airway resistance and oral cavity for 30%27.
Similar findings were presented by Pressman and Kelemen28. These results
show that especially the angulation of the airway results in decreased air
transport capacity.
Several studies showed that the orifice between the vocal cords represents
an important resistance to air flow and significantly influences total airway
resistance25,29,30. Vocal cords move apart during inspiration and close some-
what during expiration31. During panting the glottis stays wide open32.
This technique is used when performing body plethysmography.
Stanescu et al. found significant correlations between glottis opening, lung
volume and flow rate. The variation of glottis opening with lung volume
was larger during expiration. The glottis opening was greater during panti-
ng than during tidal breathing. As a result airway resistance (from the glot-
tis) was smaller during panting at comparable lung volumes. This indicates
that, to reduce the influence of the glottis during airway resistance meas-
urement, panting is a suitable method33.
The cricothyroid muscle is especially active during inspiration, contributes
to vocal cord abduction and thereby causes the airway to open34.
Infants are believed to be obligatory nasal breathers35. Indeed, when both
nose and mouth are open infants, but also most older subjects are exclusive-
ly nasal breathers36. However research by Rodenstein et al showed that
during nasal obstruction tight apposition of the soft palate and tongue
occurs, but that after a mean of 8 (range 1-30) seconds oral breathing was
initiated. The older and more awake the child, the earlier switch to oral
breathing occurred. This switch occurred by detaching the soft palate from
the tongue37. So, infants, children and adults only prefer nasal breathing but
at all ages oral breathing is possible .
When the temperature of inspired air falls below 7° C there is a marked rise
in resistance caused by vascular engorgement. Also changes in body posture
alter resistance through hydrostatic effects on vasculature. Going from ver-
tical to horizontal position increases resistance. Resistance through both
nasal passage is not similar and varies in 3-4 hour cycles.
The pharynx is the most compliant region of the upper airways and nega-
tive pressures tend to collapse the airway. This is prevented by the tone of
the airway muscles, but can cause tremendous resistance in subjects with
anatomic abnormalities or muscle dysfunction or during REM sleep.
Even minimal mucosal thickening in the nose or mild oedema of the larynx
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or trachea in infants may cause significant increases in resistance.
Both the measurement and the degree of airflow resistance is influenced by
the breathing pattern. During spontaneous breathing 80-90% of breathing
of most people is nasal38,39. Only during exercise they shift to oral breath-
ing and at maximal exercise about 60% of breathing is orally. However
some people show combined oronasal breathing and few people persist
nasal breathing even at maximal exercise40.
During oronasal breathing inspiratory nasal airflow is greater than expirato-
ry nasal airflow. Using a mouth piece will wedge open the mouth and this
will influence oral airflow resistance values. Probably respirologists have
obtained falsely low oral resistance values using mouthpieces. The opening
of the lips and the position of the tongue against the palate will influence
airflow obstruction. If nasal airflow increases there is more turbulent flow
with exponential increase in airflow resistance41.
The lower airways
The diameter of the lower airways is caused by a balance of forces distend-
ing and forces narrowing the airway.
Narrowing forces are bronchial smooth muscle contraction, mediated by
efferent autonomic nerve control. Sympathetic impulses relax, parasympa-
thetic impulses constrict these muscles. Constriction can also develop as a
reflex caused by irritants (dust, smoke, cold), hyperventilation, embolisation
of vessels and some vaso-active agents (acetylcholine, histamine, bradyki-
nine). Airways dilation may occur as a reflex to increased blood pressure
(baroreceptors in carotid sinus) and sympathomimetic agents (epinephrine,
isoproterenol).
Airway resistance is lung volume dependent and increases when lung vol-
ume decreases from functional residual volume (FRC) and approaches
infinity at residual volume. It is especially the decrease in lung elastic recoil
that is responsible for this increase. This recoil provides a tethering effect
tending to increase airway diameter. Thus older children with bigger lungs
have increased elastic recoil and thereby lower airway resistance. That’s
why the measurement of airway resistance and it’s reciprocal airway con-
ductance are normally corrected for lung volume. The resultant is the spe-
cific airway resistance (sRaw) or conductance (sGaw), which is remarkably
constant regardless of age or height.
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An extra narrowing force to airways exists during forced expiration, when
there is dynamic airway compression caused by pleural and peribronchial
pressures. This effect is counteracted by the intraluminal pressure and the
tethering action of the surrounding lung (Figure 3)
Small airways
The contribution of small airways (< 2 mm diameter) to total resistance in
adults is only some 20%, caused by the very vast number of small peripheral
airways, providing a large cross sectional area for flow. That is why small
airway disease may severely impair ventilation of distal air spaces but go
undetected by total airway resistance measurement. However, in children
small peripheral airways may contribute up to 50% of the total airway resis-
tance. This proportion does not decrease until about 5 years of age. This
increases the value of resistance measurements in small children, who can
be severely affected by small airway diseases (e.g. bronchiolitis).
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"Tethering"/intraluminal pressure
Dynamic
compression EPP:Pin=Pex
Figure 3. The relation of pressures
in- and expanding the airway
lumen. Pin = intraluminal pressure.
Pex = dynamic compression by pleu-
ral and peribronchial pressure. EPP
= equal pressure point
3. The influence of growth and development on airway
mechanics
Developmental anatomy and physiology of the respiratory system
The respiratory system is in a continuous process of development from
early embryonic stages to young adulthood. As with height and weight,
children show a constant and rapid growth of lung volume and lung func-
tion parameters. This growth however shows a wide variety within and
between individuals. Therefore normal values of pulmonary function
parameters are often presented as referenced by standing height, sex and
sometimes weight. However also age, arm-span42, body composition, sit-
ting height43 and even ethnicity44 influence lung function parameters.
Some steps in the development of the lung that bear particularly influence
on lung function during (early) childhood and on the pattern of respiratory
disease are discussed below.
Respiratory system development
In humans the lungs begin to form at 21-24 days of gestation as a bud of the
primitive foregut45. During the first, i.e. pseudoglandular phase this process
evolves rapidly resulting in complete formation of all the airways through
the terminal bronchioles by week 16 of gestation. This branching process of
the airways is more or less dichotomous. Only then the first gas-exchanging
units are formed (canalicular phase). From 26 weeks, during the final or
alveolar (or terminal sac) phase lungs prepare for gas exchange by formation
and growth of type II pneumocytes, secreting surfactant. About 50 million
alveoli are present at birth in a term infant. After birth new alveolar forma-
tion is thought to continue especially until 2, but probably even until 7
years of age46. At this stage the number of alveoli has increased to about 300
million. From then alveoli only grow by enlargement.
Airways continue to grow in length and diameter with remodelling of the
peripheral airways from week 16 of gestation, but do not increase in num-
ber47-49.
Postnatal growth of the airways has been studied in only a limited number
of anatomic investigations. One study describes the infant’s airway as a
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miniature of the adult one48, but another study suggests that peripheral air-
ways increase in size relative to the central airways after the fifth year of
life50.
Smooth muscle is present in the airways of the foetus early in development
and extends from the trachea to the alveolar ducts in newborns as in
adults51-53. Smooth muscle content appears to remain relatively constant in
airways of a given generation and mechanisms controlling airway tone in
the neonate are comparable to the adult54. Cartilage is present in the
bronchi at about 25 weeks of gestation and its distribution is similar to that
of adults47. Increased cartilage develops in the first years of life, thereby
contributing to the stiffening of the airways observed in the first months of
postnatal life55,56.
Although collagen and elastin are important in airway morphogenesis and
branching, the interstitium of the human lung contains little collagen and
elastin during late gestation and at birth. From birth elastin and collagen
formation increase. The changing ratio of elastin and collagen probably
contributes to the change in volume-pressure relationships in the develop-
ing lung. However little is known about the organisation and development
of these tissues at various stages of lung growth and in various regions of the
lung57.
Considerable structural changes occur in the chest wall, particularly during
early postnatal life. The ribs, oriented in a horizontal plane, slant in a pro-
gressively caudal direction to the downward slope seen in adults58. Also the
ossification of ribs, sternum and vertebrae and muscle mass development
contribute to changing volume pressure relationships during childhood.
In adults, the functional residual capacity (FRC) is mainly set passively by
the balance between elastic recoil of the lungs and chest wall. However in
newborns the high compliance of the chest wall would cause nearly com-
plete collapse of the lungs, if not actively counteracted by glottic narrowing
or interruption by the onset of inspiration. Probably, the major function of
the Hering Breuer reflex in young children might be the termination of the
expiratory process before lung volume gets too small. Once the chest wall
has become stiff enough to counteract elastic recoil of the lungs, this reflex
is reduced and may disappear from the age of 1 year59. Then passive charac-
teristics appear to determine end-expiratory lung volumes60. The easy col-
lapsibility of the rib cage is advantageous in utero to prevent pleural
effusion and during birth, when it allows deformation of the chest during
passage of the birth canal and expulsion of fluid before the first breath. After
birth it diminishes metabolic demands but a decrease in collapsibility is nec-
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essary to decrease the need for outward recoil of the lung, necessary to
maintain lung volume.
Respiratory function development
It may not be surprising that the remarkable change of respiratory structures
also has significant functional implications. Lung volume and volume-pres-
sure relationships (e.g. pulmonary compliance) reflect parenchymal (air
space) development, and airflows and pressure-flow relationships (resistanc-
es and conductances) reflect airway development. But the relationships are
not as direct as they might seem.
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Figure 4. Deflation volume-pressure curves of the lung at different ages (obtained from studies on excised
lungs61. With increasing age up to young adulthood the curves become straighter and at a given lung volume
elastic recoil pressure is greater. The curve from elderly subjects resembles that from a 7 year old.
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Pulmonary compliance depends on the number of air spaces expanded, the
size and geometry of the air spaces, the characteristics of the surface lining
layer and the properties of the lung parenchyma that change with growth
and maturation. This is represented by changes in the shape of the volume-
pressure curve. These curves, when normalised by expressing volumes as
the percentage of the maximal observed lung volume, are more curvilinear
in infants than in older children (Figure 4).
This reflects immature air spaces rather than mature alveoli and probably
the differences in elastin-collagen ratio with age61. The lung volume at
which airway closure occurs is higher in younger children (7 years) and eld-
erly adults than in older children and younger adults62. In infants higher
collapsibility is illustrated by atelectasis in dependent regions.
The configuration of the relationship of maximal expiratory flow and lung
volume (maximal expiratory flow-volume (MEFV) curve) is similar in the
child and in the elderly; in both age groups there is alinearity of F-V curves
compared to younger adults, compatible with decreased elastic recoil63.
Pressure-volume relationships of the total respiratory system show compa-
rable developments as those of the lung in young children in that they are
more curvilinear in infants64. However in 2-16 year children the shape of
these curves is constant. This means that there is a constant relationship
between the increasing elastic recoil of the lung and the increasing recoil of
the chest wall. Overall the total respiratory system becomes stiffer with
increasing age, especially in children under 5 years of age.
Chest wall compliance corrected for body (i.e. also lung) size is 50% greater
in infants under 1 year compared to infants over 1 year of age. In infants
chest wall compliance is threefold greater than lung compliance but in
older children and adults these values are virtually equal.
The changes in resistance of airways, lungs and total respiratory system are
substantially but also variably influenced by the upper airway resistance,
notably from the glottis. Although in adults this may comprise over 50% of
measured resistance, studies by Hogg et al, who partitioned airway resist-
ance by means of a retrograde catheter technique into central and peripher-
al components, showed that in children up to 5 years of age the
contribution of peripheral airways to respiratory resistance is greater than in
adults50. This increases the usefulness of resistance measurements in chil-
dren, especially during small airway disease. On the other hand it diminish-
es the usability of this parameter to reflect changes during development of
normal subjects. This also affirms that the infant’s tracheobronchial tree is
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not simply a miniature of the adult one48, but that the contribution of
peripheral airways to the total changes with age.
Data on compliance and resistance collected in children 3 weeks to 15 years
of age support the relatively greater increase in lung parenchymal growth
relative to airway growth throughout childhood65.
Although the increase in total alveolar content increases the absolute com-
pliance, the changes in shape of the volume pressure curve suggests that to
some extent maturation makes the lung relatively stiffer. Indeed with
increase of parenchymal volume relative to airways, there is a decrease in
specific conductance and rate of lung emptying.
In daily practice, however, individual variability in airway size and lung
volume are probably more important indicators of lung disease than matu-
rational changes. Some studies found indications of inter-individual differ-
ences in the interaction between parenchyma and airway growth66,67,
which is presumably genetically determined. There is increasing epidemio-
logical evidence that diseases in early childhood, e.g. wheezing with lower
respiratory infections, is linked to physiologic indicators of lung and airway
size, already established in early infancy68-70.
4. Techniques for the measurement of resistance in 
spontaneously breathing young children
It is important to realise that several measures or resistance are used in daily
practice. Several techniques measure different kinds of resistance, that are
not completely interchangeable. Specific techniques have been developed
for measurement of Raw, total pulmonary resistance (Rtot = RL + Raw) and
active or passive respiratory system resistance (Rrs = Raw + RL + Rcw)
(Table 1).
During measurement of resistance, pressure is measured at the two endings
of an open tube, in case of the lungs at the mouth and at the alveoli and
corresponding flow is recorded. Measurement of alveolar pressure is diffi-
cult. With most techniques pressure and flow are measured at the mouth
and alveolar pressure can be measured at the mouth after airway occlusion
when equilibration of alveolar and mouth pressure occurs.
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A. Respiratory system resistance (Rrs) 
Respiratory system resistance (Rrs) can be measured, using active and pas-
sive techniques
1. Active measurement: active breathing against occlusion
Measurements of active Rrs can be performed in infants during quiet
breathing under sedation or spontaneous sleep. Simultaneously airway pres-
sure, volume and air flow are measured. After a normal breath the airway is
occluded at end expiration. During the following occluded inspiratory
effort, repetitive measurements of pressure can be related to flow and vol-
ume measured during the preceding breath. From these relations elastance
E, compliance C (i.e. 1/E) and resistance Rrs can be calculated. Inspiratory
resistance measured in this way represents about 70% of expiratory resist-
ance during infancy71.
2. Passive measurements: airway occlusion, oscillation and interrupter
techniques
2.a. The airway occlusion technique
The basis of the airway occlusion technique is that after airway occlusion at
end-inspiration the Hering Breuer reflex causes apnoea, both inspiratory
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Table 1. Measurement of resistance in humans. Techniques that are possible in spon-
taneously breathing pre-school children are presented in bold, techniques possible in
infants in italics.
Respiratory system resistance Total pulmonary resistance Airway resistance 
(Rrs= RL + Raw + Rcw) (Rtot = RL + Raw) (Raw)
Active breathing against occlusion Intra-oesophageal balloon Body plethysmography
Airway occlusion technique
Forced oscillation technique (FOT)
Impulse oscillation technique (IOS)
Interrupter technique
and expiratory respiratory muscles relax and a passive expiratory flow-vol-
ume curve can be analysed after release of the occlusion72.
Also in children and adults changes in the mechanical properties of the
lungs and thorax can be demonstrated by the measurement upon purely
passive expiration curves. This, however is only possible under complete
apnoea, inflating the lung to a known alveolar pressure and than permitting
deflation by elastic recoil only. During this expiration the pressure of recoil
is approximately proportional to lung volume added to FRC. Flow will
only be retarded by frictional resistance, lung tissue resistance to movement
and the pressure required to overcome inertia. Flow decreases with time
during expiration. Inertia is negligible9.
In the single breath occlusion technique (Figure 5), the airway is occluded
at end inspiration, with the subsequent expiration occurring passively. A
passive expiratory flow volume curve is then constructed. The slope of the
linear part of the passive flow volume curve is equal to the reciprocal of the
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Figure 5. Calculation of the respiratory compliance (Crs) and resistance (Rrs) using the single breath occlusion
technique. Paoocc airway opening pressure following occlusion; Pao pressure at the airway opening; τrs expira-
tory time constant.
Volume above FRC
Time
Time
Crs = total exhaled volume/ PaooccTotal exhaled volume
Volume
Volume
FRC
Pao
V’ Rrs =τrs/CrsSlope = l/τrs
Paoocc 
time constant of the respiratory system (τrs) during expiration. Respiratory
system resistance (Rrs) can be calculated by dividing τrs by Crs.
In the multiple breath occlusion technique (Figure 6) pressure is measured
at the mouth during brief airway occlusions performed on multiple breaths,
at different volumes above FRC and the individual measurements are plot-
ted as volume vs. pressure. The slope of the line of “best fit” is the compli-
ance of the respiratory system.
2.b. Oscillation techniques
2.b.1. Forced oscillation technique (FOT)
Total pulmonary resistance can be measured in infants and children by the
forced oscillation technique. This measurement includes tissue viscous
resistance of lungs and chest wall. A sinusoidal pressure applied at the upper
airways changes the airflow and resistance can be calculated. When the
forced oscillations are applied at the so-called resonance frequency of the
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Figure 6. Calculation of compliance of the respiratory system using the multiple-breath occlusion technique.
Vocc volume at which occlusion is made, P pressure, Pao pressure at the airway opening, Crs compliance of the
respiratory system.
Slope =Vocc/Pao=Crs
Vocc (volume above FRC)
Volume 
Time
FRC
Time
Pao
Vocc V1 V2 V3 
V1 
V2 
V3 
P1 P2 P3 
P1 Pao P2 P3 
lung (5-7 Hz in children73), it is assumed that the force, required to over-
come elastic resistance of the lung and the force required to overcome iner-
tia are equal and opposite.
The forced oscillation technique (FOT) was introduced by Dubois et al74,
to characterise respiratory impedance (Zrs) and its two components reac-
tance (Xrs) and resistance (Rrs) over a wide range of frequencies
75.
The general set up of the oscillation system is shown in figure 7. Flow
oscillations, generated by means of a loud speaker are applied at the sub-
ject’s mouth and superimposed on normal breathing (Figure 8). A large
bore impedance tube directs the oscillations to the patient without offering
any resistance to spontaneous breathing. Fresh air bias flow prevents
rebreathing of the expirate.
The driving pressure, either sinusoidal (single frequency) or composite
(multiple frequencies), results in flow oscillations, the magnitude and phase
of which are determined by the resistive, elastic and inertial properties of
the respiratory system (Figure 9). The resulting pressure and flow signals are
recorded at the mouth using a pressure transducer and a pneumotachome-
ter and analysed. These signals are, in general, waveforms containing several
frequencies. For each of these frequencies, the ratio of pressure to flow can
be considered (i.e. the impedance), which is a complex number of the
magnitude of pressure to flow and about the phase shift between these sig-
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Figure 7. General set up of oscillation system.
Fresh air bias flow
Loudspeaker Pneumotachometer
Impedance tube Pressure transducer
nals. Most often this complex number is represented by its real part, the res-
piratory resistance (Rrs) and its imaginary part, the respiratory reactance
(Xrs)
76-79.
With the random noise or pseudo random noise method oscillations of dif-
ferent frequencies are analysed and frequency dependency of resistance and
reactance can be found76,80. Microprocessor techniques allow analysis of the
complex signals by Fourier transformation80-82.
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Figure 8. General principle of FOT and IOS. A wave form pressure signal causes flow changes superimposed
on the tidal breathing pattern
Figure 9. A sinusoidal pressure wave causes a flow wave that is analysed using Fourier analysis. From the
relationship of pressure and flow changes resistance (R) and reactance (X) can be calculated.
Time
Flow
Pressure and Flow
R
X
Time
In children and obstructive patients the resistance is frequency dependent,
with higher Rrs at lower frequencies. The fact that during inspiration the
vocal cords are more open than during expiration33 makes measurements,
obtained during inspiration more appropriate. From clinical studies it appears
that Rrs at low frequencies allows the best discrimination between healthy
subjects and various obstructive conditions83. Xrs is mainly determined by
the elastic and mass-inertial properties of the airways, lung tissue and chest
wall. At low frequencies the elastic properties dominate (negative Xrs), at
higher frequencies the mass-inertial forces take over (positive Xrs). The fre-
quency at which Xrs crosses zero is called the resonance frequency (RF). In
obstructive airway disease Xrs deviates to more negative values83,84 and
therefore the RF will be reached at higher frequencies. Both the Xrs and RF
are useful indices in establishing positive reactions to provocation tests.
The estimation of Rrs and Xrs can be made in several ways but , in principle
the two are determined by the amplitude and the phase of mouth pressure
and flow at a given frequency. In the multiple frequency technique the use
of Fourier transformation algorithm enables the assessment of the frequency
dependency of Rrs.
2.b.2. The impulse oscillation technique (IOS)
An alternative method for FOT uses an impulse oscillation system (IOS, 5-
35 Hz)3,85. In this technique an impulse (a rectangular wave form), rather
than a pseudorandom noise signal (a mixture of several sinusoidal wave
forms) is applied by a loud speaker. Also the data processing and analysis
(the so called Fourier analysis) is different.
There are recommendations for measurement of respiratory input imped-
ance by means of forced oscillations but the IOS technique has not been
standardised against the recommendations stated in this publication86.
2.c The interrupter technique (Rint)
The interrupter technique is a non-invasive method to measure airflow
resistance87. It was first described by Von Neergaard and Wirz in 192788.
During sudden occlusion of the airway pressure changes at the mouth. The
interrupter technique is based on the premise that, during this transient
interruption of the tidal airflow, alveolar pressure and mouth pressure
equilibrate within a few milliseconds. The alveolar pressure can therefore
be derived from the measurement at the mouth immediately after interrup-
tion. If the flow is measured immediately prior to interruption, the ratio of
flow to pressure changes gives the interrupter resistance (Rint). Difficulties
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in interpreting the post-occlusion pressure tracing has delayed the further
introduction of this technique and until recently the interrupter technique
has never been widely accepted as a clinical tool. Also other technical con-
siderations (e.g. the discussion if post-occlusion flows instead of pre-occlu-
sion flows should be used) have delayed general acceptance. However,
recent studies have unravelled the factors which influence the post-occlu-
sion mouth pressure tracing and the physiologic basis of this technique89-93.
Also the introduction of a small portable device to measure interrupter
resistance has caused a revival of the interrupter method technique94.
When the airway is occluded at the mouth airflow ceases and there is an
initial large and rapid increase in mouth pressure succeeded by a smaller and
more gradual one (Figure 10). Approximately 5 msec after actuation of the
valve, closure is complete94. The initial change in flow is caused by the
rapid equilibration of alveolar and mouth pressure. This is due primarily to
mouth pressure jumping to meet pre-occlusion alveolar pressure. However
alveolar pressure changes immediately after occlusion due to transference of
chest wall pressure90. In paralysed subjects the second pressure change is
caused by stress relaxation of the lung tissue and chest wall. If this is the case
in awake spontaneously breathing humans is not known but the influence
of respiratory muscles is probably less during expiration compared to inspi-
ration. However, other authors suggested the use of inspiratory values to
minimise the influence of glottic aperture33.
During brief interruption of airflow the estimate of mouth pressure (Pmo)
is more influenced by glottic resistance during expiration than during inspi-
ration33.
The time course of the post-occlusion pressure tracing is influenced by the
compliance of the upper airways (especially cheeks) and gas in the lungs,
the resistance of the airways and the inertia of the system95-97.
Both increased airway resistance and upper airway compliance prolong the
equilibration time from about 40 msec in normals up to >100 msec. Most
devices use interruption times of 100 msec. Only after 150-250 msec active
breathing against the occluded valve occurs. Back-extrapolation of the
post-occlusion pressure tracing to the time of valve closing is considered by
most authors to be the best method to approximate the resistive pressure
drop across the airways at the time of interruption90,92,98,99. For this the
pressure trace between 40 and 80 msec87 or 30 and 70 msec94 are advised
(Figure 10). This is late enough to allow equilibration of mouth and alveo-
lar pressure in most patients and early enough to prevent active breathing
against the valve.
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B. Total pulmonary resistance(Rtot)
Oesophageal balloon
Before the introduction of the bodyplethysmograph in 1956 total lung
resistance measurement was only performed in specialised centres, using
oesophageal balloons to measure transpulmonary pressure. Rtot can be
measured by placement of an intra-oesophageal balloon or catheter.
Oesophageal pressure is related to flow changes at midtidal lung volumes.
A balloon is positioned in the distal part of the oesophagus. During tidal
breathing pressure and volume changes can be measured and from these
compliance and resistance can be calculated. This technique is of course not
useful in general practice, but is frequently used in animal studies.
It is assumed that elastic forces are equal but opposite at points of equal vol-
ume during inspiration and expiration. Rtp is conventionally calculated at
the midtidal volume points during inspiration and expiration by dividing
differences in oesophageal pressure at those points by the corresponding
absolute difference between the in- and expiratory flow (Figure 11).
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Figure 10. Interrupter resistance. During tidal breathing short interruption of airflow (V’) causes changes in
respiratory system pressure that can be measured at the mouth (Pmo). Pint is computed by back-extrapolating a
line drawn through two points, centered at 30 and 70 msec (which are blocked averages of pressure during 10
ms) to the point at 15 msec from start of occlusion (t = 0)94
V’
Pint
Pmo
Time (ms)
C. Airway resistance (Raw)
Bodyplethysmography
Airway resistance (Raw) in both adults and older children is most common-
ly measured using body plethysmography. The method is based on the
assumption that when a shutter occludes the tube airflow ceases and the
mouth pressure equilibrates to alveolar pressure. At BTPS conditions Raw
can be determined from the difference between alveolar pressure (Palv) and
airway opening pressure (Pao), divided by airflow (V’).
A sitting person in an airtight box breathes spontaneously through a tube
connected to a pneumotachometer, measuring airflow (V’) and plethysmo-
graphic pressure (Pbox). Simultaneous changes in V’ and Pbox are recorded
on an x-y oscilloscope and the slope of this relationship is recorded
(V’/Pbox). After occlusion of the airway changes in volume (recorded from
Pbox) and mouth pressure (Pm, which reflects Palv) are monitored.
Provided that the ratio of lung volume to plethysmographic gas volume
remains constant, the Palv corresponding to a given Pbox remains constant
whether or not flow is interrupted. Thus derivation of Raw is obtained by
dividing the slope of Pm/Pbox by the slope of V’/Pbox:
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Figure 11. A method for calculating dynamic total pulmonary resistance (Rtot). Rtot is calculated by dividing
changes in elastic oesophageal pressure Poes by flow V’ obtained between two isovolume points during inspira-
tion and expiration
P (cm H2)
dPoes
dV’
Midtidal volume
Rtot = dPoes/dV’
1 sec
V’ (ml/sec)
V (ml)
Raw = dPalv/V’ = dPm/V’ = (dPm/dPbox)/V’/dPbox)
Higher lung volumes show lower resistance. Because this technique meas-
ures resistance and volume simultaneously resistance can be related to lung
volume and specific airway resistance (sRaw) or its reciprocal conductance
(sGaw) can be calculated. Airway conductance (Gaw) is linearly correlated to
lung volume (sGaw=Gaw/FRC) and is therefore regularly determined in
older children and adults (Figure 12).
Plethysmographic measurements of resistance are dependent on the
assumption that pleural pressures are homogeneously applied to all lung
fields. If not, the Pmo does not reflect Palv.
The plethysmograph is recording volume changes of intrathoracic gas. In a
closed system pressure changes in the airways caused by in- and expiratory
movements lead to volume changes in the airways.
Compared to spontaneous breathing during panting higher frequencies and
higher flows are applied. Both methods gave similar values in healthy sub-
jects100, but in patients with obstructive airway disease higher values were
found during spontaneous breathing. However other investigators found
slightly increased values during panting101. During panting the glottis will
open (decreased resistance), there may be turbulent flow during panting in
obstructive patients (increased resistance) and there is higher breathing fre-
quency (lower resistance). The total sum of these factors will determine if
resistance during panting is higher or lower.
Important issues in the interpretation of airway resistance measured by body
plethysmography are:
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Figure 12. The relationship of airway conductance (Gaw) and resistance (Raw) with lung volume (v).
Gaw
V V
Raw
1. This Raw represents especially resistance of extrathoracic and central
airways and hardly peripheral airways.
2. Panting is especially difficult for children and the closing of the flow
pressure loop performed to calculate resistance impairs the reliability
of results.
3. Laminar versus turbulent flow at different lung volumes impairs the
applicability of this technique in patients with high airway resistance.
4. The difference between inspiratory and expiratory flow pressure
curves impairs reliability of this technique. Especially in patients with
high airway resistance the expiratory loop is irregular.
5. Feasibility of different techniques to measure airway 
mechanics in children
During pulmonary function measurement in young children no active co-
operation nor co-ordination may be expected. Also only testing during
spontaneous breathing allows for application of the technique in all day
practice. The minimal age above which these measurements are possible
depends especially on the ability to passive co-operation. This may vary in
individual children.
Obtaining lung function measurements in young children presents a great
challenge and very rarely produces reliable results when conventional
methods are used. That’s why all possible disturbances that influence relia-
bility should be kept to a minimum. Co-operation of the children can only
be optimal, not perfect. Instruction to the child has to be made as simple as
possible in a positive encouraging atmosphere, because real passive co-
operation is essential for reliable and reproducible measurements. The child
is sitting upright and, if possible, a mouthpiece and nose clip are used. Only
in the smallest children tight fitting face masks should be used.
Several studies evaluated applicability of pulmonary function tests in young
children. A summary of these studies is presented, together with important
technical considerations.
38
Rrs measurements
1. Active measurement
This technique has only been applied in infants, not in older children. In
adults it was only studied under halothane anaesthesia
2. Passive measurement
2.a. Airway occlusion technique
This technique depends on the Hering Breuer reflex. Therefore it is possi-
ble in infants but very difficult in older children who lack this reflex and
will normally react to airway occlusion with active counteracting by trying
to “blow away the occlusion”. Considerable training is needed for older
children to relax their respiratory muscles, in order to obtain quasi static
pressure volume curves.
These methods are only applicable when a linear expiratory flow-volume rela-
tion is obtained, i.e. when τrs is constant. In obstructed airway disease curvi-
linear flow-volume relations demonstrate significant heterogeneity of τrs. In
these children the interpretation of results is hampered if not impossible.
2.b. Oscillation techniques
This method can be used in children from 3 yrs of age onwards3,75,102. The
use of forced oscillation in children has been limited by some practical
problems encountered when applying this technique and by the lack of
user-friendly commercially available equipment. Major technical problems
are caused by the interference of applied oscillations with spontaneous
breathing, by air leak around the mask or mouthpiece and by upper airway
compliance. The breathing frequency causes loss of coherence from the
forcing function, which means that no useful data are obtained at frequen-
cies below 4 Hz. Air leak results in overestimation of resistance because
mouthpiece or masks acts as an extra resistance parallel with the respiratory
system. This air leak occurs especially in obstructed patients. Compliance of
the upper airways acts as a shunt compliance in parallel with the respiratory
system. Especially at higher frequencies this causes shunting of the applied
forces and overestimation of resistance and underestimation of inertance
(higher resonance frequency). Here again airway obstruction increases this
confounding. The cheeks and floor of the mouth should be supported by
an assistant, but variation in this support will enable variable results.
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In infants the usefulness of this technique is further reduced by the fact that
there is considerable variation of Raw during the respiratory cycle and there
is no international standardisation of the technique as is in older children
and adults, in whom measurements are standardised to a flow rate of 0,5
L/sec.
Therefore it is not unexpected that Phagoo et al, but also other investiga-
tors, found that the forced oscillation technique is a rather unreliable
method to find bronchial responsiveness to challenge with methacholine.
This method combines great baseline variability with low sensitivity and
unsustained increase in Rrs with rising obstruction
4,103-106. This is especially
caused by the need to breath against the oscillating column of air, the
mandatory length of quiet breathing, consistent breathing required to
obtain a measurement and the importance of maintaining a consistently
patent upper airway.
2.c. Interrupter technique
Feasibility studies were performed recently and reported in several publica-
tions. Our study on feasibility is discussed in chapter 6 of this thesis. The
resistance measurements obtained in awake spontaneously breathing chil-
dren are only a gross approximation of airway resistance. There are many
variables that can affect the final value obtained with the interrupter tech-
nique, e.g. air leak around mask or mouth piece, compliance of the cheeks,
airflow rate at interruption, lung volume at the time of interruption, the
time and point in the respiratory cycle of flow interruption, the type of
interrupter device and especially criteria for selecting and back-extrapolat-
ing the post-occlusion pressure tracing to the time of valve closing. The
ideal interrupter device should have a solid state piezoresistive pressure
transducer. Shutter closure must be as rapid as possible to prevent air leak
during closure107. Most young children prefer the face mask108. Dead space
of the device should be as small as possible and the compliance of the upper
airways must be minimised by applying gentle support to the cheeks. This
decreases equilibration time significantly. The effect of uncontrolled tongue
position and mouth movements, variation in glottic aperture, head or neck
movements should be prevented as much as possible.
After comparison of several different ways of back extrapolation of post-
occlusion mouth pressure tracings, a linear back extrapolation was the least
variable and most sensitive in children and is recommended for standard
use103 although a comparable study by the same authors in adults showed
that a smooth curvilinear back extrapolation was the most sensitive in
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adults109. Also the number of interruptions averaged, the criteria for reject-
ing individual post-occlusion pressure curves and software used for analysis
are not yet standardised. It should be possible to define the precise flow at
which valve closure occurs. There is hardly any quality control for inter-
rupter devices. There should be a possibility to store and display pressure
and flow curves. Acceptance criteria for these curves should be defined and
standardised.
Carter stated in 1997 that, after standardisation, evaluation of normal values,
reproducibility and standard differences we will really know the Rint its
ultimate clinical potentials110. Technical considerations as mentioned above
and the moment of airway occlusion in the respiratory cycle were recently
studied by an ERS working group. Only after standardisation of these fac-
tors application in daily practice can be advised.
A studie by Sly et al. showed the applicability in infants111. Several studies
have evaluated the applicability in (pre) school children85,112-114. In 3-12
year old children, both normal and diseased, the technique proved to be
applicable87. Both children and parents prefer this technique to the forced
expiration technique. Changes in airway obstruction could be assessed,
caused both by disease and by pharmaceutical intervention85,112-115.
Feasibility defined as the ability to complete two measurements 15 minutes
apart, before and after bronchodilation was found in 53%, 71% and 91% of
2, 3 and 4 year old wheezy children respectively. The total session took
about 25 minutes112. The same authors also found that inter observer vari-
ability was rather low, indicating that training of the pulmonary function
technician should not be difficult.
Merkus et al. found no problems in applying the interrupter technique in
school children with asthma and CF116.
Phagoo applied the technique without problems in 3 year old children after
some practice117, but in infants with a history of wheeze Chavasse et al.
could only apply the technique in 15 out of 26 patients, partly because of
low flows that failed to trigger the interrupter valve118.
Total pulmonary resistance (Rtot)
Oesophageal balloon
For the measurement of pulmonary resistance using oesophageal balloons
subjects should voluntarily undergo balloon introduction through nose and
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throat. Active co-operation is required unless the procedure is performed
under anaesthesia. These premises do not allow wide spread use of the
technique, especially not in children. Therefore this technique is not used
in daily practice
Airway resistance (Raw)
Bodyplethysmography
Body plethysmography is routinely possible in most pulmonary function
laboratories. This method requires a complex equipment and is time con-
suming119. The specific technical requirements and the expensive equip-
ment limit the use of this technique to specialised laboratories. This
technique can be used in younger children but requires sedation. Recently
bodyplethysmographic measurements were also applied and validated in
children accompanied by an adult during bodybox measurements120.
Nowadays, after many years of clinical experience this technique has been
technically adapted, so that the actual measurement has become relatively
easy for the pulmonary function technician.
Bodyplethysmography has several limitations when applied in young chil-
dren. Young children have a tendency not to blow against a closed valve,
restricting volume measurement and thereby resulting in unreliable meas-
urements with increased intra-individual variability121.
6. Reference values
Respiratory system resistance (Rrs)
1. Active measurements
This approach has only been applied to infants. The mean (+SD)value of
Rrs in a group of healthy neonates averaged 45 + 21.6 cm H2O/(L/s).
These values are comparable to the estimated passive inspiratory Rrs in the
same infants122.
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2. Passive measurements
2.a. Airway occlusion technique
The mean (+SD) values of Rrs reported in a group of healthy newborns
amounted to 58,7 + 27,0 cm H2O/(L/s) (121). It is assumed that inspiratory
resistance represents approximately 70% of expiratory resistance during
infancy71.
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Table 2. Reference values of Raw and Rrs. 
Technique Ref. sex age Regression equation r
plethysmography 122 M/F 4-18 Raw = 1,660-8,772. 10
-3.H -0,8
sGaw = 2,029
121 M/F 3-17 Raw = 5,15
e-0,01473.H -0,7
sGaw = 1,0
124 M/F 0-5 sRaw = (68,205 + 4,109.H). 10
-3
oscillometry 125 M/F 3-17 Rrs = 10
0,868-0,0089.H
126 M/F 3-14 LogRrs4,9 = 2,42-1,27.H* -0,74
127 M Rrs3-10 = 6,79x10
3.H-1,93 -0,9
F Rrs3-10 = 2,22x10
5.H-2,17 -0,9
127 M/F 2-18 LogRrs4 = 1,053 - 2,18logH* 
LogRrs12 = 0,997 - 1,97logH*
128 M/F 2-16 Rrs6 = 9,2s.H*
2-34,1.H*+35,2 
129 M/F 3-18 Rrs = 13,92-0,0635.H -0,89
130,131 M/F 2,25-12,5 For abundant equation see references
132 M/F 3-17 LogRrs8 = 11,122-2,759logS -0,84
M/F 3-17 LogRrs12 = 10,380 - 2,608logS -0,83
M/F 3-17 LogRrs12 = 6,221 - 1,547 log S - 0,040A -0,84
M/F 3-17 LogRrs16 = 8,867 - 2,278logS -0,81
M/F 3-17 LogRrs8 = 110,990-2,370logH -0,82
M/F 3-17 LogRrs12 = 10,357 - 2,259logH -0,84
M/F 3-17 LogRrs12 = 6,225 - 1,349 logH – 0,040A -0,85
M/F 3-17 LogRrs16 = 8,705 – 1,945 log H -0,81
Rrsx = kPa/L/s, measured at frequency x; Raw = kPa/L/s; sGaw =1/(kPa.s); sRaw = kPa.s, H =
standing height in cm; H* = standing height in m; S = sitting height in cm; A = age in years.
No normal values for older children are available. In adulthood, as in
infants, similarity between active and passive measurements exists.
2.b. Oscillation techniques and body plethysmography
Several authors have studied FOT and IOS parameters in healthy subjects.
Most authors use regression equations for resistance versus height (Table 2).
Ducharme among others found that height is the best predictor for total
respiratory resistance in children at 8, 12 and 16 Hz131. Because standing
height is easier measured than sitting height and the latter does not add any-
thing extra, standing height should be considered as the main predictor. In-
and expiratory Rrs have been shown to be equal
133. Rrs decreases with
growth127.
2.c. Interrupter technique
Until recently no reference values were reported in literature for Rint.
Reference values are subject of chapter 6 of this thesis. In this chapter other
recent publications of reference values are discussed.
Reference values have only recently been established for specific age
groups. The range is wide and therefore a single measurement in any indi-
vidual is of limited value.
McKenzie et al presented reference values based on measurements in 48
healthy pre-school children. For the age group 2-5 years they found:
logRint = -0.078 x age(yrs) + 0.24. Because height did not better predict
Rint the authors preferred age, which is simpler to determine115.
Klug and Bisgaard presented reference data for 2-7 year old healthy chil-
dren, using a face mask113. Merkus presented reference values in pre school
children using a mouth piece134. Lombardi et al presented reference values
in pre school children135. They used a card board mouth piece and nose
clip, valve closure occurred at peak expiratory and peak inspiratory flow,
but they did not support the cheeks. Although the latter is generally accept-
ed as essential to minimise the influence of upper airway compliance using
this technique136, they found no differences between supporting and not
supporting the cheeks. Also in contrast to other studies they found no dif-
ferences between inspiratory and expiratory values. Significant correlations
with age, height and weight were found for inspiratory Rint but only
height was independently correlated with expiratory Rint135.
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Total pulmonary resistance (Rtot)
Using the approach as described earlier Rtot was found to average 21 (SD 4)
to 29 (SD 13 cm H2O/L/sec in healthy newborns71, with similar values
found during the first 2 years. When corrected for lung size the specific
expiratory conductance was reported to be relatively high in newborns
compared to older infants and children137. Conductance values were signif-
icantly linearly correlated with height:
Gtot = 0,000475 x height - 0,0079 (r = 0,937).
(Gtot in L/(cm H2O.sec), height in cms)
However, despite numerous reports of dynamic lung mechanics in healthy
infants and children, none are based on large enough populations of sub-
jects either studied longitudinally or cross sectionally to be considered as
reference values.
Airway resistance (Raw)
Reference values derived from bodyplethysmographic measurements of air-
way resistance are presented in Table 2. Best correlations are found
between Raw and height.
7. Comparison of different techniques
Different techniques to measure resistance consider different aspects of
anatomy and physiology of the respiratory system. Therefore direct and
perfect correlation between individual techniques can not be expected.
Correlations with other measures of pulmonary function such as FEV1 may
be expected to be even worse, because not only other physiology but also
other parameters are concerned. The relation of resistance measurements
with FEV1 is discussed in the next paragraph of this chapter. Here several
techniques for resistance measurement are compared.
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Comparison of oscillation techniques, Rint and body plethysmography
Methodological considerations
With all techniques considering resistance measurement, flow is measured
at the mouth, but the location of pressure measurements varies. With body-
plethysmography the difference between alveolar pressure and mouth pres-
sure is the driving pressure for flow. Thus the measured resistance
represents only airway resistance (Raw).
With the oesophageal balloon the pressure difference between mouth and
pleura is measured. The measured resistance therefore gives the total lung
resistance (Rtot), composed of both airway resistance (Raw) and resistance of
lung tissue (RL) (Rtot = Raw + RL)
Both forced oscillation and interrupter technique measure pressure change
over airways, lungs and chest wall, i.e. they measure the resistance of the
total respiratory system (Rrs) (Rrs = Raw + RL + Rcw). The indices derived
from IOS and FOT are, in principle , comparable81.
Rrs is expected to be higher than Rtot and Raw. Rint and R5 are expected
to be comparable.
Studies comparing values in healthy subjects.
In animal studies values of Rint were higher than those measured with
bodyplethysmography, probably due to a contribution of chest wall rigidity
and the glottis to airway resistance90,138. The latter is reduced by the pan-
ting manoeuvres performed during bodyplethysmography.
Both interrupter and oscillation techniques measure total respiratory system
resistance but the oscillation method can show frequency dependency.
With lower frequencies the tissue deformation factor can be distinguished
and with higher frequencies the gas inertia factor. In healthy persons the
most representative resistance values are found with frequencies around 10
Hz. These values correlate well with those found with the interrupter
method139. Hellinckx et al. found resistance and reactance measured by
IOS similar but not identical to those provided by the FOT140.
Phagoo et al. showed in their study that the method of back extrapolating
post interrupter pressure changes considerately influences the correlation
between Raw and Rint values. When back extrapolation of the post occlu-
sion pressure was performed from 100 msec post occlusion to mid occlu-
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sion pressure, Rint showed good correlation with Raw, with other methods
Rint significantly exceeded Raw measured with bodyplethysmography
109.
Rrs determined by the oscillation technique correlates well with airway
resistance73,81 and with total lung resistance141,142
Rrs measurements reveal significant frequency dependency especially in
young children and in subjects with airway obstruction, probably reflecting
inequality of the distribution of ventilation. In young children this is proba-
bly not an indicator of abnormal airway function, supported by the finding
of frequency dependency in healthy young children130. Klug and Bisgaard
also presented normal values for IOS, Rint and sRaw in 2-7 year old chil-
dren. Mean values of sRaw, Rint, Rrs5, Xrs5 and Zrs in children were 1.09,
1.04, 1.38, -0.5, 1.48 kPa/L/s in the under 5 group and 1.13, 0.9, 1.18, -
0.37 and 1.23 in the over 5 group. Surprisingly the best correlations were
found for all parameters with weight compared to age or height (although
not significant). As could be expected there was no correlation between
sRaw and either age, height or weight. The authors presented linear regres-
sion equations for all techniques113.
Studies comparing values in diseased subjects.
In a recent study evaluating the agreement between Rint and Raw in chil-
dren with asthma and cystic fibrosis (CF) Rint was found to underestimate
Raw, especially in children with severe airway obstruction
143. In these
patients equilibration times are probably longer than 70-80 msec, and in
these patients the extrapolation method underestimates true resistive pres-
sure drop across the airways and thus airflow resistance87. Substantial differ-
ences between Rint and Raw have also been found in individual patients
94.
In obstructed patients longer equilibration times may be required to pre-
vent underestimation of resistance.
In a recent study IOS was validated against the FOT and body plethysmog-
raphy in children. Klug and Bisgaard found good correlations of IOS with
both whole body plethysmography85 and also the correlation with results of
FOT is acceptable144. These results were recently confirmed in adults.
Klug and Bisgaard found that both Rint and IOS techniques revealed
abnormal results in 44% (Rint) and 8% (Rrs5) of asymptomatic asthmatic 2-
5 year old children but the outcome after 1.6 to 4.5 years was unrelated to
baseline pulmonary function. Hence lung function measurement using IOS
or Rint is not helpful in identifying children with a poor prognosis145.
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Studies comparing feasibility.
In a study by Klug and Bisgaard, IOS, Rint and sRaw values could be
obtained in 80% of all children, and almost 100% of children above 5 years
of age113.
Studies comparing reproducibility
Most studies on the reproducibility of different techniques applicable in
(young) children were recently performed in research centres in Great
Britain and Danmark.
In a study in school children Bridge et al. found that the coefficient of vari-
ation (CV) of Rint was 11%, higher than Rrs (9%), FEV1 (5%) and PEF
(5%)146. From the same centre results were presented describing repeatabili-
ty of Rint in 3 year old children with an intra subject CV of 13% (ranging
from 4-35%) compared to 1,6% (0,4-3,2%) for PtcO2117.
In a Danish study in 4-6 year old children reproducibility was much better
for FEV1 (CV =5%) compared to sRaw (CV =13%), Rrs5 (CV = 10%),
Xrs5 (CV = 17%) and Rint (CV = 12%)
3.
In 2-4 year old asthmatics the reproducibility findings were more or less
comparable to the former study: better for Rint (8%), sRaw (9%) and Rrs5
(10%) than for Xrs5 (16%)
85.
The same authors also compared IOS, interrupter technique and whole
body plethysmography in healthy 2-7 year old children and found that the
repeatability was age independent and best for Rint (CV = 8.1%) compared
to Rrs5 (10.2%), Zrs (10.8%) and sRaw (11.1%). For all parameters no signif-
icant sex differences were found and frequency dependency was con-
firmed113.
In a recent study Klug et al. compared within observer and between
observer variability of the interrupter technique (Rint), impulse oscillation
(Rrs5 and Xrs5) and whole body plethysmography (sRaw) in 2-6 year old
children and found that the within subject standard deviation (SD) was not
significantly different in observers but the between observer variability was
greater for Rint than for the other parameters147.
Reproducibility of the oscillation technique has shown to be dependent on
the support of cheeks and mouth floor, is strongly related to the patience of
the investigator and can vary from 5-20%73,78,128,129.
Phagoo et al. compared the interrupter technique with forced oscillation
and transcutaneous oxygen tension (PtcO2) measurement in 5 year old
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asthmatic children during methacholine challenge. The lowest variability
was found for PtcO2 (CV = 1.2%) compared to Rint (12-15%) and Rrs
(12%)103. The CV for inspiratory and expiratory Rint values are similar in
children146.
Bridge and McKenzie evaluated the Rint in expiration and inspiration in
2.5-5 year old children and found that expiratory Rint was significantly
higher (mean 4%), but no significant differences were found for the CV of
inspiratory and expiratory values, nor for bronchodilator response. Mean
and median of 5-10 values contributing to a measurement were similar.
The authors recommend to use the median148.
Of course these findings on reproducibility should be taken into account
when judging changes in the parameters in disease or after interventions of
any kind.
Several confounders that have been discussed before may be responsible for
the relative lack of reproducibility of resistance measurements in general,
e.g. a switch from nasal to oral breathing or vice versa in young children
using a face mask, changes in breathing patterns, respiratory muscle activity,
tongue movements, glottic aperture etc.116.
The use of a face mask with inner mouthpiece versus mouth piece with
nose clip in 4-7 year old children resulted in comparable repeatability (CV
= 11% for both) but in higher Rint values (p = 0.0002). This might be due
to another breathing pattern, more rapidly and with greater tidal volumes.
Maybe also a more turbulent flow in the mask because of a small ridge at
the connection with the mask mouthpiece added to this higher value3.
Studies comparing sensitivity
The sensitivity to detect changes in airway resistance (e.g. after interven-
tion) can be expressed as the sensitivity index (SI):
SI = (R after intervention - baseline R)/ within subject SD of baseline R
or:
SI = (Rpost - Rpre)/ SDRpre
In adults the SI for measurement of the response to bronchial challenge is
significantly smaller for Rint(1.9-3.1) than for Raw (10.5) 
109.
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Bisgaard and Klug found in 21 4-6 years old children that the order of sen-
sitivity of different techniques to assess airway obstruction was Zios > sRaw
> FEV1 > Rint. Parallel changes in all parameters were found but Zios was
significantly more sensitive than FEV1
3. It should be stated that they per-
formed interruptions using a pneumotachometer and they measured mouth
pressure during the last part of interruption during inspiration and measured
flow directly after occlusion. This is another technique than used during
later studies3.
In another study in school children SI was not significantly different for
Rint (3.5), Rrs (3.6), PEF (3.0) and FEV1 (2.4)
146. Phagoo et al found a SI
for Rint of 3 in 3 year old children compared to 16 for PtcO2. They found
better sensitivity for detecting bronchodilator response (SI = 4.9%) than for
detecting induced bronchoconstriction in asthmatic children. In up to half
of the children a significant decrease in PtcO2 was not detected by Rint, in
only 1 of 12 subjects bronchodilation was not found117.
In a recent study Rint was measured to distinguish pre school children with
recurrent wheeze from those with recurrent cough and healthy peers. Rint
was significantly higher in wheezers and coughers did not differ significant-
ly from normals. The bronchodilator response defined as the ratio between
pre bronchodilator Rint and post bronchodilator Rint differed significantly
between all three groups (wheezers 1,40, coughers 1,27 and normals 1,07).
A bronchodilator response of >1,22 had a specificity and sensitivity for
wheeze of 80% and 76% respectively115.
In a study by Klug and Bisgaard Xrs5 was significantly more sensitive to
induced bronchoconstriction than sRaw, FEV1, Rrs5 and Rint. In patients
with subclinical bronchoconstriction after provocation, this subclinical
increase in muscle tone was detected by IOS, Rint and sRaw but not by
FEV1 or PtcO23. In another study the same authors compared IOS and
interrupter technique with body plethysmography in 2-4 year old asthmatic
children at baseline, during bronchoprovocation and after bronchodilation.
In this study the sensitivity was best for sRaw and Xrs5. Both were signifi-
cantly more sensitive than Rint and Rrs5 (4%). Measurements during an
asthma exacerbation yielded comparable results. In the latter study
improvement after bronchodilation was best determined with PtcO285.
Both studies indicate that both Rint and Rrs5 are less useful for determina-
tion of reversible airway obstruction than Xrs5 (unless worse reproducibili-
ty) and sRaw. The usefulness of Xrs5 was supported by results of Buhr et
al149 and Duiverman et al83.
Phagoo et al. compared the interrupter technique with forced oscillation
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and transcutaneous oxygen tension (PtcO2) measurement in 5 year old
asthmatic children during methacholine challenge. PtcO2 was significantly
more sensitive than the other methods to find airway responsiveness (SI =
18.9 compared to 4.2 (Rint) and 4.6 (Rrs)
117. Important possible causes for
the relative lack of sensitivity of Rint are retarded pressure equilibration in
the presence of airway obstruction (underestimation of Rint), inhomogene-
ity of airway patency and extrathoracic airway compliance (underestimation
of Rint). Their conclusion was that because of its simplicity the interrupter
method provides a better method for assessing airway obstruction in this
age group compared to the oscillation method117. Buhr and colleagues
found comparable sensitivities for FOT and sRaw (SI = 8.2 and 12.0 respec-
tively) to detect bronchial responsiveness in school children induced by car-
bachol149. In adults, Rint shows a close correlation to airway resistance
(Raw) measured by whole body plethysmography (r = 0,86). The methods
were equally sensitive in detecting changes in airway resistance following
bronchodilation94.
8. Comparison of resistance measurements with MEFV 
curves
Evaluation of airway calibre can be performed either by measuring airway
resistance during spontaneous breathing or by indices obtained from a
forced expiration. Tests of forced expiration, such as PEF and FEV1 are
widely used especially because of their simplicity and reproducibility.
However there are several disadvantages of forced expiratory manoeuvres.
They require full co-operation and co-ordination of the patient, which can
not be expected from young children. Forced expiration parameters appear
to be less sensitive to changes in airway calibre than are resistance measure-
ments. Also the deep inspiration necessary for these tests is known to influ-
ence bronchial tone119,150,151.
Forced expiration manoeuvres and resistance measurements during tidal
breathing represent different physiologic parameters. Therefore the rela-
tionship between resistance and maximal expiratory flow volume (MEFV)
parameters is expected to be not very significant.
In the first place, it is important to realise that FEV1 is not a measure of air-
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ways resistance but of airway patency. Resistance is especially determined
by the patency of (upper (large)) airways, both intra and extrathoracic.
Maximal expiratory flow is especially influenced by patency of lower
(smaller) airways and also by lung compliance. Lower airway obstructive
disease can present with normal airway resistance and severely reduced
FEV1. Spirometry assesses the combined interaction of lung recoil and air-
way resistance and can not distinguish which of these has caused a specific
change in lung function. That’s why specific measurement of airway resist-
ance is required to assess what change in spirometry is due to changes in
airway resistance, and not to changes in elastance.
Secondly, it should be stated that FEV1 is a useful measure of airway
obstruction, not because it represent a specific physiologic entity, but rather
because it correlates with changes in airway calibre.
Nevertheless comparison of both methods gives significant correlations152,
probably caused by an important common mechanism, namely the airway
obstruction.
In a study by Duiverman et al they found favourable sensitivity of the oscil-
lation technique compared to FEV1 in revealing short term changes in the
bronchial status either during bronchial provocation tests or after adminis-
tration of bronchodilators83.
Mijnsbergen et al. found the correlation of Rint with FEV1 to be some-
what higher in asthmatic than in CF patients (r = -0,74 versus -0,58)152. As
in adults, also in children changes in Rint (and its reciprocal Gint) correlat-
ed with changes in FEV1 and Raw measured by body plethysmography.
The linear correlation of Gint and FEV1 showed a r=0,77 (p,0,001), The
curvilinear correlation of Rint and Raw showed a r=0,91 (p<0,001), but
Rint was higher than Raw
87.
In their study Bridge et al. found significant correlations of interrupter con-
ductance (Gint), the reciprocal of Rint, with FEV1 (r = 0,837, p < 0,001
and peak expiratory flow (PEF) (r = 0,773, p < 0,001), as well as with Rrs
(r = 0,942, p < 0,001)146.
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9. Final considerations
Although the functional evaluation of patients with lower airway obstruc-
tion is probably best performed using FEV1, resistance measurement can be
applied when MEFV measurements are impossible (e.g. infants and pre
school children, geriatric patients, myopathic or mentally retarded patients).
The development of simple and easily available techniques to measure air-
way and respiratory system resistance might open new doors for diagnosis
and follow up of these patient groups76,80,88.
Different techniques measure different aspects of resistance. Only with
bodyplethysmography the measured pressure causes hardly anything else
but flow, so their relationship really gives resistance (only the inertia of gas
should be overcome by alveolar pressure, but this is minimal and can be
denied at breathing frequencies not exceeding 120/min).
Also with the interrupter technique no correction for volume is necessary
because no volume changes occur during this technique, so all pressure is
applied to overcome respiratory system resistance. Interrupter resistance
measurements are considered as only estimations of the resistance of the
total respiratory system. Especially due to confounding variables and arbi-
trary choices that have to be made prior to the calculation of Rint, absolute
Rint values have no general acceptance. With all other techniques only
indirect resistances are measured3,154.
Interrupter and oscillation technique, applied during tidal breathing, are not
very burdensome. Therefore these techniques are suitable in both daily
practice and in a laboratory setting or for research purposes. The availability
of these techniques has come with devices, that are currently tested and
presented by commercial manufacturers. Although this does encourage
more widespread use of these techniques, it does not imply that standardisa-
tion of these techniques has been performed and e.g. reference values and a
good relation to pathophysiology are available.
Several drawbacks of resistance measurements in young children can be
mentioned. The paediatric lung is not a miniature of the adult lung and
developmental changes significantly influence pulmonary function test
results. Especially in infants with airway obstruction, airway occlusion does
probably not lead to even distribution of airway pressure between mouth
and alveoli. This might lead to inaccurate estimation or airway resistance.
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Because specific techniques are only possible at specific ages or in specific
patients (e.g. baby body box, squeeze jacket technique, airway occlusion
technique) follow up studies using the same technique throughout life are
nearly impossible. Until now no single pulmonary function test is applica-
ble in spontaneously breathing children and adults of all ages. This impairs
longitudinal studies on pulmonary function development from early infancy
to late adulthood (i.e. “cradle to grave”). Many techniques are not yet stan-
dardised (interrupter technique, tidal breathing technique) and normal val-
ues are not available (for all patient/age groups). Comparison to the “gold
standard” shows that the reproducibility is worse which impairs clinical
applicability.
However, there are several aspects that make resistance measurements
preferable.
In the first place, resistance parameters are measured during spontaneous
quiet breathing, so without forced respiratory manoeuvres. Therefore these
values might be more representative of normal breathing, i.e. daily life situ-
ations. Forced expiratory manoeuvres are hardly applied during all day
activities, not even during exercise.
Secondly, resistance measurements and tidal breathing analysis require only
passive co-operation and each measurement may be accomplished within
short time. The methods are non-invasive, apart from a closely fitting mask,
eventually equipped with a mouth piece. The general acceptance of these
methods is therefore good among young children in whom the methods
are used.
Thirdly, during childhood the most important pulmonary diseases have an
obstructive character and especially peripheral airway resistance is better
mirrored by resistance measurements in children than in adults. Also,
changes after intervention or in disease are at least similarly reflected by
these techniques compared to “gold standards”.
Finally, most criteria for pulmonary function tests as mentioned in Chapter
1 are met by the interrupter resistance, forced and impulse oscillometry
(and tidal breathing analysis). Therefore these are useful alternatives for
objective evaluation of obstructive airway disease in children.
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Tid l br athing
nalysis in young
children
Abstract
The shape of flow pattern during tidal expiration is influenced by peripher-
al airway obstruction. The time from the start of expiration to peak expira-
tory flow (tPTEF) divided by the total expiratory time (tE) is significantly
decreased in children with asthma. Experimental studies in the cat have
shown that the expiratory flow pattern is the result of mechanical properties
of the respiratory system (resistance and compliance) and of post-inspiratory
activity of inspiratory muscles. Computerised modelling of these mechani-
cal and muscular properties during tidal breathing allows to derive the
resistance and compliance of the respiratory system from the expiratory
flow pattern.
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Pulmonary function in young children
The increasing incidence of lower respiratory illnesses and wheezing in
young children and the diverse aetiology of these complaints are a challenge
to the clinician. Diagnosis and treatment of these children are often largely
based on medical history and physical examination. Assessment and quantifi-
cation of airflow obstruction can be helpful in the formulation of proper
therapeutic strategies and follow-up of these patients. Several objective
methods are available to evaluate pulmonary function in these young chil-
dren. Lung volume can be measured with body plethysmography or with
gas dilution techniques. Resistance and compliance of the respiratory system
can be measured both non-invasively (passive deflation or oscillation tech-
niques) and invasively (e.g. with an oesophageal balloon). Partial expiratory
flow-volume curves can be obtained in young children using rapid chest
compression techniques. All these techniques, however, are hard to apply in
daily practice, because they require fully equipped research laboratories, are
often only applicable under sedation and are (more or less) invasive.
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Figure 1. Representative recordings of tidal breathing flow over time in (A) a normal subject and (B) a patient
with moderate airway obstruction. The ratio tPTEF/tE can be calculated as a/(a+b) x 100%. The ratio is
decreased in patients with airway obstruction.
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Tidal breathing analysis - historical perspective
The need for simple, objective methods to measure pulmonary function in
young children led to several studies on the evaluation of tidal breathing
patterns. In 1905 Ten Have was the first to describe differences in expirato-
ry flow patterns between healthy persons and patients with obstructive lung
disease: “The expiratory flow-curve in patients with asthma is particularly
different from normal. At first flow increases rapidly, afterwards it decreases
rapidly and eventually slowly reaches zero flow”1 (Figure 1).
Later, in 1956, Bouhuys (in his thesis “Pneumotachography, the Clinical
Significance of Respiratory Airflow Recording”) was the first to describe
the parameter tPTEF/tE, which was decreased in patients with asthma2. In
this ratio, tPTEF is the time to peak tidal expiratory flow and tE is the total
expiratory time. It was not until 1981 that Morris and Lane3 showed
renewed interest in the changes in expiratory flow patterns in patients with
airway disease. They found significantly decreased values of tPTEF/tE in 51
adult patients with obstructive airway disease compared to 24 healthy con-
trols. They also described a significant correlation between the parameter
tPTEF/tE and FEV1, the gold standard of airway obstruction
3.
Analysis of flow pattern in children
In 1980 the parameter tPTEF/tE as a measure of airway obstruction was
also investigated in young children. The recording of flow patterns is easily
performed in young children, using a mouthpiece or facemask and pneu-
motachograph. These measurements do not require active co-operation or
co-ordination and children are allowed to breathe quietly while laying in
bed or sitting upright.
In 1996 a study was performed in our centre to evaluate the validity of the
ratio tPTEF/tE as a measure of airway obstruction in children4. In a group
of 226 healthy schoolchildren (age 3-11 years) tPTEF/tE was measured. The
mean value (43.0 ± 7.6%) was significantly higher compared to a group of
64 asthmatic children (30.0 ± 8.2%, p<0.001) (Figure 2). Moreover
tPTEF/tE in children with asthma increased after bronchodilation and was
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significantly correlated to other parameters of airway obstruction including
FEV1, MEF50 and MEF25
4. These findings demonstrated that tPTEF/tE is
related to airway obstruction not only in adults, but also in children.
Practical application of tidal breathing analysis
Although these findings were very promising, the application of tidal breath-
ing analyses in daily practice was not easy. Although group analysis showed
significant differences in mean tPTEF/tE values between healthy and asth-
matic children there was a huge overlap of values in these groups, caused by
a wide variation in normal values. That is why a single measurement in the
individual patient does not allow to discriminate between healthy children
and those with obstructive airway disease (Figure 2). Another disadvantage is
the wide intra-subject variability of tPTEF/tE. The development of special
software for on-line automatic data processing improved analysis of the tidal
breathing pattern in children. Using this software a fast measurement of
mean tPTEF/tE can be obtained from 20 breaths, thereby decreasing the
intra-subject variability5.
However, using the same software, it was difficult to record the tidal breath-
ing pattern in each individual child for almost 1 minute. In daily practice this
method appeared to be possible in infants using a facemask, and in children
from the age of 2-3 years using a mouthpiece. In these children tPTEF/tE
can be used as a measure of airway obstruction, especially when studying
groups rather than individual children.
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Figure 2. tPTEF/tE values in 226 healthy volunteer children (interrupted bars) and 64 patients with asthma
(closed bars).
Tptef/Te (%)
Physiological background of tPTEF/tE
The physiological background of tPTEF/tE was also studied6. It was
assumed that the expiratory flow follows the laws of elasticity from the end
of inspiration. This “lung-emptying curve” is characterised by the time-
constant of the respiratory system (τrs), the product of flow resistance and
compliance. At the start of expiration the expiratory flow during tidal
breathing is decreased by the post-inspiratory activity of inspiratory muscles
(especially the diaphragm). This muscle activity decreases exponentially,
characterised by the time-constant of the muscle (τmuscle). The expiratory
flow can be considered the result of the elastic recoil pressure of the lung
and the post-inspiratory muscle activity of the diaphragm. In this way the
parameter tPTEF follows the equation6
tPTEF = (1/τmuscle - 1/τrs)
-1ln (τrs/τmuscle)
In studies on cats, simultaneous measurement of flow patterns and muscle
activity showed that real-life tPTEF-values significantly correlated with the
values predicted by the above model6.
Based on these observations it then was postulated that tPTEF/tE is not a
direct representation of airway obstruction but especially a reflection of
breathing control, expressing both the mechanics of airway and lungs (τrs)
and the inspiratory muscle activity (τmuscle). This explains why the relation-
ship between tPTEF/tE and other parameters of airway obstruction is not
always unequivocal.
Tidal breathing analysis, the future
The important disadvantages, described above, explain the diminished
interest in the parameter tPTEF/tE in recent literature. However latest
studies (unpublished data) have shown that this model can describe and
analyse not only the single tPTEF/tE value in the expiratory flow volume
curve but the complete expiratory flow pattern. The most important
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parameters of this model are still the mechanics of airway and lungs (τrs) and
the inspiratory muscle activity (τmuscle). Therefore, very accurate recording
of both τrs and τmuscle can be obtained by recording the patient’s flow pat-
tern followed by computerised fitting of these data to the above-described
model. Because τrs is the product of resistance and compliance of the respi-
ratory system, this parameter can provide important information to the
physician. When this technique is followed by expiration through an exter-
nal known resistance, both resistance and compliance of the respiratory sys-
tem can be calculated.
Summary
Tidal breathing analysis has been studied for almost 100 years. After a sim-
ple phenomenological description both animal and human studies have
evaluated the parameter tPTEF/tE. The availability of a computerised lung
model enables accurate description of the mechanics of the respiratory sys-
tem. Although several disadvantages still exist, this technique has con-
tributed significantly to our understanding of airway mechanics.
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Abstract
Flow-volume curves are the most frequently used pulmonary function test
during childhood. Even pre school children are sometimes able to perform
the maximal effort breathing techniques, required for this pulmonary func-
tion test. We report on the most important conditions for reliable measure-
ment of flow-volume curves at all ages. Especially testing atmosphere and
equipment, pulmonary function technician requirements, testing proce-
dure, reliability criteria, report making and interpretation are discussed.
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Introduction
Pulmonary function testing (PFT) provides an objective method to place a
disease into physiologic proportions. The combination of medical history,
physical examination and PFT can elicit a clinical diagnosis. In this way
PFT does not make, but can confirm a clinical diagnosis, monitor response
to therapy and follow progression of disease. The most commonly used test
to objectivate lung disease is the flow-volume curve1. Results of flow-vol-
ume measurements can be presented graphically as flow-volume curves and
as corresponding parameters of flows and volumes. More than hundred
years after Hutchinson described spirometry, which still is the most basic
PFT, the well-known flow-volume curve was described by Hyatt who
plotted flow and volume on the y- and x-axes, respectively, of an oscillo-
scope2. This graphic display of results has advantages over the use of
spirometry. Simple visual inspection of the flow-volume curve is very use-
ful as a screening method for peripheral airflow obstruction (e.g. asthma),
upper airway obstruction (e.g. vascular rings), or restrictive lung disease,
although especially restrictive lung disease can not definitely be proven by
flow-volume curves . Interpretation of the numeric data of flow-volume
measurements, as described in Table 1 takes more time, is less convenient
and is less informative compared to interpretation of the graphic flow vol-
ume curves of the same patients, as presented in Figure 1. International
guidelines for this technique have been developed, in order to guarantee
standardised performance and interpretation world-wide3.
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Table 1. Lung function test results (expressed as percentage of predicted values) in
patients with various conditions: a patient with peripheral airway obstruction (A),
with central airway obstruction (B), and restrictive lung disease (C). 
PEF FEV1 MEF50 MEF25 FVC
A 90% 60% 35% 25% 100%
B 65% 100% 95% 100% 100%
C 95% 60% 100% 100% 65%
Flow-volume curves of these three patients and a normal subject are shown in Figure 1.
Because of the relative simplicity to perform and to interpret flow-volume
curves, this technique has widely entered paediatric practise. Respiratory
diseases represent the most common cause of morbidity in childhood4. In
the Netherlands every paediatrician treats some 500-600 asthmatic children
each year, for general practitioners this is about 170 children per year5.
Nowadays, the flow-volume curve is considered as ‘gold standard’ mea-
surement for airway obstruction in children and many paediatric patients
are tested in adult lung function labs. However, children are not small
adults and a lot of child-specific items in the performance and interpretation
of flow-volume curves can be overlooked, resulting in errors in diagnosis
and treatment. This article reviews the most important differences in flow-
volume measurement between children and adults.
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Figure 1. Artificial presentation of flow-volume curves in a normal subject and in a patient with peripheral air-
way obstruction (A), central airway obstruction (B), and restrictive lung disease (C). Numeric lung function
test results of these patients are shown in Table 1.
Atmosphere
For many children the first visit to a pulmonary function laboratory can be
considered as the beginning of a long (if not ever) lasting PFT career and
“well begun is half done”. At this stage many things in the lung function
lab can cause anxiety or distract the child. That’s why the testing area
should be child-friendly and safe. No unpleasant experiences should be
related to this area, so to test a child in the same area in which blood is
drawn or painful examinations are performed will reduce the amount of
co-operation and effort. The first contact with the lung function lab in
children aged 5 to 7 years should be no more than a first acquaintance.
Working with children puts several requirements on the investigator.
Pulmonary function technicians are often used to stress their adult patients
to an utmost performance in a direct way. With children they should take
time and pay special attention to welcome the child and to draw its atten-
tion from the beginning. They should be able to judge the developmental
level of the patient and to explain and instruct the procedure in a catching
way. A formal period of instruction and practice can enhance
performance6. Not every technician is able to work with children.
Therefore, it is advisable to have a special lab for children, or to have a lim-
ited number of technicians who are specifically trained for children in the
adult lab. The importance of a calm, success-oriented environment with an
experienced tester cannot be overemphasised.
Most young children have a short span of concentration which can inter-
fere with good results. The technicians’ custom to measure the next patient
while the first is waiting for his bronchodilator effect can destroy the child’s
motivation to do it’s best. Flow-volume measurements in children take
much more time than in adults. For a routine flow-volume measurement
with reversibility testing at least 30 minutes should be scheduled. When the
management of the laboratory is not willing to take this time, children
should not be measured.
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Equipment
The lung function equipment should fit to children of several ages. This
requires mouthpieces of different sizes to be available, permitting convenient
closure of mouth and lips to every child. Improper mouthpieces can result in
air leakage and can influence lung function results by changes in upper air-
way resistance7 and by trigeminal nerve stimulation8. In adults most times a
nose-clip is used. However, for flow-volume measurements this is not nec-
essary and it can better be withheld from some children. The equipment
should be height adjustable, to prevent flexion or extension of the neck
because this can influence maximal expiratory flows9. It has been advised to
keep the child’s torso and head erect throughout testing in either sitting or
standing posture10. When measuring in sitting position often a footstool to
support the feet is necessary to facilitate maximal expiratory manoeuvres.
Paediatric pulmonary function test equipment should have low inertia, be
responsive to small changes in volume and flow. Also it must provide
reproducible results. This “technical reproducibility” is a conditio sine qua
non. One of, if not the, most important reason to require optimal equip-
ment reproducibility is the fact that in all day clinical practice each patient is
his or her own reference for future measurements (e.g. after bronchodila-
tion, challenge or treatment)
Most flow-volume equipment uses commercial software. Software pro-
grammes should be explicitly developed for use in children. Apart from the
routine requirements for adults (e.g. for flow range, calibration and BTPS
corrections) the software should be provided with child specific options. An
on-line presentation of flow-volume curves improves co-operation and
endurance. Also artefacts (e.g. coughing) can easily be discovered.
The user must have the ability to introduce data on gender, height and
weight and should be able to choose the right reference values (see below).
Reports of lung function tests must show a flow-volume curve with appro-
priate scaling of the axes (see below).
When children are measured in a lung function lab, devices for adequate
measurement of weight and height have to be available. The growth veloc-
ity in children ranges between 5 an 12 cm per year. Important deviations in
lung function test results can emerge when recent growth data are not
implemented in the measurement. For example, a healthy 12 years old boy
who showed a FEV1 of 100% predicted at the age of 11, can show FEV1 of
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125% predicted when the technician fails to take and implement a current
measurement of body height.
Children’s performance of flow-volume measurements
The performance of a flow-volume curve implies an, especially for young
children, relatively complicated manoeuvre, that requires maximal and
forced expiratory and/or inspiratory efforts. In most cases of obstructive
airway disease especially forced expiration parameters are desired. After a
few tidal breaths the child is asked to inspire maximally from functional
residual capacity to maximal inspiration, followed by a rapid, forced and
complete expiration to residual volume. For detection of upper airway
obstruction rapid, forced and complete inspiration follows maximal expira-
tion. Pulmonary function technicians should support these maximal
manoeuvres subjectively and control the child’s effort with each testing.
Reliability criteria
For adults reliability criteria have been defined by the ATS and ERS soci-
eties3. Flow-volume measurements can be interpreted when the curve is
technically acceptable and when it is reproducible (Figure 2). Criteria for
technical acceptability and reproducibility are summarised in Table 2.
Although many authors state that children can perform reliable flow-volume
measurements from the age of about 5 years11, most children can not reach
the above mentioned criteria. Kanengiser and Dozor reported that even
most children aged 3 to 5 years of age are able to co-operate and perform
forced expiratory manoeuvres, but they failed to test for reliability criteria12.
Recent data from our own lung function lab showed that more than 90%
of children aged 5 - 19 years can perform “technician accepted” flow-vol-
ume curves that reach the start-of-test criterion13. A flow-volume curve
with a rapid rise to peak flow and a sharp peak, nearly always has a back
extrapolated volume (Vbe, (see Chapter 4.2, Figure 1)) of less than 5% of
FVC as defined by the ATS-ERS (Table 2). However, the end-of-test cri-
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terion (exhalation time of more than 6 sec) was reached in only a small
minority of patients. We suggested to lower the minimally required exhala-
tion time to 1 second in children below 8 years of age and to 2 sec in older
children13.
A minimum of three technically acceptable manoeuvres should be repeated
in order to judge reproducibility of the measurement (Figure 2). We have
shown that the ATS-ERS reproducibility criteria (i.e. a difference between
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Table 2. Criteria for acceptability and reproducibility of flow-volume curves as defined
by ATS-ERS.
Curve is acceptable if:
- Vbe is less than 5% of FVC or less than 0.15 l
- Exhalation time is more than 6 sec
- No more volume change during 1 sec
Curve is reproducible if:
- difference between highest and next highest FVC < 200 ml
- difference between highest and next highest FEV1 < 200 ml
Figure 2. Algorithm for getting a reliable flow-volume curve according to ATS-ERS statement.
the highest FVC/FEV1 and the next highest FVC/FEV1 less than 200 ml) is
not suitable for children. Especially in young children with small lung vol-
umes, this criterion can easily be met despite considerable variability. A dif-
ference between highest and next highest FVC or FEV1 values of less than
5% would be a more appropriate criterion for reproducibility in children13.
After assessing technical acceptability and reproducibility the best flow-vol-
ume curve is defined as the curve with the highest sum of FEV1 and FVC.
This best curve can be used for interpretation (Figure 2).
Reference values
In general numeric results of flow-volume measurements are compared
with reference values and are expressed as percentage of reference value,
also called percentage of predicted. To be able to judge to what extent the
reference values are acceptable in a particular situation, information is
required about the population from which they are derived, and the cir-
cumstances during the measurement. Lung function results largely depend
on height, gender and race of the patient.
During childhood, especially during puberty, lung growth is not linearly
related to height. It is definitely incorrect to extrapolate reference values
form adult populations to paediatric values. Figure 3 shows that important
differences exist between different reference value data sets. The figure
shows that a healthy boy with a height of 130 cm and a FEV1 value of 1,5 l
has a predicted value ranging from 68 - 107 %, depending which reference
data set is used. These findings show that it is extremely important to use an
adequate reference value data set. Reference value data sets are most often
obtained from relatively small groups of children and/or adults who are
considered to be free from disease or circumstances, that influence testing
(pulmonary disease, smoke (or other irritant) exposure, viral infections,
etc.). These value sets are reduced to simple regression equations with
standing height as the only independent variable.
The reference population should match the patient with regard to sex, age,
weight and height, genetic, ethnic and social background, and geographical
location17.
Unfortunately such reference values are not available in all countries and
one should use the ‘best fitting’ population. In most modern lung function
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measurement software a panel of reference value data sets is available.
In lung function laboratories for adults, the risk for the use of wrong refer-
ence values for children is more than imaginary when the lab is visited by
children only incidentally. Measurement of current height and selection of
the most adequate reference value data set should be a standard operating
procedure in every lung flow-volume measurement in children. Ideally
paediatric normal values are included in the software.
Report making
Reports of paediatric flow-volume measurements should not be printed at
adult settings. Because, as stated above, the visual inspection of the curves is
the most important part of the interpretation of the test, curves should be
printed in a standardised way. The optimal way is to print the flow-volume
curve as large as possible, with the smallest possible scaling of the flow- and
volume axes in a 2 to 1 ratio (Figure 4). Discrete bronchial obstruction can
be easily overlooked when the flow-volume curve is printed too small, or
when the axis scales are too large (adult sizes in young children). When the
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Figure 3. Regression curves of 3 different sets of predicted values for FEV1 in boys. A healthy boy with a
height of 130 cm and a FEV1 value of 1,5 l has a predicted value of 68% according to set A
14 (100% =2.2
L), of 88% according to set B15 (100% =1,7 L) or of 107% according to the extrapolated set of values in ado-
lescents in regression line C16 (100% =1,4 L).
axes are changed in the computer software, the 2 to 1 ratio for flow and
volume should be maintained in order to prevent changes in the shape of
the curve which can lead to misinterpretations (Figure 4).
In most young children it is very difficult to perform both inspiratory and
expiratory flow-volume curves in the same manoeuvre. Because most times
the lung function technician will focus on the expiratory manoeuvre, it is
advisable to print only the expiratory curves in order to prevent the inter-
pretation of non-informative inspiratory curves.
The numeric data on the paediatric lung function report should be relevant
and concise. In young children it is sometimes more relevant to print out
FEV0.5 values in stead of FEV1 values. A main restriction is that, to our
knowledge no normal values for FEV0.5 are available. With the increasing
use of flow-volume curves in pre school children this should be a main
objective of further research. Inspiratory parameters should be left out if the
inspiratory manoeuvre was not explicitly performed. Adequate reference
value data for the different parameters should be given together with the
parameters as percentage of predicted. For lung function parameter ratios
4
C
H
A
P
TE
R
FLOW VOLUME MEASUREMENTS
85
Figure 4. Flow-volume curves of a healthy child printed with wrong axis-scaling. Discrete abnormalities can be
overlooked when scales are too large (A) or misinterpretation can occur as restrictive lung disease (B) or upper
airway obstruction (C) when scales are not printed in the standard 2 to 1 ratio for flow and volume.
(e.g. FEV1/FVC) no percentage of the reference value should be calculat-
ed, because a percentage of a percentage is most often not informative.
Use of incentives
During the last years several computerised visual incentives have been
developed to stimulate young children to perform maximal forced breath-
ing manoeuvres. For example, children are stimulated to blow out burning
candles on the computer screen18 or to ring the bell by blowing up a bal-
loon in the hands of a clown. Such programmes can be very helpful in the
instruction of young children. The use of a programme with burning can-
dles was proven to be helpful in 4 to 6 years old children18.
When visual incentives are used, it is important to realise what is the trigger
of the incentive. Incentives can be triggered by PEF, FVC or both. When
incentives are triggered by e.g. PEF alone this can have unfavourable effects
on other parameters, because children tend to stop their manoeuvre as soon
as they have triggered the incentive19. In general, incentives are useful to
instruct the manoeuvre, but they do not improve the results. Therefore,
they should not be used in children who can perform forced breathing
manoeuvres without these tools.
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Forced expiratory
manoeuvres in
children: 
do they meet ATS and ERS
criteria for spirometry?
Abstract
The aim of this study was to evaluate the applicability of ATS and ERS cri-
teria for spirometry in children.
Methods: We studied maximal expiratory flow volume (MEFV) measure-
ments of 446 school-age-children, experienced in performing MEFV
manoeuvres and applied to these manoeuvres acceptability criteria (start-of-
test (backward extrapolated volume as a percentage of FVC (Vbe%FVC) or
as absolute value (Vbe)) and end-of-test (forced expiratory time (FET)) and
reproducibility criteria (absolute and percentual difference between best
and second best FVC and FEV1 (dFVCabs, dFVC%, dFEV1abs and
dFEV1%)).
Results: The Vbe%FVC criterion was met by 91.5%, the Vbe <0.15L crite-
rion by 94.8% and the Vbe<0.10L by 60.1% of children. Vbe <0.15L
appeared to be a more useful parameter than Vbe%FVC. The FET criterion
was met by only 15.3% of children. dFVCabs<0.2L and dFEV1abs<0.2L
were met by 97.1% and 98.4% and dFVCabs<0,1L and dFEV1abs<0,1L by
79.8% and 84.3% of the children respectively. These criteria appeared to be
less useful compared to percentual criteria (dFVC% and dFEV1%).
Conclusions: Even experienced children do not meet all international criteria
for spirometry. However, most of their MEFV curves are useful for inter-
pretation. Based on the performance of these children, we propose a re-
evaluation of criteria for MEFV measurements in children.
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Introduction
Maximal expiratory flow volume (MEFV) measurements were introduced
as a valuable tool in the assessment of respiratory disease in 19471. Since
then MEFV measurement has become the cornerstone of pulmonary func-
tion testing (PFT) and the most widely used tool in diagnosis and follow up
of both adults and children with respiratory illness.
However, for young children, the technique of MEFV measurement is
often more complicated, because they may lack co-ordination and co-oper-
ation. For these children, especially those under the age of 7 years, the
instruction and performance of MEFV manoeuvres can be facilitated by the
use of computerised visual incentives2. In everyday practice MEFV curves
are judged to be acceptable when they show a rapid rise to peak flow at the
start and a subsequent gradual decrease of flow during the rest of the maxi-
mally prolonged expiratory manoeuvre. However, criteria as described by
the ATS3 and ERS4 for acceptability and reproducibility of MEFV
manoeuvres are lacking for (young) children. A summary of these criteria is
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Table 1. Criteria for acceptability and reproducibility of MEFV curves as stated by
the ATS3 and ERS4.
Acceptability
Start of test criteria:
* Vbe%FVC < 5% or Vbe < 0.15 L (whichever is greater) (ATS)
* Vbe%FVC < 5% or Vbe < 0.10 L, (whichever is greater) (ERS)
End of test criteria:
* FET > 6 seconds (ATS)
* Exhaustion of patient or plateau in volume-time curve (no volume change during 1
second) (ATS and ERS)
No coughing, Valsalva manoeuvre or hesitation (ATS and ERS).
Reproducibility
* dFVCabs < 200 ml and dFEV1abs <200 ml (ATS)
* dFVC% <5% or dFVCabs <100 ml (whichever is greater) and dFEV1% <5% or
dFEV1% <100 ml (whichever is greater) (ERS)
shown in Table 1. In daily practice, when children perform computer con-
trolled MEFV manoeuvres, the ATS or ERS criteria will be indicated most
times as being not reached.
We investigated whether children with experience in lung function testing
meet acceptability and reproducibility criteria for MEFV manoeuvres as
defined by the ATS and ERS, during routine PFT. For criteria that were
not met by these children, new criteria are proposed.
Patients and methods
All MEFV measurements were performed using a pneumotachometer sys-
tem with a heated Lilly head (MasterScreen Pneumo and Jaeger Masterlab,
Erich Jaeger, Würzburg, Germany). Equipment calibration was performed
conform ECSC (European Community for Steel and Coal) guidelines4. All
measurements were BTPS corrected. Measurements were performed with
the child sitting straight and wearing a nose clip. Only pre-bronchodilator
manoeuvres were evaluated.
Most patients were known with recurrent respiratory symptoms, mostly
due to obstructive pulmonary disease such as asthma and cystic fibrosis or
recurrent pulmonary infections. A minority of patients were seen preopera-
tively (e.g. for scoliosis, pectus excavatum) or after chemotherapy.
In the period between January 1997 and January 1999 852 children (436
boys) performed 8388 MEFV tests at the PFT laboratory. We selected all
children who were experienced in performing MEFV measurements, i.e.
they had previously performed MEFV manoeuvres on at least two earlier
occasions. The children were optimally encouraged and performed, after
full inspiration, a maximally forced and prolonged expiration. Their MEFV
manoeuvres were acceptable, according to our trained and experienced
pulmonary function technicians, when the flow-volume curves showed: 1)
a rapid rise to peak flow and 2) a full, maximally prolonged expiratory
curve, shown by a gradual, asymptotic approach of the curve to the volume
axis. If necessary, especially for the first MEFV tests in young children, a
computerised visual incentive was used to stimulate this manoeuvre. This
consisted of a peakflow triggered series of burning candles on the comput-
erscreen2. All MEFV curves with a gradual rise to peak flow, with blunt
peaks and/or with sudden end expiratory drop of flow to the volume axis
92
were not accepted for further evaluation. All children performed at least
three technician-accepted curves and for each child the two curves with the
highest sum of FVC and FEV1 during the last PFT were used for final
analysis5.
Finally, we could evaluate 446 children (age range 5-19 years) who had per-
formed MEFV manoeuvres on an average of 16.7 occasions. Patient charac-
teristics are given in Table 2.
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Table 2. Patient characteristics: mean values (SD, range).
Male/female 234/212
Age (years) 12.1 (3.5, 5-19)
Weight (kg) 43.3 (15.8, 17-83)
Height (cm) 151.2 (17.9, 107-188.5)
FEV1%pred 95.5 (25.0, 26.5-155.0)
FVC%pred 95.6 (20.1, 28.4-142.6)
FEV1%FVC 83.6 (11.1, 44.5-100)
Figure 1. Method to determine the backextrapolated volume (Vbe) from a volume-time curve. Vbe should be
<5% of the FVC to represent an acceptable start of forced expiration.
Expired 
volume
FVC
Vbe
TimeTime zero
We evaluated whether these technician-accepted curves met the ATS and
ERS criteria3,4 for acceptability and reproducibility (Table 1): backward
extrapolated volume (Vbe) as an absolute value and as percentage of FVC
(Vbe%FVC) (Figure 1) for the start of test and the forced expiratory time
(FET) for the end of test. The best value of the two curves of each patient
was used for evaluation of acceptability criteria. Reproducibility was evalu-
ated by the absolute and percentual difference between forced vital capaci-
ties (dFVCabs and dFVC%) and the absolute and percentual difference
between forced expiratory volumes in 1 sec (dFEV1abs and dFEV1%) of the
two best curves out of a minimum of three curves per individual.
Time to peak flow (tPEF) as start of test criterion, mentioned in earlier
standardisation reports6 but not accepted in later consensus reports3, was
also analysed.
All values of ATS and ERS criteria were also related to age, height, gender
and pulmonary function results. In order to be able to propose new criteria
we calculated the values that could be achieved by 90% of the children
studied.
Statistical analysis
Mean values (SD, range) were calculated for all criteria. Correlations
between criterion values and age, height and pulmonary function were
studied with Pearson’s correlation coefficients.
Differences between separate groups were analysed using unpaired t-tests.
A p-value < 0.05 was considered statistically significant.
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Results
Results for the different criteria are given in Tables 3 and 4.
Acceptability criteria: start of test
Vbe%FVC
The Vbe%FVC was < 5% in 91.5% of all patients. The mean best
Vbe%FVC was 3.3 (+1.7, 0.7-9.5)% (Table 3 and 4). The Vbe%FVC was
weakly though significantly related to height, age and pulmonary function
(Table 4). 77.2% of children under the age of 8 years was able to reach this
criterion (Table 3 and 4).
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Table 3. Percentages of ‘technician-accepted’ MEFV curves that meet the ATS
and/or ERS acceptability and reproducibility criteria.
Criterion <8yr. 8-11yr. 12-15yr. >15 yr. Total
(n=36) (n=175) (n=146) (n=89) (n=446)
Vbe%FVC < 5% 77.2 80.6 91.7 96.5 91.5
Vbe < 0.15L 97.5 95.6 94.5 85.4 94.8
Vbe < 0,10 L 77.8 61.7 59.6 50.6 60.1
tPEF < 0.1sec 75.3 77.8 89.9 92.0 84.7
FET > 6sec 8.6 13.3 15.6 36.0 15.3
dFVCabs < 200ml 100 99.5 94.5 95.5 97.1
dFVCabs < 100ml 91.7 85.7 74.7 70.8 79.8
dFVC% < 5% 82.7 89.8 85.6 89.5 87.9
dFEV1abs < 200ml 100 99.0 98.2 97.5 98.4
dFEV1abs < 100ml 91.7 90.9 78.1 79.8 84.3
dFEV1% < 5% 91.4 85.7 87.2 88.5 87.2
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Vbe
The Vbe was < 0.15 L in 94.8% of the children. The mean best Vbe was
0.09 (0.03, 0.04-0.24)L. The Vbe was significantly related to height and age
(Table 4).
tPEF
A tPEF < 0,10 sec was seen in 84.7% of all children. Mean tPEF was 0.07
(0.03, 0.01-0.22) sec. tPEF was significantly inversely related to height and
age, with better results in older children (Table 3 and 4).
Acceptability criteria: end of test 
FET
During maximal stimulation the maximal forced expiratory time (FET) was
< 6 sec in 84.7% of all children. Mean FET was 4.3 (2.5, 0.5-18.7) sec.
There was a significant relationship of FET with age and height, but espe-
cially with parameters of airway patency (Table 4).
Reproducibility criteria
dFVCabs
The absolute difference between the two highest FVCs (dFVCabs) was <
200 ml in 97.1% of children. The mean dFVCabs was 58 (50, 0-280) ml.
dFVCabs was significantly related to age and height, but not to gender
(Table 4).
All patients in the youngest age group and 95.5% in the oldest age group
met this criterion (Table 3).
dFVC%
dFVC% < 5% as a criterion for reproducibility was met by 87.9% (Table 3)
of children. Mean dFVC% was 2.3 (2.1, 0-10.7)%. In the older age group a
higher proportion of the children reached the criterion, but correlation
with both height and age was not statistically significant. There was a weak,
although significant correlation between pulmonary function and dFVC%
(Table 4).
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dFEV1abs
Differences between the two highest FEV1’s (dFEV1abs) were < 200 ml in
98.4% of all children. All patients in the youngest age group and 97.5% in
the oldest age group met this criterion (Table 3). The mean dFEV1abs was
51 (50, 0-330) ml. The dFEV1abs was significantly related to age and height
(Table 4).
dFEV1%
The percentual differences between the two highest FEV1s (dFEV1%) were
< 5% in 87.2% of the children (Table 3). The mean dFEV1% was 2.5 (2.7,
0-14.6)% and there was no significant correlation with height or age, but a
weak, although significant, correlation with pulmonary function (Table 4).
Feasibility
Table 5 gives the values of the different criteria, achievable by 90% of the
children. The end of test criterion of FET > 6 sec is the least feasible crite-
rion, especially in the younger age group (Table 3).
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Table 5. Cut-off points for acceptability and reproducibility criteria for values which
can be achieved by 90% of the study population.
Criterion <8 yr. 8-11 yr. 12-15 yr >15 yr. Total
(n=36) (n=175) (n=146) (n=89) (n=446)
Vbe%FVC (%) 6.4 5.8 4.6 4.2 5.4
Vbe (L) 0.11 0.12 0.12 0.16 0.13
tPEF (sec) 0.11 0.12 0.10 0.09 0.11
FET (sec) 1.3 2.1 1.8 2.1 1.8
dFVCabs (ml) 83 101 159 150 127
dFVC% (%) 5.0 4.9 5.6 4.7 5.3
dFEV1abs (ml) 60 92 128 136 110
dFEV1% (%) 4.7 6.3 6.7 5.4 6.2
Discussion
The majority of the children studied could perform acceptable flow-vol-
ume manoeuvres according to the ATS and ERS start-of-test criteria, but
only a minority of the children exhaled as long as required by the ATS,
notwithstanding the curves were judged to be acceptably performed. When
the absolute difference in FVC or in FEV1, as proposed by the ATS, was
taken as a criterion of reproducibility, this was easily met by the majority of
children. Despite these findings, most of the criteria showed dependency of
age and height, which precludes the applicability of these criteria for chil-
dren of all ages. In children we consider absolute criteria to be less suitable,
especially when they are age dependent and designed for adults. The focus
should be on the applicability of relative criteria which are designed to con-
trol for changes in the absolute magnitudes of measurements with (pul-
monary) growth. Apart from growth, in childhood many other factors may
influence the results of pulmonary function testing, such as time and
patience of the PFT technician, equipment, use of incentives and disease
state. To perform acceptable and reproducible MEFV manoeuvres the child
should be able to blow out forcefully, immediately after maximal inhala-
tion, and to continue forced expiration until no further air can be expired.
The instruction and control of technique, combined with sufficient
patience requires a well-trained pulmonary function technician, able to
cope with and to encourage children and able to judge the expiratory
process7. Several groups reported successful MEFV measurements in young
children. Kanengiser and Dozor reported that many 3-5 year old children
are able to co-operate and perform rudimentary forced expiratory manoeu-
vres that are reproducible, but reliability could not be assumed and hardly
any MEFV curve met the ATS criteria for acceptability8. Le Soeuf and col-
leagues found that children can perform adequate forced expiratory
manoeuvres from the age of 4-5 years9.
The present study investigates the applicability of the currently officially
accepted reliability criteria, as defined by the ATS3,5 and the ERS working
groups4.
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Start of test criteria
In young children the initial efforts to produce a sharp peak flow are often
not very rapid in onset. The present study shows that with guidance of a
well-trained technician the majority of experienced children can reach the
current start-of-test criteria.
In earlier reports on spirometry criteria, tPEF was described as a start of test
parameter6. If applicated, a good start of the forced expiratory manoeuvre
(i.e. tPEF < 0.10 sec) was seen in 84.7% of children. For PEF meters the
use of dwell and rise time for PEF as recently described by Miller et al.
needs further study and has not been used in MEFV manoeuvres in chil-
dren10. Their results showed that especially males and asthmatics have
shorter “start times” compared to women and non-asthmatics. In the pres-
ent study the percentage of children who reached a peak flow within 0.1
second was rather low compared to the current ATS and ERS start of test
criteria and therefore would exclude MEFV measurements in a consider-
able number of children. Therefore, our study supports the former recom-
mendation not to use tPEF as a criterion of acceptability.
Our study indicates that the subjective criterion of a ‘rapid rise to peak
flow’, often estimated by eye by pulmonary function technicians, is suffi-
cient to select acceptable curves. Optimally, criteria for acceptability should
be independent from age or height. However, our data show that none of
the ATS start-of-test criteria are independent from growth. Age and height
are negatively correlated with Vbe%FVC and positively correlated with
Vbe. This can be explained by the rise in FVC during growth.
The parameter Vbe, although an “absolute” parameter, is most independent
from age and height and therefore this parameter seems to be the most
appropriate start-of-test criterion. The Vbe < 0.15 L criterion was met by
over 94.5% of children under the age of 15 years and 85.4% of children
aged 15 years and older (Table 3). The ERS criterion of Vbe < 0,10 L
excludes up to 50% of MEFV curves in older children. We suggest to adjust
the advised minimal Vbe to 0.12 L in children aged < 15 years; in that case
90% of children would be able to reach the acceptability standard (Table 5).
End of test criteria
The second part of the MEFV manoeuvre was far more difficult to perform
for children. The ATS criterion for acceptability demands a minimal FET
100
of 6 sec, unless there is an obvious plateau in the volume time curve dis-
play. The ATS recommendations state that in children shorter exhalation
times are acceptable, but fail to be more specific3. The ERS working group
does not present numeric criteria for maximally prolonged expiration4. In
this study all children had extensive experience with lung function testing
and were maximally encouraged to reach complete exhalation.
Nevertheless only 36% of the oldest age group in our study exhaled for
over 6 seconds. Although mean FET rises with age, even adolescents not
always exhaled (forcefully) during more than 6 seconds, making this criteri-
on unsuitable for use in paediatric practice.
Desmond et al found comparable results. In their study a minimal FET of 6
seconds was reached by 28% and 7% of children over and under the age of
7 years respectively11. In contrast a recent study by Enright et al. showed
that display of a real time tracing of exhaled volume versus time, used to
stimulate subjects and PFT technicians, allowed higher FETs in children
over the age of 9 years. However, start-of-test criteria were less easily
reached, compared to our group of children. These results show that the
use of a particular device will enable more children to satisfy specific criteria
but probably not all criteria. In our study we considered a complete expira-
tion and not an exhalation time of 6 seconds as the goal of MEFV measure-
ment. We endorse the statement of Enright and co-workers that
underestimation of the FVC is not clinically very important when monitor-
ing children with obstructive pulmonary disease12. Therefore, when neces-
sary, especially in inexperienced and young children, we recommend the
use of computerized visual incentives that visually stimulate especially a
rapid and forced start of maximal expiration such as images of burning can-
dles2.
Warwick et al. described that young children may empty their lungs within
1 sec because of small lung volumes13. This causes the FEV1 to be equal to
FVC and could reduce the usefulness of FEV1 and FEV1%FVC as an index
of airway obstruction. Kanengiser stated that for this age group the FEV0.5
could be more appropriate for determination of airway obstruction8.
As could be expected the degree of airway obstruction was positively relat-
ed to the FET. The correlation of FET with age was more evident than
with height (Table 4), which suggests that apart from lung volume also age-
ing, and therefore probably effort and co-operation, influences FET.
Although Enright et al. found better results12 using specific stimulation one
may question how many adults can reach this FET criterion during routine
pulmonary function testing.
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In our study we defined time criteria which were reached by 90% of chil-
dren. Assuming that the flow volume curve shows no abrupt termination of
expiratory flow and/or the volume time curve shows a plateau (Table 5) we
propose to decrease the minimal FET to 2 seconds for children over the age
of 8 years and to 1 second for children under the age of 8 years. Other
researchers suggested to take 3 sec11 or 4 sec as goals for exhalation times.
Our data show that when children reach a FET of at least 2 seconds, this
confirms a maximal effort in more than 90 percent of children.
Reproducibility
In our study the children, especially the younger ones, had no problems in
meeting the “absolute volume” criteria for reproducibility (Table 3). This is
to be expected because of small lung volumes in children, but does not
guarantee reproducibility. Reproducibility criteria using absolute differ-
ences for both FVC and FEV1 are significantly influenced by age and height
(Table 4). Criteria using the relative difference as mentioned by the ERS4
are not correlated with either age or height and therefore seem to be more
appropriate in paediatric practice. The 5% difference criteria was reached
by 87.9% and 87.2% of children for FVC and FEV1, respectively (table 3).
Increasing these numbers to 90% would require a cut-off point of 5.3% for
FVC and 6.2% for FEV1 (Table 5). The current 5% criteria seems to be
more useful in childhood than the absolute criterion of 100 or 200 ml.
It should be stressed that all children in our study were experienced with
MEFV manoeuvres. Most children underwent regular PFT during visits to
the outpatient clinic. The mean number of PFTs performed by the children
before the study was rather high. This means that for inexperienced chil-
dren several attempts may be necessary to reach the same skills and results.
As it could be the start of a “pulmonary testing career” that may last for
many decades in children with chronic respiratory symptoms it is important
for inexperienced children to become familiar with the procedure and
especially use the first laboratory visits to adapt to the situation and get a
positive experience. If the first “PFT battle” is lost one may loose a good
compliance and performance in later visits.
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Conclusion
Even MEFV manoeuvres of experienced children do not reach the goals of
all ERS and ATS criteria. However, most of their MEFV curves are useful
for interpretation. We propose a re-evaluation of international criteria for
MEFV measurements in children. Based on evaluation of MEFV measure-
ments in 446 experienced children we propose as minimum criteria:
Start of test: Vbe<0.12 L (<15 years) and <0.15 L (>15 years); end of test:
FET>2 sec (>8 years) and FET>1 sec (<8 years), provided that complete
exhalation with a gradual, asymptotic approach of the flow volume curve
to the volume axis is seen; reproducibility: dFEV1 and dFVC <5%.
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Abstract
This study was performed to evaluate the applicability of a simple device
(MicroRint®) for measuring airway resistance, to derive normal values and
to compare values with maximal expiratory flow volume (MEFV) parame-
ters in asthmatic and healthy children.
Repetitive Rint measurements were performed in 125 healthy children and
107 asthmatic children (age range 0.8-16.8 years). In 42 asthmatic patients
Rint and MEFV values were compared and in 29 asthmatic children bron-
chodilator testing was performed.
Successful Rint measurements were possible in 91% of the children. The
mean coefficient of variation of repeated measurements was 7.1(SD6.1)%.
Rint values of healthy children showed a significant curvilinear correlation
with age (r = -0.80, p<0.001) and height (r = -0.81, p<0.001). In asthmatic
and healthy children Rint values were comparable. A significant inverse
correlation was found between Rint and MEFV values (for FEV1 and Rint
r = -0,80, p<0.001). After bronchodilation there was a significant increase
in FEV1 and decrease in Rint, but changes between the two parameters did
not correlate.
In conclusion, the interrupter technique is feasible and repeatable in chil-
dren and has a significant correlation with other parameters of airway cal-
iber. Baseline values do not discriminate healthy from asthmatic children.
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Introduction
Medical history and physical examination are the most important parame-
ters for diagnosis and treatment of recurrent respiratory problems in young
children, because objective parameters of lung function can not always be
obtained.
During the last decade several pulmonary function devices for young chil-
dren have been developed, but most are only applicable in a research set-
ting. Moreover, application of these devices often requires sedation of the
child, special equipment and a laboratory setting.
One of the techniques, used for measuring resistance of the respiratory sys-
tem is the interrupter technique, which was first described by Von
Neergaard and Wirz in 19271.
The MicroRint® is a small portable data recording airway resistance meter,
using the interrupter technique. It measures airway resistance during quiet
breathing, requires minimal subject co-operation and can be used during
spontaneous breathing and without sedation. Theoretically this makes it
applicable even in very young children and in patients unable to co-operate
with normal (forced) breathing techniques.
The basis of the interrupter technique is that, during transient interruption
of the tidal airflow, alveolar pressure and mouth pressure equilibrate within
a few milliseconds. The alveolar pressure can therefore be derived from the
measurement at the mouth immediately after interruption. If the flow is
measured immediately prior to interruption, the ratio of pressure to flow
gives the interrupter resistance (Rint). It should be stated that pressure
equilibration is incomplete in case of severe airway obstruction and that this
is a limitation of the model on which Rint is based.
In adults, Rint shows a close correlation to airway resistance (Raw) meas-
ured by whole body plethysmography. In asthmatic subjects the methods
were equally sensitive in detecting changes in airway resistance following
bronchodilation2,3, but Rint tended to measure higher resistances, probably
due to a contribution of chest wall rigidity, lung tissue resistance and the
glottis to airway resistance4,5. Only recently studies have also evaluated the
applicability of the Rint technique in children6-12.
The purpose of the present study was to evaluate the applicability of the
MicroRint© in children with and without asthmatic symptoms in daily
practice, to establish normal values and to compare Rint values with maxi-
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mal expiratory flow volume (MEFV) parameters as measures of airway
patency.
Subjects and methods
Subjects
Interrupter resistance was measured during spontaneous breathing in 232
children (112 male, 120 female). 107 children were known with doctor’s
diagnosed asthma according to the British Thoracic Society (BTS) defini-
tion13. These children were tested in a clinically stable situation. The other
125 children were recruited from two primary schools and two day care
centers. For the latter group parents had completed a modified
International Study of Asthma and Allergies in Childhood (ISAAC)14 ques-
tionnaire. Patients with a history of asthma, asthma treatment, dyspnoea,
eczema, wheezing or recurrent coughing were not included into the study.
Measurements in these children were performed during a visit to the
schools. Informed consent was obtained from the parents of all children.
Subject characteristics of 107 asthmatic and 125 healthy children are shown
in Table 1. There were no significant differences between asthmatic and
healthy children.
In 42 asthmatic children (mean age 8.7(3.4) years, FEV1 107.0(13.3) %pred.)
MEFV curves were performed and MEFV parameters were compared with
Rint values. In 35 of these children Rint and MEFV measurements were
repeated, 15 minutes after inhalation of 800 micrograms salbutamol (pMDI
through spacer). Because 6 children could not perform Rint measurements
before bronchodilation, comparison of MEFV and Rint values could only
be made in 29 children. Prior to pulmonary function testing no bron-
chodilators had been used for at least 6 hours.
Methods
Airway resistance was measured using the MicroRint® (Micro Medical
Limited, Kent, UK). Flow was measured with a pneumotachometer con-
sisting of a steel resistive element and a high frequency solid-state pressure
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transducer. The same pressure transducer was used to measure the mouth
pressure post-occlusion. Measurements were performed in a sitting posi-
tion. Children were entertained and attention was diverted to reduce their
anxiety and to prevent abnormal breathing. Measurements were made
using a cardboard mouthpiece (>10 years: 2.7 cm diameter, <10 years 2.0
cm) and the subjects were instructed to wear a nose clip, seal their lips
around the mouthpiece and to lay their tongue on the floor of the mouth
to prevent obstruction of air flow. Cheeks and mouth floor were supported
by the hands of the investigator to prevent energy loss and to reduce the
effect of mouth compliance. During spontaneous normal and quiet breath-
ing the interrupter valve was operated manually twice to accustom the
child to the shutter action. Thereafter, 10 airflow interruptions were made
on the peak flow of an expiration; these occurred at random frequency and
automatically so that they could not be anticipated, thus independent of the
investigator’s timing. After 10 interruptions the median Rint value was dis-
played as were the flow and pressure curves. A single interruption resistance
value was (automatically) rejected when an artifact on the pressure curve
occurred. Manual rejection was performed in case of tachypnoea, usage of
vocal cords, extreme neck flexion or extension or leakage of the mouth
piece. Tracings not showing the timing of interruption on the flow tracing,
or tracings with a horizontal or declining pressure signal suggesting leakage
at the mouth, or with an altered ventilation pattern were discarded as well.
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Table 1. Patient characteristics of the asthmatic and healthy children who performed
baseline MicroRint measurements.
asthma healthy
number of children 107 125 
male/female 52/55 60/65
age (years (SD)) 7.6 (3.3) 8.2 (2.8)
height (cm (SD)) 125.8 (19.6) 132.2 (18.2)
weight (kg (SD)) 27.4 (11.5) 29.8 (10.4)
no successful measurements 10 (9%) 10 (8%)
one successful measurement 17 (16%) 19 (15%)
two successful measurements 80 (75%) 96 (77%)
total successful measurements 97 (91%) 115 (92%)
Before a Rint measurement was considered successful, a median Rint value
had to be obtained from a minimum of 5 out of 10 interruptions. Reasons
for failure were recorded. The number of successful measurements and the
number of acceptable interruptions per measurement were recorded. All
Rint measurements were attempted twice in order to evaluate inter-meas-
urement variability. Rint measurements always preceded MEFV maneu-
vers.
We evaluated the validity of Rint measurements by measuring the inter-
measurement repeatability of two tests 30-60 seconds apart and the intra-
measurement variability for every individual measurement consisting of
5-10 acceptable interruptions. Normal values were calculated for healthy
subjects and these were compared with those for asthmatic children
(according to age, height and gender).
MEFV curves were measured using a pneumotachometer system with a
heated Lilly head (MasterScreen Pneumo or Jaeger Masterlab, Erich Jaeger,
Würzburg, Germany). Equipment calibration conformed to ECSC
(European Community for Steel and Coal) instructions15. All measure-
ments were BTPS corrected.
Values for the following parameters were obtained: FEV1, FVC, PEF,
MEF75 and MEF50. All parameter values were described both as absolute
values and as percentage of predicted values, described by the summary
equations of Zapletal et al.16.
Statistical analysis
Data are reported as mean (SD), unless indicated otherwise.
The repeatability of Rint measurements was evaluated by inter-measure-
ment and intra-measurement coefficients of variation (CV=SD/n). Bland
Altman plots were constructed to find limits of agreement between two
repeated measurements17.
The reliability coefficient (RC), also called the intra class correlation coeffi-
cient, was used to describe the within-subject stability of average Rint val-
ues. In children with “n” successful interruptions the subject’s true Rint
value was estimated by taking the average over n interruptions. The RC of
this average calculated Rint was defined as:
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RC = σ2inter / (σ
2
inter +σ
2
intra/n)
in which σ2inter is the between-subject variance of true Rint mean, σ
2
intra is
the within subject variance of single Rint values within one subject, and n
is the number of interruptions used to calculate the average Rint within a
subject. The nearer RC is to 1, the more stable the average ratio.
A student’s t-test was used for comparison of data. Correlation between
two parameters was evaluated by Pearson correlation coefficients.
Correlation between age and number of successful measurements was ana-
lyzed using logistic regression with the number of successful measurements
as the dependent variable
Results
A. Feasibility
Results are shown in Table 1 and 2. At least one (out of two) acceptable
baseline Rint measurement could be performed in 212 of the 232 children
(91%) (Table 1); this percentage was similar in asthmatic (97/107 = 91%)
and healthy children (115/125 = 92%). In 5 asthmatic children measure-
ment was possible after, but not before bronchodilation (Table 2). Age dis-
tribution is shown in Figure 1.
Of all children, 76% were able to produce two successive measurements. A
significant although weak correlation was found between age and number
of successful measurements (r = 0.18, p < 0.01). Of 20 preschool children
(15 in kindergarten, 5 in outpatient clinic) in whom two repetitive efforts
were made at least one succesfull measurement was possible in 15 (75%) of
children. Results for pre school children are presented in Table 3. The
main reasons for failure were blowing into or sucking on the device, or
refusal to take the device into the mouth.
The mean number of successful interruptions per measurement was not sig-
nificantly different between healthy (7.6 (2.2)) and asthmatic (8.0 (2.1))
children. There was a significant correlation between age and the number
of successful interruptions (i.e. during 1 measurement), (r = 0.17, p =
0.012).
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Table 2. Feasibility of Rint measurements in the different subject groups (n = num-
ber, meas = measurements). * Because 5 children in the bronchodilator group were
only able to produce values after B2, only 212 usable baseline measurements were
evaluated.
n meas. Number of successful ≥1 good All good 
measurements test tests
0 1 2 3 4
A 15 2 3 5 7 80% 47%
B 158 2 8 21 129 95% 82%
C (no B2) 24 2 3 4 17 88% 71%
(-/+ B2) 35 4 1 3 3 5 23 97% 66%
total 232 15 * 33 156 5 23 94% 76%
A = kindergarten, B = schoolchildren, C = outpatient clinic patients
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Figure 1. Age distribution of children able to perform Rint measurement
Age
N
B. Validity
Rint measurements of 212 children were evaluated before or without bron-
chodilation. The mean inter-measurement coefficient of variation (CV)
was 7.1(6.1). CV correlated significantly with both age (r = -0.214,
p=0.004) and height (r = -0.215, p =0.004). There were no significant dif-
ferences between girls and boys, or between asthmatic and healthy children.
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Figure 2. Analysis of agreement between MicroRint values of two consecutive measurements (Bland Altman
plot [13]).
Table 3. Feasibility of Rint measurements in pre school children (n = number).
n No successful One successful Two sucessful At least one
measurement measurement measurements succesful 
measurement
0-1 year 1 1 0 0 0
1-2 years 2 2 0 0 0
2-3 years 8 0 5 3 8 (100%)
3-4 years 9 2 3 4 7 (78%)
Total 20 5 8 (35%) 7 (40%) 15 (75%)
upper limit of agreement
lower limit of agreement
mean Rint (kPa/L/s)
di
ff 
R
in
t 
(k
Pa
/L
/s
)
The mean difference between 2 consecutive measurements was -0.005
(+0.11) kPa.L-1.s, indicating that 95% of the values of Rint in the second
measurement fell between -0.23 and +0.21 kPa.L-1.s (lower and upper lim-
its of agreement, Figure 2). There was a significant inverse correlation
between the absolute difference between two measurements and both age
(r = -0.283, p<0.001) and height (r = -0.256, p<0.001)
The mean intra-measurement CV was 12.2 (5.5)%. There was a significant
correlation between CV and both age (r = -0.277, p<0.001) and height (r
= -0.317, p<0.001). No significant differences were found between girls
and boys or between asthmatic and healthy children. Reliability coefficients
of 1-10 interruptions are shown in Figure 3. The use of one single inter-
ruption (n=1) would result in a Rint value with a reliability coefficient of
0.90. An increase in the number of interruptions would increase the relia-
bility coefficient of the subsequently measured Rint value.
C. Normal values
The mean Rint of healthy children was 0.64 (0.26) kPa.L-1.s. There was a
significant correlation between age and Rint (r = -0.80, p<0.001) and
between height and Rint (r = -0.81, p<0.001). Figure 4 shows the Rint
values for healthy children in relation to their height. This curvilinear rela-
tion was best represented by the regression formula:
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Figure 3. Reliability coefficients of the Rint value calculated as an average of n sequential interruptions.
Number of averaged sequential interruptions
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Rint (kPa.L-1.s) = 0.0001x(height)2 - 0.0399x(height) + 4.0288, with
height expressed in cm. (R2 = 0,65). Addition of age to this model did not
improve R2. There were no differences between boys and girls.
For asthmatic children the mean Rint value was 0.70 (+0.27) kPa.L-1.s,
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Figure 4. Rint values in healthy children versus height.
Figure 5. Rint values in asthmatic
children versus FEV1.
height (cm)
y = 0.0001x2 - 0.0399x + 4.0288
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which was not significantly different from normal values and was also sig-
nificantly correlated with age and height. There was a large overlap
between the Rint values of healthy and asthmatic children, irrespective of a
doctor’s diagnosis or a questionnaire based diagnosis of asthma.
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Table 4. Correlation between Rint and MEFV parameters in 42 asthmatic children (r= correlation coefficient) 
r p
FVC -0.775 <0.001
FEV1 -0.797 <0.001
PEF -0.754 <0.001
MEF50 -0.65 <0.001
MEF75 -0.63 <0.001
Figure 6. Rint values before (baseline) and
after bronchodilation in 29 asthma patients
(dashed line is mean value).
baseline after bronchodilation
R
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D. Comparison with MEFV measurements
Rint correlated significantly with FEV1 in asthmatic children (r = -0.800,
p<0.001, Figure 5). Significant inverse correlations were observed between
Rint and absolute values of FVC, PEF, MEF25, MEF50 and MEF75 (Table
4), but not between Rint and MEFV parameters presented as percentage of
predicted.
E. Reversibility
After bronchodilation a significant increase in mean FEV1 from 1.59
(+0.60) L to 1.69 (+0.69) L (mean increase +0.10 (+0.13) L, p < 0.001)
coincided with a significant decrease in mean Rint from 0.71 (+0.21)
kPa.L-1.s to 0.54 (+0.18) kPa.L-1.s (mean decrease -0.15 (+0.11) kPa.L-1.s,
p < 0.001) (Figure 6). In only 8 children an increase of more than 8% of
FEV1%pred. was observed. 21 pairs were concordant (increase in FEV1 and
decrease in Rint). However, the linear correlation between changes in Rint
and FEV1 was not significant (r=0.12, p=0.59).
Discussion
We evaluated the feasibility and repeatability of the MicroRint© in a group
of asthmatic and healthy children. The majority of children of all ages was
able to perform Rint measurements and repeatability was good. Rint values
showed a significant correlation with absolute MEFV parameters. Although
in most asthmatic patients a decrease in Rint was found after bronchodila-
tion, there was no linear correlation between changes in Rint and changes
in FEV1.
A. Feasibility
The setting for measuring Rint was either a simple office setting in schools
(and day care centers) or the outpatient department. Measurements were
performed by rather inexperienced medical students, formerly unknown
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with the method, who received only minimal instructions about use of the
device before starting Rint measurements. All children were inexperienced
with MicroRint measurements. We tried to distract the children from
“conscious breathing” by playing games, parental presence or observer
attendance. Parents were encouraged to attend the measurements in order
to reassure their children and encourage the correct use of the device; ide-
ally there should be a quiet testing area with sufficient “quiet” distraction.
The use of a facemask (without nose clips) might enable measurements in
smaller children but may also introduce problems such as leakage, increase
of dead space, intranasal obstructions and nasal breathing7. Klug and
Bisgaard used a facemask with a built-in non compressible mouthpiece in
order to prevent nasal breathing and to support the cheeks7. In a recent
study Child et al found higher values of Rint using a mouth piece com-
pared to face mask. They were equally reproducible, but values were not
interchangeable18.
In our study, children 4 years and older were generally quite able to co-
operate in MicroRint measurements, which led to reliable results. In
younger children co-operation was less easily achieved. In the present study
only 40% of 1-3 year old children were able to perform two measurements;
similar data were reported by Bridge and co-workers, who performed suc-
cessful reversibility testing in 53%, 71% and 91% of 2, 3 and 4 year old chil-
dren, respectively6.
B. Validity
Inter-measurement variability of two tests, 30-60 seconds apart, was small.
The mean difference between two Rint measurements was comparable
with data found by Bridge et al7. These differences decreased with increas-
ing age (and height) as could be expected. In our study the variability is low
compared to earlier reports12, especially when we take into account that
measurements were performed in inexperienced children and by relatively
inexperienced medical students. Intra-measurement variability for individ-
ual measurements consisting of 5-10 interruptions was also small, especially
in the older children. Both intra- and inter-measurement variability were
independent of gender, diagnosis and bronchodilation, which augments the
applicability.
The small inter-measurement variability allows for the application of this
technique in bronchial challenge testing, using the “variance based” provo-
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cation dose (giving a change in Rint to “baseline Rint + 2 SD”). This method
proved to be a very good discriminator between healthy and asthmatic19.
Reliability coefficients for statistical evaluation of the stability of Rint after
1-10 interruptions showed that even after one or two interruptions a reli-
able Rint value can be found, which indicates that the premise to use a
minimum of 5 acceptable interruptions to measure Rint is acceptable. In
the present study after 5 interruptions the reliability coefficient rose to 0.98.
In an earlier study we evaluated the reliability coefficients of tidal breathing
flow pattern analysis in quietly breathing children; reliability coefficients
were much lower20, indicating that MicroRint measurements can be per-
formed in a much shorter time span.
C. Reference values
We found a significant correlation between height (and age) and Rint,
reflecting a decrease in airway resistance during growth. The data were not
log-transformed to achieve normal distribution prior to the fit. In this study
only a general impression of height-Rint correlation was presented. In a
recent study we presented reference values for children 3-13 years of age,
using log-transformed data21.
The range was wide and no differences were found between healthy and
asthmatic children.
There were no relevant gender differences. Few data on reference Rint
values were available until recently. Van Altena et al. evaluated Rint values
in adults and reported a mean Rint of 0.38 (+0.17) kPa.L-1.s and a signifi-
cant relationship between Rint and both age and height22. For a more
extensive use of the interrupter technique in children reference values are
needed for the (whole) pediatric age group. Until now no reference values
are available for children over 7 years of age. In young children reference
data were presented in two recent studies23,24. In 1998 Klug and Bisgaard
published reference values of Rint for 2-7 year old children, related to
height8; they also found a wide range and that a single measurement could
not demonstrate airway obstruction. In preschool children Mckenzie et al
found significant differences between children with recurrent wheezing and
both healthy controls and recurrent coughers24. The present study failed to
distinguish healthy from asthmatic subjects using only baseline values. This
might be due to the fact that these patients were symptom free during
examination and were probably only mildly affected (normal FEV1%pred).
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Recently we found in a study on ICS efficacy that baseline FEV1 in mildly
asthmatic children is often in the normal range25. Probably also Rint in mild
asthmatics can be in the normal range.This may explain the inability of a sin-
gle Rint measurement to discriminate between healthy and asthmatics.
Recent studies showed comparable results for airway resistance measured
by impulse oscillometry, e.g. Hellinckx et al. found no difference in respi-
ratory system resistance at 5 Hz (Rrs5) between healthy and asthmatic chil-
dren, nor in changes after bronchodilation26.
D. Comparison between Rint and MEFV parameters
We found a significant curvilinear relation between maximal expiratory
flow volume parameters and Rint. The Rint values correlated well with
FEV1, FVC and PEF, but only when absolute values were concerned. The
latter is caused by the fact that during growth there is an absolute gradual
decrease of airway resistance and increase of air flows, but of course not of
pulmonary function parameters, expressed as percentage of predicted.
Comparable results were reported by Mijnsbergen et al. who found a cor-
relation coefficient of -0.74 in asthmatic patients and -0.58 in CF patients27.
Two other studies compared FEV1 and interrupter conductance (Gint), the
reciprocal of Rint; both reported highly significant correlations between
Gint and absolute FEV1 and PEF values
3,28.
E. Reversibility testing
As with FEV1 and many other pulmonary function test parameters baseline
Rint measurements could not differentiate between asthmatic and healthy
children. There was a significant decrease of airway resistance after bron-
chodilation, coinciding with a small increase in FEV1 and PEF. In our
group of asthma patients with rather mild airway obstruction only small
changes in airway resistance and patency could be expected. Mean per-
centual improvement of Rint values after bronchodilation was higher than
that of FEV1 (22.5% versus 6.3%). In this study reversibility testing was not
performed in healthy children. The latter has been performed in a recent
study by Beydon et al. In a group of 5.3 (1.4) year old children they found a
change (% of predicted values) in expiratory Rint of -12% (95% CI -46%
to+22%)29.
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In our very young children, the repeatability was relatively poor, which
restricts reversibility testing. If we consider a decrease in Rint greater than
two SD of variance (i.e. 0.22 kPa.L-1.s) to reflect reversibility, this
reversibility was found in only a small percentage of children with proven
reversibility, shown by FEV1 measurements. Bridge and co-workers studied
reversibility in wheezy pre-school children and found a significant decrease
in most children; however, because no MEFV measurements were per-
formed in these children the correlation with FEV1 was unknown
6.
McKenzie et al compared Rint reversibility in healthy, coughing and
wheezing preschool children and showed that percentual Rint decrease is
less in healthy preschool children compared to wheezing children30.
We found a poor and non-significant correlation between changes of FEV1
and Rint after bronchodilation. Morrison et al reported comparable results
in young CF patients9. To our knowledge no studies have evaluated this
correlation in adults (MEDLINE search 1965-2001). In our opinion the
poor correlation between changes in FEV1 and Rint is probably due to the
fact that measures of lung function obtained from a forced expiratory
maneuver may have different physiologic implications than those measured
during tidal breathing, as was also mentioned by other investigators3,12.
This and the fact that these children were probably only mildly asthmatic
may explain the lack of correlation between FEV1 and Rint changes.
We conclude that MicroRint® measurement provides a feasible and repeat-
able method for measuring airway resistance in children of all ages. Normal
values show a highly significant correlations with age and height. The cor-
relation with MEFV measurements is good. A single measurement cannot
identify airway obstruction and reversibility testing shows a significant
decrease in many asthmatic children, although not significantly correlating
with changes in FEV1.
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Abstract
The interrupter technique is a convenient and sensitive technique to study
airway function in subjects who cannot actively participate in (forced) ven-
tilatory function tests. Reference values for pre-school children exist but
are lacking for children over the age of 7. We obtained reference values for
expiratory interrupter resistance (Rinte) in 208 healthy Dutch Caucasian
children 3-13 years of age. A curvilinear relationship between Rint and
height was observed, similar to published airways resistance data measured
plethysmographically. No significant differences in cross-sectional trend or
level of Rint were observed according to gender. Based on the reference
equation: 10log (Rinte) = 0.645 - 0.00668 x standing height(cm) kPa/L/s
and residual standard deviation (0.093 kPa/L/s), Z-scores can be used to
express individual Rint values and to describe intra- and interindividual dif-
ferences. Rint provides a tool for clinical and epidemiological assessment of
airway function in a large age range.
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Introduction
The interrupter technique is one of the few lung function tests which can
be used for assessment of airway calibre in young children1-3. With this
technique, measurements of the resistance of the respiratory system (Rint)
can be carried out quickly, with minimal co-operation of the child. Rint
measurements have been shown to be reproducible1,4-6, sufficiently sensi-
tive to detect (sub)clinical airway obstruction6,7, and correlate satisfactorily
with measurements of airway resistance4,8,9. The technique can not only be
used as a tool to screen for airway obstruction, but also to assess the
responses to bronchodilating and bronchoconstricting agents1,3,10. It is
especially suitable for pre-school children because it only requires passive
co-operation. However, passive measurements of airway function may also
be required for clinical research in older children, or in older children who
are unable to perform forced expiratory manoeuvres because of develop-
mental disorders or neuromuscular disease. Till now, reference data are
available for young children6,7,11,12 and adults13, but not for children over 7
years of age. The aim of the present study was to expand the previous data
set in order to better describe relationships between expiratory resistance
and body size. We obtained normal Rint values during expiration (Rinte)
in 208 healthy Caucasian children aged 3-13 years, from a general popula-
tion. Measurements were preferably made during expiration rather than
during inspiration because Rinte appears to be more sensitive to detect
changes in resistance within children due to respiratory infections, and to
discriminate better between children with and without respiratory symp-
toms or disease as compared to Rinti6.
Methods
Dataset
Rint measurements were carried out using identical equipment and the
same measurement protocol in 2 sets of healthy Dutch Caucasian children
aged 1-13 years, recruited from 2 day-care centres, 2 kindergartens, and 2
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elementary schools. Information on respiratory symptoms, eczema, allergy,
parental smoking, doctors diagnosis of asthma, and asthma medication was
obtained using modified ISAAC questionnaires14. Children were included
in the reference population when they had no respiratory symptoms in the
month prior to or during the measurements. Exclusion criteria were: histo-
ry of asthma, recurrent rhinitis, eczema, cardiorespiratory or other chronic
disease, known anatomical abnormalities of the upper or lower airways, and
vocal cord disorders. We intended to obtain reference values from a normal
population rather than from an ideal population15. Therefore, mild respira-
tory symptoms not requiring medical care in the past, and involuntary
exposure to parental smoking without a history of respiratory symptoms or
disease were no exclusion criteria. The study and its protocol were
approved by the medical ethics committees of the medical centres and by
the principals and boards of the institutes involved. Informed consent was
given by the parents of all participating children. When children refused
co-operation, no Rint measurements were attempted.
Equipment
Interrupter resistance was assessed using the MicroRint (Micro Medical
Ltd, Rochester, UK), as described previously6. Rint was calculated using
the back extrapolation technique to t=0 ms after shutter closure during 100
ms1. Daily calibrations of pressure and flow (volume) were carried out
using a manometer and a 2 litre precision pump. All measurements were
carried out with a filter (Micro Medical Ltd, Rochester, UK) in place to
prevent contamination and dysfunctioning16.
Measurement protocol
The protocol has been described previously6. After the supervisor of the
children explained the purpose of the measurements, a measurement was
demonstrated on the supervisor and subsequent measurements were carried
out in groups of 2-4 children at a time, in a familiar and quiet room.
Children were seated and no physical exercise was allowed during 10 min-
utes prior to the measurements. During measurements, children were
instructed to breathe quietly, sitting upright while the cheeks and chin were
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supported from behind by the investigator. The head was positioned in
slight extension and a nose clip was used. The position of the MicroRint
was adjusted on a support arm to facilitate unobstructed breathing. A mini-
mal number of 5 correct tracings (maximal 10) was obtained at the peak of
expiratory tidal flow, because expiratory interruptions seem more sensitive
in detecting airways obstruction than those during inspiration6. Tracings
were rejected in the cases of: tachypnoea, usage of the vocal cords, extreme
neck flexion or extension, or leakage of the mouth piece. Tracings not
showing the timing of interruption on the flow tracing, or tracings with a
horizontal or declining pressure signal suggesting leakage at the mouth, or
altered ventilation pattern were discarded as well (illustrated in Figure 2).
Data analysis
The individual Rinte data were expressed as median values because indi-
vidual data are not normally distributed6. Reference values for Rinte were
described based on a model assuming a linear or curvilinear relationship
with the standard independent variables standing height, weight, and age.
Because of physiological similarities between Rint and plethysmographical-
ly obtained Raw, we hypothesised that an exponential model with standing
height would make the best fit for the Rinte data, similarly as published re-
ference equations for Raw
17,18. Trends of residuals with height or age were
assessed from linear regression analyses. The threshold for statistical signifi-
cance was set at p=0.05.
Results
Subjects
The first dataset consisted of 135 healthy Dutch children (60 boys) studied
in Rotterdam, the Netherlands, who were selected from a survey in which
the parents of 698 children were asked for participation. Permission was
given for 341 (49%) children: 36 refused participation, and 12 failed to
complete the measurements. Of the remaining 293 children 135 (39%) met
the inclusion criteria and completed the measurements. This included 54
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healthy children described previously6. The second dataset consisted of 79
Dutch children (41 boys) studied in Utrecht, the Netherlands. These were
selected from a study in which parents of 445 children were asked for par-
ticipation. For 212 (48%) of these children such permission was obtained. In
200 children reliable Rint measurements were carried out of whom 79
(40%) met the inclusion criteria listed above. Both studies were carried out
in suburban parts of the cities, inhabited with middleclass income Dutch
families. Only 2 out of the 24 children who failed to complete the measure-
ments were older than 4 years of age. Anthropometric data of all 214 chil-
dren are summarised in Table 1. The children from dataset 1 were slightly
younger than those from dataset 2 (Table 2). The coefficients of variation
from dataset 1 showed a trend to be larger than that from dataset 2 (Table
2). This seemed to be explained by the differences in age between centres:
Especially below the age of 6 yrs , there was a negative correlation between
coefficient of variation and age (r=-0.21, p=0.004). Because reliable meas-
urements could only be obtained in 6 children younger than 3 years of age
the reference equation was based on the 208 children 3-13 years.
132
Table 1. Anthropometric data of the reference population.
Age range (n) Gender Mean (SD) Mean (SD)
M/F height weight
1-3 yrs (6) 4/2 88.2 (6.8) 12.9 (2.5)
3-4 yrs (8) 3/6 104.9 (6.2) 17.2 (2.0)
4-5 yrs (17) 7/10 109.5 (3.7) 18.6 (2.1)
5-6 yrs (28) 12/16 116.4 (4.3) 21.1 (2.0)
6-7 yrs (29) 12/17 119.8 (4.9) 22.8 (3.0)
7-8 yrs (25) 13/12 129.9 (4.6) 26.5 (3.5)
8-9 yrs (29) 8/21 133.1 (7.5) 29.1 (6.2)
9-10 yrs (21) 15/6 142.3 (5.0) 35.1 (5.2)
10-11 yrs (17) 10/8 149.1 (4.3) 39.1 (6.7)
11-12 yrs (24) 11/13 154.7 (6.7) 41.1 (6.7)
12-13 yrs (8) 6/2 156.7 (10.6) 47.8 (12.9)
Reference equation for Rint
An inverse, curvilinear relationship was found between Rinte, and the
independent variables standing height, age and weight. When standing
height was used in an exponential model instead of a linear model with
Rinte, the explained variance increased from 59 to 63 % and the residual
standard deviation (RSD) decreased from 0.150 to 0.093 kPa/L/s. Residuals
of the exponential model were homoscedastically distributed, demonstrat-
ing no trend with standing height (Figure 1). When age was added next to
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Table 2. Differences between 2 data sets. *: p<0.03, unpaired t-tests.
Dataset 1 Dataset 2 
(Rotterdam) (Utrecht)
Age (yrs, mean(SD)) 7.4 (2.6) 8.4 (2.9)*
Standing Height (cm, mean(SD)) 128 (18) 133 (20)*
Weight (kg, mean (SD)) 27.2 (9.3) 30.7 (11.5)*
Boys/Girls 62/76 41/38
Coefficient of Variance (%, median(range)) 11.7 (1.2 - 21.4) 6.9 (0 - 35)
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Figure 1. Relationship between10log(Rinte) and standing height for 208 children. The solid and dotted lines
illustrate the exponential model (mean and 95% confidence bands).
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Figure 2a-c. Examples of Rinte recordings. Fig 2a: correct manoeuvre, clearly visible timing of interruption on
the flow tracing and approved interpolation and extrapolation of pressure signal. Fig2b: Visible leakage at the
mouth, and a horizontal pressure signal following interruption. Fig2c: Flow signal affected by the usage of the
vocal cords, and horizontal pressure signal.
standing height in an exponential model, the explained variance increased
with less than 3%, and the improvement of RSD was less than 0.0003
kPa/L/s. When age was used as the only independent variable in an expo-
nential model with Rinte, the explained variance was 64% (RSD = 0.091
kPa/L/s), but the distribution of the residuals became heteroscedastic for
subjects older than 10 years. In the age range>10 years, the variability of
standing height for age was larger than in the younger subjects. Using
weight as the only independent variable, explained variance was 49%,
(RSD=0.108 kPa/L/s).
Reference equations for Rinte are:
linear model:
Rinte = 1.927 - 0.00992 x standing height (cm) kPa/L/s
r = -0.77, RSD = 0.150 kPa/L/s (p<0.001).
exponential model: 
10 log (Rinte) = 0.645 - 0.00668 x standing height (cm) kPa/L/s
r = -0.79, RSD = 0.093 kPa/L/s (p<0.001).
Based on the exponential model, the mean (SEM) of standardised residuals
for 97 boys and 111 girls were -0.079 (0.096) kPa/L/s and 0.071 (0.097)
kPa/L/s, respectively, with a mean (95% CI) difference between boys and
girls of 0.15 (-0.12, 0.42) kPa/L/s. No trend was observed between stand-
ing height and standardised residuals for boys or girls. The separate regres-
sion equations from the 2 datasets did not differ significantly in a multiple
regression model that included centre (p=0.33) and interaction between
standing height and centre (p=0.59).
Discussion
Few studies have reported reference equations for the interrupter technique
in young school children6,7,11,12, but for older children these are lacking.
Because of the possible applications for this technique in a larger age range
(epidemiological and clinical research, children unable to participate in
active lung function measurements), we obtained normal values for Rinte
in 208 healthy Caucasian children between the ages 3 and 13 years. In our
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previous study a linear model to describe the relationship between height
and Rinte was considered satisfactory6 but in the present study, due to the
larger range for height, an exponential model appeared more appropriate
because of a curvilinear relationship. This pattern is consistent with reports
of data of Raw in healthy children
19.
This is the largest study of Rinte in healthy pre-school and school children
studied so far. Despite the large number of observations, we could not
demonstrate a significant sex-related difference in airway patency. This sug-
gests that a possible small difference of airways resistance between sexes is
not clinically relevant, or that it can not be detected measuring resistance of
the respiratory system with this technique.
We used height and not age as independent variable because of physiologi-
cal arguments, and not because the relationship between height and Rinte
was statistically superior. It is conceivable that body size can function as a
proxy for airway calibre, whereas age may indirectly reflect airway size in
children below the age of 13 years as well, but not in adolescents or adults.
Age may be equally valid and a more convenient independent variable in
reference equations for Rinte7, but this is probably limited to young chil-
dren only. Indeed, the variability of the residuals in the children over 10
years of age from the present study was considerably increased compared to
that in children below that age, which is explained by a larger variation of
height for age.
Because the residuals of the exponential model were normally distributed
(with RSD=0.093 kPa/L/s), individual measurements can be expressed as
Z-scores:
Z=(10 log(measured Rinte) -10 log (predicted Rinte))/RSD, which facili-
tate comparisons within and between individuals. As long as there is no
international standardisation for Rinte measurements20, reference equations
are likely to differ according to the equipment and protocol of shutter tim-
ing and back-extrapolation, as well. In the protocol of the present study,
interruptions were programmed at peak tidal expiratory flow which appears
to standardise inflation level6,9.The linear model of the present study fits
remarkably well with the reference equation (Rint = 1.993-0.0092 x
height(cm) - 0.0009 x age(yrs)) kPa/L/s of van Altena et al.13 who studied
Rint in 172 adults and teenagers, although the exact measurement proce-
dure was not described and the population and equipment differed marked-
ly. Our results are not comparable with those of Klug et al.11 who
programmed inspiratory interruptions at 50 ml above FRC. The effect of
this procedure might have been that with increasing body size, interrup-
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tions occurred at progressively lower inflation levels. This could very well
explain the lesser slope with height and lower explained variance of their
reference equations.
It is difficult to compare Rint values with those of measurements of Raw or
RL from healthy populations because of differences in technique, and pop-
ulation characteristics, but our reference equation compares favourably with
those of Dab et al.17 (log Raw = 0.712-0.0064 x height(cm)), and those of
Helliessen et al.18 (logRL = 0.627-0.0068 x height(cm)).
We were able to measure Rinte reliably in only 6 children younger than 3
years of age and do not recommend routine assessment of Rint below 3
years of age because of low feasibility in that age range6. The use of face
masks in those children may enhance the feasibility of the test, but Rint
measurements obtained using face masks can differ from those obtained
with mouthpieces21. This will depend on compliance and resistance of the
mask, and on the degree of airways obstruction. Rint measurements using
face masks may require specific reference equations. For young children
over 3 years of age, the interrupter technique remains probably one of the
most convenient and sensitive tests for airway function available, with the
possibility to use the same technique over a wide age range.
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Impulse oscillometry; 
a measure for airway
obstruction
Abstract
The Impulse Oscillometry System (IOS) was introduced as a new tech-
nique to assess airflow obstruction in patients who are not able to perform
forced breathing manoeuvres, like subjects with cerebral palsy, severe men-
tal retardation and young children. This study evaluates the sensitivity and
specificity of IOS parameters to quantify changes in airflow obstruction in
comparison with FEV1 and PEF measurements.
Measurements of FEV1, PEF and Resistance (R) and Reactance (X) at fre-
quencies of 5 to 35 Hz were performed in 19 children with asthma before,
during and after methacholine challenge and subsequent bronchodilation.
All parameters changed significantly during the tests. Values of R5 and R10
correlated with FEV1 (r = -0.71, and -073, respectively, p<0.001), as did
values of X5 and X10 (r = 0.52, and 0.57, respectively, p<0.01). Changes in
R preceded changes in PEF and FEV1 during methacholine challenge. The
area under the Receiver Operating Characteristic curve to predict a 15%
fall in FEV1 showed better sensitivity and specificity for R5 (area under the
curve 0.85) compared to PEF (0.79) or R10 (0.73).
We conclude that IOS parameters can be easily used as an indirect measure
of airflow obstruction. This might be helpful in patients who are not able
to perform forced breathing manoeuvres. In individual subjects, R values
measured at 5 Hz showed to be superior to PEF measurements in the
detection of a 15% fall in FEV1.
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Introduction
Lung function tests can often contribute to proper therapeutic strategies and
follow-up of patients with lower respiratory illnesses. The forced expiratory
volume in the first second (FEV1) is regarded as the ‘gold standard’ for the
assessment of airflow obstruction and general consensus exists about criteria
for performance and standardization of this measurement1. Unfortunately,
some categories of patients, such as mentally retarded patients and young
children, have a high risk for lower respiratory illnesses, but are not able to
perform forced expiratory manoeuvres.
Respiratory disease is the major cause of death in children with cerebral
palsy2,3, with a 140 fold increased mortality risk4. Because modern tech-
nologies for assessment of pulmonary function and treatment of pulmonary
obstruction are not routinely applied in children with intellectual disability
and young children, recognition and treatment of respiratory diseases might
not be adequate in this group5. In young children the incidence of lower
respiratory illnesses and wheezing is increasing6.
Children with severe neuromuscular disorders and children under the age
of five rarely can generate forced expiratory manoeuvres that meet the
above mentioned acceptability and reproducibility standards7. Also a rela-
tively simple forced breathing test as peak expiratory flow (PEF) measure-
ment is difficult to perform for these patients. During infancy several other
lung function tests can be performed (e.g. partial flow volume curves,
occlusion techniques), but most of these tests are limited to the first two
years of life and can only be performed in research laboratories because of
high technical requirements8. For large numbers of patients with lower res-
piratory illnesses lung function test facilities are very limited.
Recently, impulse oscillometry was introduced as a new technique for the
assessment of airflow obstruction in children9. The Impulse Oscillometry
System (IOS) does not require active co-operation of the patient and has
become commercially available. The purpose of this study was to evaluate
the sensitivity and specificity of IOS parameters to quantify changes in air-
flow obstruction. In order to compare the method with conventional
forced breathing tests as the ‘gold standard’ for airflow obstruction, the
study was performed in children who were able to perform FEV1 and PEF
measurements.
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Subjects
We studied 19 children (7 boys) with asthma attending the outpatient pae-
diatric pulmonology department of the Wilhelmina Children’s Hospital,
Utrecht (age range 5 - 17 years). They all had moderate to severe asthma
according to the International Consensus Report on Diagnosis and
Treatment of Asthma10 and were treated with inhaled corticosteroids
(beclomethasone dipropionate or budesonide 200-800 microgram daily)
and rescue medication (salbutamol or terbutaline). All children were free of
symptoms in the period of the study. All children had a baseline FEV1 of
more than 70% of predicted. The children were not allowed to use bron-
chodilators during a period of at least 24 hours prior to the test.
The study was approved by the Hospital Medical Ethics Committee, and
informed consent from the parents was obtained prior to inclusion in the
study.
Methods
Forced flow volume measurements
Maximal expiratory flow volume (MEFV) measurement was performed in
all children, with use of a pneumotachometer system with Lilly head
(MasterScreen Pneumo, Erich Jaeger, Germany). The best MEFV curve,
according to the ATS criteria, from at least 3 trials was used1. Children who
were not able to reach the ATS criteria of acceptability and reproducibility
were not included into the study. All values were corrected to body tem-
perature, ambient pressure saturated (BTPS) conditions. For reference val-
ues data of Zapletal were used11.
Peakflow measurements
Peak expiratory flow (PEF) was measured using a calibrated Wright
spirometer (Clement Clarke International Ltd, London, UK). The children
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were in a standing position and were instructed to exhale maximally after
inhalation to total lung capacity. The best value of three repeated measure-
ments was recorded.
Impulse Oscillometry (IOS)
The impedance of the total respiratory system was measured using a com-
mercially available oscillometry system which has been described
elsewhere9 (Masterlab-IOS, Erich Jaeger, Germany). During tidal breathing
through a mouthpiece on a Y-piece an impulse generator produced brief
pressure pulses at intervals of 0.2 sec. The power spectrum of the pulse was
constant from 0 to 5 Hz and had a decrease of 20 dB in the range up to 40
Hz. These pressure fluctuations were superimposed on the spontaneous
breathing pattern and were measured at the mouth by means of a differen-
tial pressure transducer with a total resistance below 50 Pa/l/sec and a pres-
sure range of ± 1 kPa. The digitised pressure and flow signals were sampled
at a rate of 200 Hz and were fed into a fast Fourier transformation, which
transformed the complex pulse signals into their elementary sinusoidal
components. The spectral ratio of the amplitude of the pressure wave signal
to the resulting flow signal constituted the Impedance (Z) of the total respi-
ratory system, from which the total resistance (R) and reactance (X) of the
respiratory system were calculated12,13. In this study mean R and X values
were calculated over a measurement period of 60 sec in the frequency
range 5 - 35 Hz. During IOS measurement the children were sitting
upright, their head resting against the back of the chair. They were
instructed to breath quietly through a mouthpiece. To reduce loss of energy
in the upper airways their cheeks and chin were supported by the hands of
the investigator who was standing behind the patient.
Study protocol
After baseline IOS, FEV1 and PEF measurement methacholine challenge
was performed according to a standardised protocol. Methacholine bromide
aerosols were generated by calibrated DeVillbiss 646 nebulizers which were
attached to a Rosenthal dosimeter. During quiet breathing from FRC to
TLC the dosimeter was triggered. After performing baseline measurements
normal saline was inhaled to rule out non-specific reactions and subse-
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quently methacholine was administered in doubling doses (3, 6, 12, 24, 50,
98, 196, 392 and 784 microgram methacholine). Three minutes after every
dose of methacholine IOS, FEV1 and PEF measurements were performed,
each time in this same sequence. To prevent an unfavourable effect of deep
inhalation on IOS parameters, IOS measurements were always performed
immediately before FEV1 and PEF measurements. Performance of all tests
took 3 minutes. Provocation was continued until the dose at which FEV1
had dropped 20% or more from baseline (PD20). After achieving PD20 400
microgram of salbutamol dose-aerosol was administered via a spacer device
(Volumatic). Fifteen minutes after administration of salbutamol, all tests
were performed in the same sequence as at baseline.
Statistical analysis
Distributions of parameters are summarised by mean (standard deviation),
unless indicated otherwise. For comparison of paired data paired Student’s
t-tests were used. To study the relationship between FEV1, PEF and IOS
parameters Pearson’s correlation coefficients were calculated. Both for t-
tests and correlation coefficients statistical significance was assumed if p-val-
ues were < 0.05. Changes in FEV1, PEF and R during methacholine
challenge are expressed as percentage of baseline value. X values can not be
expressed in this way, because these values range from negative to positive
and cross the zero value in many children. In order to stratify the results of
bronchial challenge for all children, the methacholine doses are expressed as
the number of doubling doses prior to the maximal dose for each child. To
describe the sensitivity and specificity of changes in PEF and IOS parame-
ters in response to bronchial challenge in comparison to changes in FEV1
receiver operating characteristic curves (ROC) were used14. The area
under the ROC curve is a measure for the overall discriminatory perform-
ance of a test.
Results
Mean age of the children was 10.5 (3.5) years, height 146.6 (19.8) cm and
weight 42.5 (14.6) kg.
146
At baseline all children had normal lung function according to FEV1 (mean
100.4 (17.1) % of predicted). After the maximal dose of methacholine FEV1
fell significantly with simultaneously significant changes in PEF, R and X
values at all frequencies (p < 0.001, Table 1). After inhalation of salbutamol
all lung function parameters changed significantly compared to the post-
challenge level (p < 0.001, Table 1). The largest changes in absolute values
of R and X for both bronchoprovocation and bronchodilation were
observed at the lower values of the frequency spectrum (especially at 5 and
10 Hz). No significant differences between baseline and post-bronchodila-
tor values for any of the lung function parameters were observed (Table 1).
Results of Pearson correlation coefficients between the ‘gold standard’
FEV1 and PEF and R and X values are shown in Table 2. PEF, R5-35 and
X5-25 correlated significantly with FEV1, but X35 did not. The highest
coefficients of correlation between FEV1 and R and X values were seen at
the lower frequencies (5, 10 and 15Hz).
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Table 1. Values of FEV1, PEF, R, and X at baseline after bronchial challenge and
after subsequent bronchodilation in 19 children with mild to moderate asthma. All
changes were significantly different from the prior level (all p values < 0.001).
Baseline post-challenge Post-bonchodilator
FEV1 (ml) 2251 (780) 1776 (639) 2351 (779)
PEF (ml) 2740 (873) 2310 (795) 2870 (869)
R5 (kPa/L/s) .84 (.32) 1.27 (.36) .70 (.29)
R10 (kPa/L/s) .71 (.24) .92 (.21) .60 (.22)
R15 (kPa/L/s) .62 (.21) .75 (.18) .53 (.17)
R20 (kPa/L/s) .57 (.19) .67 (.17) .50 (.15)
R25 (kPa/L/s) .54 (.17) .63 (.16) .50 (.13)
R35 (kPa/L/s) .54 (.16) .63 (.15) .51 (.13)
X5 (kPa/L/s) -.13 (.12) -.35 (.25) -.08 (.08)
X10 (kPa/L/s) -.13 (.12) -.36 (.21) -.08 (.10)
X15 (kPa/L/s) -.08 (.11) -.26 (.14) -.02 (.09)
X20 (kPa/L/s) -.02 (.09) -.15 (.10) -.05 (.08)
X25 (kPa/L/s) .04 (.08) -.06 (.08) .11 (.07)
X35 (kPa/L/s) .18 (.06) .11 (.09) .23 (.06)
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Table 2. Pearson correlation coefficients between ‘gold standard’ measurements FEV1
and PEF, R, and X values in 19 children with mild to moderate asthma.
FEV1
PEF .83**
R5 -.71**
R10 -.73**
R15 -.71**
R20 -.70*
R25 -.63*
R35 -.65*
X5 .52*
X10 .57**
X15 .58**
X20 .58**
X25 .51*
X35 .02
** p < 0.001, * p < 0.01
Figure 1. Relative changes in FEV1, PEF, R5, and R10 (expressed as percentage change from baseline level)
during methacholine challenge (expressed as number of doses prior to the maximal dose) and subsequent bron-
chodilation (after) in 14 children with a fall in FEV1 of more than 20%. The open symbols represent changes
statistically different from baseline value.
In 14 of all 19 children who completed the bronchial challenge test a more
than 20% fall in FEV1 was achieved (responders). The mean PD20 in these
children was 98 microgram. In five children no threshold was achieved
(non-responders). Figure 1 shows the relative changes during the challenge
test of FEV1, PEF and R5 and R10 (expressed as percentage of the absolute
baseline value) of the responders. Figure 1 shows concomitant significant
changes in FEV1, PEF, and R10 from methacholine dose max-2, while R5
was already significantly increased from methacholine dose max-3. The rise
in resistance (especially in R5) values preceded the fall in FEV1 and PEF. In
the non-responders also concomitant changes in FEV1, PEF, R5 and R10
were observed, but these changes were not statistically significant (except
for R5 at dose max-1).
Figure 2 shows the relationship between mean changes (expressed as rela-
tive changes compared to baseline values) in FEV1 and in PEF, R5 and R10
during bronchoprovocation (negative changes) and bronchodilation (posi-
tive changes). This Figure shows a linear relationship between changes in
FEV1 and PEF, but a curvilinear relationship between changes in FEV1 and
R5 and R10.
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Figure 2. Relative changes in PEF, R5, and R10 (expressed as percentage change from baseline level) com-
pared to the relative changes in FEV1 during methacholine challenge and subsequent bronchodilation in 19
children with asthma.
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Figure 3. Receiver operating characteristic curve describing the relationship between sensitivity and specificity of
changes in PEF, R5, and R10 to detect a 20% fall of FEV1 during methacholine challenge.
Figure 4. Receiver operating characteristic curve describing the relationship between sensitivity and specificity of
changes in PEF, R5, and R10 to detect a 15% fall of FEV1 during methacholine challenge.
A ROC curve of the sensitivity and specificity of changes in PEF and R5
and R10 as a measure to detect a 20% fall in FEV1 during bronchial chal-
lenge is shown in Figure 3. The area under the ROC curve for PEF > R5
> R10 (0.80, 0.75, and 0.68, respectively). Because this study showed that
the rise in resistance values preceded the fall in FEV1 and PEF (Figure 1) a
second ROC curve was constructed, combining sensitivity and specificity
of changes in PEF and R5 and R10 to predict a 15% fall in FEV1 (Figure
4). The area under the ROC curve for R5 > PEF > R10 (0.85, 0.79, and
0.73, respectively). An increase in R5 of 50% to baseline showed an optimal
combination of sensitivity and specificity to detect a 15% fall in FEV1 (0.63
and 0.89 , respectively).
Discussion
The present study showed significant changes in all lung function parame-
ters after methacholine and salbutamol induced changes in airflow obstruc-
tion in children with asthma. Resistance (R) and reactance (X) values as
measured with IOS were significantly correlated with the ‘gold standard’
FEV1, R-values correlated better with FEV1 than X-values. The sensitivity
of R and X to experimentally induced changes in airway obstruction was
best at the lowest frequencies, especially at 5 to 15 Hz. This study also
showed that during bronchial challenge a rise in resistance values preceded
the fall in FEV1, which shows that both parameters are likely to reflect dif-
ferent pathophysiological aspects of airflow obstruction.
FEV1 is a widely accepted and well standardised parameter of airflow
obstruction1. In patients with neuromuscular diseases and in children under
the age of five years, the parameter is often not useful, because FEV1 meas-
urement requires forced expiratory manoeuvres. These groups of patients
lack co-ordination and co-operation. Kanengiser and Dozor showed that
only 32% of children aged three to five years do meet the ATS criteria of
reproducibility7. Therefore, in this study we studied children aged 5 to 17
years, to be sure of a reliable ‘gold standard’ for airflow obstruction. All
children met the ATS criteria of acceptability and reproducibility1.
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Home PEF meters are often recommended in monitoring airflow obstruc-
tion and bronchial hyperresponsiveness in patients with asthma15,16. In this
study PEF measurements were performed to compare the sensitivity and
specificity of this well-known parameter with the values of the relatively
new IOS parameters.
PEF values were strongly correlated with FEV1 values (Table 2), and fell
significantly after bronchial challenge and restored to baseline values after
subsequent bronchodilation (Table 1). Changes in FEV1 linearly correlated
with somewhat smaller changes in PEF (Figure 2). These results show that
PEF values can be easily used in population-based studies as a surrogate
when FEV1 is not available as a ‘gold standard’ for airway obstruction.
However, in individual subjects the use of PEF values to detect a prede-
fined level of airflow obstruction is hampered by suboptimal sensitivity and
specificity of the parameter (Figures 3 and 4). The PEF results of the pres-
ent study in children confirm the data from literature17 and are in line with
findings in adults18.
In this study results of a relatively recently described technique, the Impulse
Oscillation System (IOS) were compared with results of forced breathing
tests. The indices derived from IOS (R and X) are in principle comparable
to those obtained by the pseudo random noise method of Landsèr and co-
workers19. This method has proved to be valuable for measuring lung func-
tion and bronchial hyperresponsiveness in young children20. High technical
requirements to the recording systems, energy loss in the upper airways and
lack of sensitivity, especially at the higher frequencies impeded widespread
use of oscillation techniques. Recently, the Impulse Oscillation System
became commercially available and good sensitivity of R and X measured
at 5Hz for methacholine induced lung function changes were described in
2-4 and 4-6-year-old children21,22. The method is easy to perform and
might be helpful as a routine diagnostic.
In this study significant changes in mean values of both R and X values at
all frequencies were observed after bronchoprovocation and subsequent
bronchodilation (Table 1). Significant correlation of R and X values with
FEV1 was observed, especially when measured at low frequencies (5 - 10
Hz) (Table 2). Other studies also showed that R and X values, especially R
values at 5Hz were most sensitive to changes in airflow obstruction21-23. In
a recent study R5 and X5 values were used to study lung function in
groups of young asthmatic children24. These data show that IOS R and X
values measured at 5 and 10 Hz can be useful in population-based studies,
which can be attractive in patients who are not able to perform forced
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breathing manoeuvres, like patients with neurological or muscular disorders
and young children.
When lung function parameters are used to quantify changes in airflow
obstruction, changes have to be expressed relative to baseline values. In
children, lung function parameters are most time related to weight or
height, and this also true for R5 and X5 values25. Both deterioration (e.g.
during bronchial challenge) and improvement (e.g. during reversibility test-
ing) of lung function changes in children are to be expressed as a percent-
age of baseline values26. In this study changes in R values but not in X
values can be expressed in this way. X values range from negative to posi-
tive in many subjects (Table 1). Expression of changes in X-values as a per-
centage of baseline values would result in unrealistic or impossible numbers.
For this reason only R values are helpful to quantify relative changes in
individual subjects.
In this study a gradual increase in R values was observed during bronchial
challenge both in children who reached a FEV1 related PD20 level (Figure
1) and those who did not. The increase in R values during the challenge in
the non-responder group was not statistically significant (except for R5 at
methacholine dose max -1). In the responder group, R values were already
rising (R5 significantly at methacholine dose max -3) while FEV1 values
were still unaffected (Figure 1). The relationship between changes in FEV1
and changes in R5 and R10 were further analysed in Figure 3. This Figure
shows a curvilinear relationship between changes in FEV1 and R values,
with large changes in R5 and R10 when FEV1 changes from 100 to 90% of
baseline value and rather small changes of R5 and R10 when FEV1 further
decreases from 90 to 80% of baseline value. The curvilinear relationship
between changes in FEV1 and changes in R5 and R10, in contrast to a lin-
ear relationship between changes in FEV1 and PEF suggest that FEV1 and
R values are likely to reflect different pathophysiological aspects of airflow
obstruction. FEV1 is measured during maximal expiration from the maxi-
mal inspiratory lung volume, while R values are measured during tidal
breathing. Airway resistance is known to be related to lung volume27.
Changes in FEV1 values are largely caused by changes in airflow limitation,
while R values are more directly related to airway calibre.
The present study shows that the sensitivity and specificity of R5 and R10
to detect a 20% fall in ‘gold standard’ FEV1 do not exceed the performance
of PEF values, resulting in a smaller area under the ROC curve (Figure 3).
However our results showed that changes in R were more sensitive to
detect smaller changes in FEV1 in subjects with normal baseline lung func-
6
C
H
A
P
TE
R
IMPULSE OSCILLOMETRY
153
tion. The best combination of sensitivity and specificity to detect a 15% fall
in FEV1 was observed when an increase of 50% compared to baseline R5
values was chosen as cut-off point. The area under the ROC curve for R5
(0.85) exceeded the area for PEF and R10 (0.79 and 0.73, respectively,
Figure 4), but was also superior to the area under the curve for PEF in the
detection of a 20% fall in FEV1 (0.80, Figure 3). These findings suggest that
IOS R5 measurements can be used as a parameter in bronchial challenge
testing in individual subjects with normal baseline lung function.
In conclusion, R and X values can easily be acquired using the IOS. They
showed significant changes during changes in airflow obstruction and have
significant correlation with FEV1. In groups of patients, R5 and X5 can be
used as an indirect measure of airflow obstruction. In individual patients R5
showed to be superior to PEF measurements in the detection of a 15% fall
in FEV1. Although the parameters do not exactly reflect the ‘gold standard’
FEV1, this technique might be helpful in patients who are not able to per-
form forced breathing manoeuvres.
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Children with mild
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from inhaled 
corticosteroids?
Abstract
In children with mild asthma, who show hardly any abnormalities in pul-
monary function, objective measurement of the effect of inhaled corticos-
teroids (ICS) is difficult.
We evaluated the short term effect of fluticasone propionate (FP) in these
children, using both subjective and objective parameters. 68 children (5-10
years old) were randomly assigned to either FP 250 µg or placebo twice
daily as pMDI via spacer during 12 weeks. Symptom scores, use of rescue
medication, wheezing, parent global evaluation and pulmonary function
tests (PFTs) including forced expiratory volume in 1 second (FEV1), peak
expiratory flow (PEF) and bronchial responsiveness were evaluated.
FP treated versus placebo treated children showed significant changes in %
symptom free days (OR FP versus placebo =1.9, p=0.03), use of β2-
mimetics (OR=3.08, p<0.01), morning (+16L/min, p<0.01) and evening
PEF (+19 L/min, p<0.01), FEV1%pred (+4.6%, p=0.04) and wheezing
(OR=0.38, p=0.04). No significant improvements were found for parent
global evaluation, absolute values of FEV1, nor for PD20.
These findings show that ICS are effective in children with mild asthma. This
effect can be assessed by both objective and subjective parameters. Even
when pulmonary function is normal early start of ICS should be considered.
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Introduction
Inhaled corticosteroids (ICS) are considered the most effective anti-inflam-
matory drugs in the treatment of asthma in both children and adults. They
reduce symptoms and number of hospitalisations, improve pulmonary func-
tion and bronchial hyperresponsiveness (BHR)1-3 and are more effective
than β2-agonist alone4. International guidelines consider ICS to be indicat-
ed in moderate to severe asthma, but more recent studies promote their use
as well in less symptomatic and also in younger patients, because this
approach might prevent permanent impairment of pulmonary function and
irreversible structural airway remodelling5-7. However, until now interna-
tional consensus reports do not recommend the use of ICS in subjects who
have only mild and infrequent symptoms and who have normal airway cali-
bre most of the time8.
In patients with severe and moderate asthma PFT parameters abnormal and
can be used as effect parameters to evaluate ICS treatment. However, these
parameters are often in the normal range in patients with mild asthma. In
children these normal ranges are wide and PFT parameters could be
decreased in a relative sense and show improvement after proper treatment.
Especially in young children there is a lack of proper effect parameters.
Symptom scores and the use of short-acting β2-agonists are the most fre-
quently used parameters, but these are sensitive to placebo effects (4). There
are only few studies on the short9,10 or long term effect11 of ICS in children
with mild asthma. Especially placebo controlled studies are rare12-14.The
aim of this study was to evaluate the effect of short term treatment with
ICS on both subjective and objective disease parameters in 5-10 year old
children with mild asthma.
Patients and Methods
Patients
5-10 years old children with a doctor’s diagnosis of asthma15 were recruit-
ed. Patients were excluded if prior to the study they had used systemic cor-
7
C
H
A
P
TE
R
THE EFFECT OF ICS
161
ticosteroids in the last 2 months, ICS >100 µg budesonide (BUD) or
beclomethasone dipropionate (BDP) daily in the last 4 weeks, salbutamol
>1600 µg daily during more than 30% of days of the last year prior, if they
had been hospitalised for asthma in the last 2 weeks or if they had other res-
piratory disorders, systemic disease or anatomical abnormalities. Written
informed consent was obtained from parents of all participating patients.
Power analysis was performed with percentage of days without asthma
symptoms as calculated from the diary cards as the primary outcome vari-
able. For the power calculation the change from baseline of this variable
was used. The standard deviation of this change was set at 30 percent
points. The clinically relevant difference of change from baseline between
the placebo group and the FP group was set at 20 percent points. To detect
this difference with 80% power, 35 patients per treatment group were
needed, given a test size of 5% (two sided).
Study Design and methods
This was a multi-centre, double blind, placebo controlled, randomised, par-
allel group study. Patients were recruited from one paediatric pulmonology
outpatient clinic of a university hospital, one asthma centre and seven gen-
eral hospitals. The study was approved by all local ethic committees.
Subjects were randomly assigned to use either two puffs of FP 125 µg or
two puffs of placebo bd from a pMDI via a plastic spacer device
(Volumatic, Glaxo Wellcome, Zeist, The Netherlands) during 12 weeks.
During the whole study salbutamol 200 µg via spacer was allowed as rescue
medication. Exacerbation of asthma, defined as an increase in asthma symp-
toms not controlled with salbutamol up to 8 times 2 puffs daily, was treated
at the discretion of the investigator with prednisolone 1-2 mg/kg daily dur-
ing 3 days.
At visit 1, at the beginning of a 2 week run in period, the study was
explained, medical history, concurrent medication and demography were
recorded, together with the presence or absence of wheezing and PFTs
were performed. Parents and children were instructed to use the PEF meter
at home, to fill out the daily record card (DRC) and to use rescue medica-
tion if necessary. After comprehensive instructions they were able to inhale
medication properly via a spacer device and perform PEF measurements.
Only patients using BDP or BUD < 100 µg daily, prior to the study, were
instructed to continue this medication throughout the study in addition to
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the study medication.
At visit 2 after 14±3 days only patients with symptoms on at least 50% of
days during the run in period were randomised, excluding patients who
used rescue medication > 8 puffs/day on >4 days during the run in period.
Further visits were scheduled 3, 11 and 12 weeks later (visit 3, 4 and 5
respectively). At all visits baseline PFTs were performed. At visit 2 and 4
bronchoprovocation tests were performed after baseline PFT. At every visit
adverse events, concurrent medication, asthma exacerbations and compli-
ance with the study were checked.
Assessments
Throughout the study the parents filled out a DRC for presence of asth-
matic symptoms, use of rescue medication, both morning and evening PEF,
adverse events and concurrent medication.
PEF measurements were performed using the Personal Best PEF meter
(Healthscan, Cedar Grove, NJ, USA). The highest value of a minimum of
three acceptable measurements was recorded.
Maximal expiratory flow volume (MEFV) measurements were performed
conform the ECCS recommendations16 using a pneumotachometer system
(Masterscreen Pneumo, Erich Jaeger, Würzburg, Germany). The best of
three technically good measurements was recorded. The following parame-
ters were recorded: FEV1 and FEV1 as percentage of predicted
(FEV1%pred)
17. No bronchodilator had been used less than 8 hours before
PFT.
Bronchial responsiveness was measured using methacholine bromide
provocation according to a standardised protocol18.
At all visits wheezing, defined as the presence of a prolonged audible expi-
ratory phase during auscultation and/or use of accessory respiratory mus-
cles, was judged on physical examination by the same paediatrician. During
the last visit the parents were asked to rate the effect of study medication on
symptoms on a scale from 1 (strongly improved) to 4 (worsened).
Data analysis
The symptoms and use of rescue medication were summarised daily as
symptom-free (yes/no) and rescue medication-free (yes/no). Within each
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patient these daily scores constituted a series of repeated 0/1 data that were
analysed using a generalised linear model for repeated measurements with
model fitting based on Generalised Estimating Equations (GEE)19. Because
of the binary (0/1) outcome scores, the binomial distribution was assumed
with the dependency of the probability parameter on the explanatory vari-
ables modelled through a logistic function. The day to day correlation
structure of the outcome scores was assumed to be first order auto-regres-
sive (“AR(1)”). In the logistic model the treatment effect was represented
by an odds ratio (OR) (95% confidence interval (CI)) of active relative to
placebo treatment. Adjustment was made for the percentage of (%) symp-
tom free (or rescue medication free) days during the baseline period as con-
tinuous cavort and for time under treatment defined by four consecutive
periods of three weeks as a within patient factor. The point of dividing the
treatment period in four equal periods of 3 weeks was to find a general cat-
egorical treatment by time interaction without having to assume a priori a
linear trend in this treatment by time interaction. The interaction between
treatment and time was tested. If this interaction turned out to be signifi-
cant with p < 0.10, then the treatment effect was presented per period.
Else, one overall treatment effect (assumed to be constant in time) was pre-
sented.
Morning and evening PEF values, measured at home were used to calculate
3-week averages per patient for each of the four 3-week periods, for morn-
ing and evening separately. These averages constituted the four repeated
measurements of the outcome variable, which were analysed using mixed
model ANOVA. The independent variables in this analysis were treatment
group ( a 2-level between patient factor) and period (a 4-level within
patients factor); the average PEF per patient over the baseline period was
included in the model as a continuous cavort. An AR(1) correlation struc-
ture between the repeated measures was assumed. The treatment by period
interaction was tested and dealt with as described for DRC data.
Repeated PFTs were performed at baseline and three times during the 12
weeks treatment period. In a mixed model analysis of variance (ANOVA)
the values of each PFT parameter during treatment were compared
between the two treatment groups, adjusted for period (3 levels) and base-
line measurement of the outcome variable at hand. Also the treatment by
period interaction was tested and dealt with as described for DRC data. No
structure was assumed for the (co)variance matrix of the residuals.
The dose of methacholine causing a 20% decrease of FEV1 (PD20) was
analysed as doubling doses after ln2-transformation using non-parametric
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tests, because values higher than 8 were coded as 8. The PD20 at visit 3 was
compared between the two treatment groups, using the Mann-Whitney
test. Within group changes from baseline were tested using the paired
Wilcoxon test. PD20 was also analysed after dichotomization in hyperre-
sponsive yes (ln2 PD20 < 8) versus no. The measurement at visit 3 was
compared between the two treatment groups using logistic regression
analysis, with the baseline score as covariant. The treatment effect could
then be expressed as an OR, adjusted for baseline.
There were four repeated physical examinations during the 12 weeks treat-
ment period: visit 2 to 5. The absence or presence of wheezing was
analysed using the same generalised linear model as described for DRC
parameters. The between visit correlation structure of the responses was left
unstructured. The treatment effect was represented by an OR (95% CI) of
active versus placebo.
The parent global evaluation for both treatment arms was compared using
the χ2 trend test.
Results
88 patients entered the run in period. 20 patients were withdrawn before
randomisation, due to insufficient asthmatic symptoms (n=14), too frequent
use of rescue medication (n=1), poor compliance (n=2), an asthma exacer-
bation (n=1), adverse effect of salbutamol (n=1) and withdrawal of parental
informed consent on second thoughts (n=1) during the run in period. 68
patients were randomised and completed the study.
Patient baseline characteristics are shown in Table 1. There were no signifi-
cant differences between withdrawn patients and included patients nor
between patients in both treatment arms. During the run in period mean
symptom scores and clinical scoring indices were low and mean pulmonary
function parameters were within normal ranges.
Prior to the study 6 patients received maintenance treatment with bude-
sonide (4) or beclomethasone < 100 µg daily (2). These ICS were contin-
ued by 1 (3%) and 5(15%) of FP and placebo treated patients respectively.
There were no significant differences between both treatment arms in
number of asthma exacerbations, adverse events, concurrent medication,
and compliance with the study.
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Symptom score, use of rescue medication and home PEF assessments.
The mean % symptom free days increased from 14% during the run in peri-
od to 25-49% in the placebo versus 42-66% in the FP treated group over
the four consecutive periods (Figure 1). The estimated OR for FP versus
placebo was 1.93 (95% CI 1.05-3.54; p=0.04). There was no suspicion that
the OR changed in time (p=0.89).
The mean % rescue medication free days increased from 48% to 57-67% in
the placebo versus 83-86% in the FP treated group over the four periods
(Figure 2). The estimated OR of FP versus placebo was 3.08 (95% CI:1.49-
6.36; p<0.01) without suspicion of changes of OR in time (p=0.76).
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Table 1. Patient demographics and baseline characteristics 
fluticasone Placebo drop outs
n 35 33 20
sex F/M 16/19 10/23 5/15
age(yrs) 6.86 (1.5) 6.97 (1.48) 6.55 (1.7)
height(cms) 127 (10.2) 126 (10.4) 124.1 (9.8)
weight(kg) 24.6( 4.4) 27.4 (6.7) 25.2 (5.2)
% symptom free days (%) 16.2 (20.7) 10.6 (15.9)
% rescue med free days (%) 49.4 (36.3) 45.8 (38.3)
FEV1 (L) 1.54 (0.37) 1.53 (0.39)
FEV1 (%pred) 104.1 (10.8) 99.8 (17.0)
bronchodil. response (FEV1%pred) 6.9 (6.2) 10.9 (6.2)
FVC (%pred) 99.0 (10.8) 94.1 (18.7)
tPTEF/tE (%) 27.4 (7.7) 26.4 (7.6)
PEF morning at home(L/min) 213.4 (63.9) 210.6 (58.6)
PEF evening at home(L/min) 219.1 (62.3) 219.8 (58.0) 
PEF at laboratory (L/min) 231.7 (68.6) 228.6 (70.5)
ln2 PD20 6.8 (1.9) 5.8 (2.1)
Values are presented as mean (SD) unless stated otherwise. Percentage of symptom free and percentage
of rescue free days were calculated from the 14 ±3 days during the run in period. ln2 PD20 was meas-
ured at visit 2. All other baseline characteristics were determined at the beginning of the run in period.
The mean difference in PEF between the FP and placebo treated group
varied significantly over the periods (p<0.10) both for morning (p=0.01)
and evening (p=0.09) values. Mean PEF was higher in the FP treated than
in the placebo treated group (Figure 3). For morning PEF the mean differ-
ences between both groups was 16 L/min (p<0.01), varying from 11 to 24
L/min, for evening PEF this was 19 L/min (p<0.01), varying from 14 to 26
L/min. For all periods these effects were significant.
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Figure 1. Changes in % symptom free days adjusted for baseline during 12 weeks of treatment with study
medication.
Figure 2. Changes in % rescue medication free days adjusted for baseline during 12 weeks of treatment with
study medication.
placebo
fluticasone propionate
placebo
fluticasone propionate
run in week 1-3 week 4-6 week 7-9 week10-12
run in week 1-3 week 4-6 week 7-9 week10-12
%
 s
ym
pt
om
 fr
ee
 d
ay
s
%
 r
es
cu
e 
m
ed
ic
at
io
n 
fr
ee
 d
ay
s
Pulmonary function tests
Compared to placebo treated children absolute values of FEV1 (FEV1abs)
showed no significant change (+0.06 L, p=0.08), but there was a small but
significant increase in FEV1%pred in the FP treated children (+4.6%,
p=0.04) (Figure 4).
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Figure 4. Changes in FEV1%pred (+ SE) during 12 weeks of treatment with study medication.
Figure 3. Changes in morning and evening PEF values adjusted for baseline during 12 weeks of treatment
with study medication.
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After 11 weeks of treatment ln2 PD20 was significantly higher in the FP
treated group compared to placebo (7.14 versus 5.96, p=0.04) but there was
no significant difference between the two groups in change of ln2 PD20
from baseline to week 11 (p=0.11).
Wheezing score.
At the end of treatment 32 of 35 FP treated (91%) and 26 of 33 (79%) place-
bo treated patients showed normal wheezing scores. This difference was
not statistically significant (p=0.11), but significant improvement in wheez-
ing score were seen in the FP versus placebo group at visit 4 (p=0.008
respectively), not at other visits. The OR for FP versus placebo for wheez-
ing was 0.38 (95%CI 0.15-0.96, p=0.04) for the whole study period.
Parent global evaluation
71% of parents of FP treated versus 52% of placebo treated children report-
ed an improvement of symptoms. Increasing symptoms were experienced
by 15% of parents of placebo versus 0% of FP treated children. This differ-
ence was not significant (p=0.062).
Discussion
In this study the effects of ICS in 5-10 year old children with mild asthma
was compared to placebo, using both subjective and objective parameters.
Treatment with FP significantly improved % symptom free days, % rescue
medication free days, both morning and evening PEF values, FEV1%pred
and wheezing score. No significant improvements were found for parent
global evaluation, absolute values of FEV1 and PD20.
In mildly symptomatic adult patients there is evidence of airway inflamma-
tion, improving after treatment with ICS20. In adults improvement of night
time symptoms, rescue medication use and morning PEF were recorded as
well21.
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Until now only few studies evaluated the effect of ICS in children with
mild asthma9-13. Most of these studies were performed in older children
and using different effect parameters. Partially contradictory results were
found. Effects were found on symptom scores. Some found improvement
of PEF values9,10, others did not or found only improvements in evening,
not in morning PEF12,13. Hoekx et al. found a significant improvement of
PEF values in older children after 8 weeks of treatment with both FP 400
µg and budesonide 400 µg, despite the fact that at the beginning of the
study the lung function was near normal. However, the latter study was not
placebo controlled and patients were not steroid naive10. An improvement
of bronchial responsiveness in children with mild asthma was described in
two papers12,13. In contrast to the present study, no significant effect on
FEV1 was found in most studies
9-13.
The present study provides further evidence for a positive effect of ICS in
children with only mild asthma. The conjecture that asthma in the patients
studied was mild is supported by the fact that at an age > 5 years most of
the patients were not treated with anti-inflammatory agents, on average had
mild symptoms, pulmonary function and bronchial responsiveness were
rather normal and salbutamol use was low. Still improvements in both sub-
jective and objective effect parameters were found. Most prominent were
changes in symptom scores and use of rescue medication, but significant
changes were found in PFT results as well. No significant changes in BHR
were recorded.
The use of symptom scores and use of rescue medication is easy and can be
used even in young children who cannot perform lung function tests. The
participating patients were selected on basis of symptoms and the use of B2
agonists, so that bias because of regression to the mean may have caused
part of the improvements in both the treatment and placebo groups.
Although baseline FEV1%pred values were high (>100% pred) and
reversibility was poor in contrast to other studies12,13 a small, though signif-
icant improvement in FEV1%pred was recorded after only 12 weeks of
treatment. The only comparable study was performed by Jonasson et al12.
In a later study, they also found a significant dose response effect on FEV1
in a 24 months follow up study with ICS in 122 mildly asthmatic chil-
dren14. Recently, in a large, placebo controlled, long term study, the
Childhood Asthma Management Program Research Group found signifi-
cant improvements of pre bronchodilator FEV1%pred and FEV1/FVC (%)
in mildly to moderately symptomatic 5-12 year old children after 4-6 years
treatment with BUD. However, the improvement of FEV1%pred was
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attributed to a smaller stature in the BUD treated group. Also airway
responsiveness and symptom control improved11.
The present study shows that in children with mild asthma pulmonary
function can improve after only short term treatment. Improvements are
only small but significant, especially when normal baseline parameters are
considered. Normal lung function in children with symptoms of asthma
does not rule out airway obstruction, improving after proper treatment.
As in earlier reports this study demonstrated that after the start of ICS treat-
ment the improvement of PEF and symptoms often precede the improve-
ment of other lung function parameters4. In the present relatively short
study it could be expected that these parameters would change most promi-
nently. The improvement of PFT parameters gradually increased during the
study (Fig 3 and 4). Earlier studies in children with normal lung function
may have been too short or the ICS dose too low to observe these effects.
In the present study no changes in BHR were found in both treatment
arms. The finding of BHR in this study population indicates that airway
inflammation is present even in mild asthma. Although this finding supports
treatment with ICS, no significant benefit of treatment on BHR could be
established in the present study. As mentioned before this may be due to
the relatively short treatment period and is in agreement with the existing
concept that improvement of BHR is a relatively late response after institu-
tion of ICS and that improvement can continue over years. Van Essen
Zandvliet et al showed that reduction in BHR increases gradually and only
stabilises after 20 months of treatment with ICS4. The value of long term
treatment and the possible preventive effects on remodelling still need to be
established.
Normally lower doses of ICS are used for treatment of children with mod-
erate (or mild) asthma. However larger doses are sometimes used by paedia-
tricians and paediatric pulmonologists especially in a step down therapy.
With the present dose we did not expect serious adverse reactions in this
relatively short study, while optimal treatment effects could be expected,
compared to placebo.
In conclusion, in 5-10 year old children with mild asthma treatment with FP
results in improvement of symptoms, salbutamol use, PEF and FEV1%pred.
These findings suggest that normal lung function does not rule out airway
obstruction and even in young patients with mild asthma early start of ICS
maintenance might be considered. In view of these results and the emerging
knowledge of long term airway remodelling in patients with chronic asthma
treatment of mildly asthmatic patients with ICS is recommended.
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agonists in preschool 
children with recurrent
asthmatic symptoms:
are they effective and
can the effect be 
predicted?
Abstract
We evaluated the short term effects of inhaled corticosteroids in pre-school
children with recurrent or chronic asthma-like symptoms, using both sub-
jective and objective parameters. The predictive power of several baseline
characteristics for this effect was studied too.
99 children (1-4 years old) were randomly assigned to receive either flutica-
sone propionate (FP) 250 µg or placebo twice daily during 6 weeks.
Changes in symptom scores, use of rescue medication and pulmonary func-
tion test (PFT) parameters were assessed. Interrupter resistance (Rint),
oscillation resistance and reactance (R5 and X5) and time and volume to
peak tidal expiratory flow divided by total expiratory time (or volume)
(tPTEF/tE and VPTEF/VE respectively) were measured.
FP treated children showed significant improvements of Rint (p = 0.024),
tPTEF/tE (p = 0.009) and VPTEF/VE (p = 0.003), compared to placebo.
Almost significant changes were found for R5 (p = 0.13) and X5 (p =
0.07). No significant changes in % symptom free days or % rescue medica-
tion free days were found. PFT improvement could not be predicted from
baseline characteristics, but children with decreased baseline pulmonary
function showed the best improvement of subjective markers.
We conclude that the effect of 6 weeks treatment with ICS in pre-school
children with asthma-like symptoms is best demonstrated by PFT markers,
not by subjective markers. Decreased pulmonary function appears to pre-
dispose to a beneficial effect.
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Introduction
During early childhood as many as 40% of children experience recurrent
asthmatic symptoms such as wheezing, cough or breathlessness1. In more
than half of these children symptoms disappear around the age of 6 years.
These symptoms are thought to reflect congenitally narrow airways, which
predispose to wheezing during viral infections2. In other children symp-
toms persist and the latter group is eventually labelled as asthma. Pulmonary
function testing (PFT) in asthmatic children shows bronchial hyperrespon-
siveness and bronchodilator responsiveness. Many of these patients have a
positive family history for atopy and personal skin prick test positivity and
increased levels of total and specific IgE.
The treatment of asthma with inhaled corticosteroids (ICS) has shown to
be effective and safe in adults and older children3,4. There is a tendency to
treat young children with recurrent asthmatic symptoms in a similar way.
However, in most of these patients the diagnosis of asthma is uncertain and
the effect of ICS is less well established.
Few studies concentrate on the effect of ICS in pre-school children. Some
small clinical trials showed variable effects of continuous, prophylactic treat-
ment with ICS in pre-school children5-10. Recently some bigger studies
showed improvement in “subjective” effect parameters during treatment
with ICS11,12.
One of the major problems in evaluating the effect of ICS in pre school
children is the lack of proper objective effect parameters. In most studies
only subjective parameters as symptom scores, use of rescue medication and
number of exacerbations were used. Objective effect parameters of ICS
have been used scarcely in pre-school children13.
Although there are certain “predictors” of asthma in pre school children,
there is no readily available instrument to identify pre-school children with
recurrent asthmatic symptoms who will benefit from ICS treatment.
The purpose of this study was to evaluate both the subjective and objective
effects of ICS treatment in symptomatic 1-4 year old children with recur-
rent or chronic respiratory symptoms and to determine specific patient
characteristics and risk factors that might predict these effects.
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Methods
The primary efficacy endpoint of this study was the effect of treatment on
percentage (%) of symptom free days and the secondary endpoints the effect
on % rescue free days and change in lung function parameters.
This was a prospective double blind, placebo controlled, randomised, paral-
lel group study, conducted at the outpatient departments of 8 centres in the
Netherlands (one paediatric pulmonology department of a university hospi-
tal and seven general hospitals) conform the Declaration of Helsinki and
Good Clinical Practice14. The study was approved by all local ethic com-
mittees and written informed consent was obtained from parents of all par-
ticipating patients.
For the power calculation the change from baseline of % symptom free days
was used. The standard deviation of this change was set at 29 percent points
(calculated from the study by Bisgaard et al.11. The clinically relevant differ-
ence of change from baseline between the placebo group and the FP group
was set at 15 percent points. To detect this difference with 75% power, 50
patients per treatment group were needed, given a test size of 5% (two-
sided). Study drugs were randomly assigned numbers in blocks and arbitrar-
ily distributed among sites and each patient was assigned a medication
number on entry. Treatment assignments were not known to patient nor
investigator during or after the trial.
Study population.
Children aged 12-48 months with a documented history of recurrent (≥ 5 peri-
ods of ≥ 10 days during the last year) or persistent (≥ 1 month) asthmatic symp-
toms (coughing, wheezing and/or breathlessness) were recruited for this study.
Patients were excluded if they had used systemic corticosteroids or inhaled cor-
ticosteroids in the 2 months and 1 month before the run in period, respective-
ly. Patients were excluded if they had used salbutamol ≥ 800 µg daily during
more than 30% of days of the year prior to the study, had been hospitalised for
their asthma in the 2 weeks prior to the study or had other respiratory disor-
ders, systemic disease or anatomical abnormalities.
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Study design.
At visit 0, at the beginning of a 2 week run in period, the study was
explained and medical history, concurrent medication and demography
were recorded. Parents were instructed to fill out a daily record card.
Children proved to be able to inhale study medication and rescue medica-
tion using a plastic spacer (Babyhaler (BH), Glaxo Wellcome, Zeist, The
Netherlands) with support of their parents. During the run in period all
patients used placebo 2 puffs twice daily to minimise placebo effects due to
changes of therapy routine. Throughout the study patients used inhaled
salbutamol 200 µg, 1 puff delivered via the pMDI and spacer, each time as
needed for relief of asthmatic symptoms. Parents were instructed to wash
the spacer once monthly, or more often if necessary and let it dry on air.
At visit 1, after 14±3 days, all patients who had shown any respiratory
symptoms (coughing, wheezing and/or dyspnoea) on at least 50% of days
during the run in period were definitively included. Patients who experi-
enced an exacerbation of symptoms that had to be treated with extra
inhaled or systemic steroids during the run in period or patients who need-
ed >4 puffs of salbutamol 200 µg during >7 days during the run in period
were excluded.
During the following week patients received salmeterol xinaphoate 25 µg
per puff twice daily. After 7 days the effect of salmeterol was checked via a
telephone call and the parents were instructed to restart placebo 2 puffs
twice daily during the following week (wash out period).
At visit 2, 14 (±3) days after visit 1, pulmonary function tests were per-
formed and blood samples taken for allergy markers.
For the next 6 weeks subjects were randomly assigned to use either two
puffs of fluticasone propionate (FP) 125 µg or placebo twice daily.
Three weeks after visit 2 a telephone call was made for control and reassur-
ance of treatment.
At visit 3, 6 weeks (± 3 days) after visit 2, pulmonary function tests were
performed, study medication was stopped and parents were instructed to
use rescue medication on demand (wash out period).
At the final visit 4, 4 weeks(±3 days) later study medication was stopped
and further treatment was started at the discretion of the investigator. The
study was completed with follow-up telephone contact after 2 weeks.
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Assessments
Patient history, daily record card check, parent global evaluation, subjective
effect of rescue medication and physical examination were performed at all
visits. Pulmonary function tests were performed before (visit 2) and after
(visit 3) treatment.
Daily record cards
Throughout the study the parents filled out a daily record card, rating their
child’s asthmatic symptoms (coughing, wheezing and/or shortness of
breath) on a scale from 0 to 4 for both daytime (0 = no symptoms, 1 =
once short symptoms, 2 = more than once symptoms, 3 = frequent symp-
toms and 4 = almost continuous symptoms) and night-time (with 0 = no
symptoms, 1 = once symptoms, without waking up, 2 = waking up
through symptoms once, 3 = waking up through symptoms more frequent-
ly and 4 = hardly or not sleeping at all). Also the number of salbutamol
puffs (rescue medication), adverse events and concurrent medication were
recorded.
Clinical scoring index and physical examination
The clinical scoring index provided a description of the general impression
of the paediatrician about the patient’s asthma related physical condition.
Both pulmonary auscultation and inspection were rated, ranging from 0
(=normal breathing, no wheezing), 1 (= expiratory wheezing without use
of accessory respiratory muscles), 2 (=in and expiratory wheezing without
use of accessory respiratory muscles), 3 (=in and expiratory wheezing with
mild use of accessory respiratory muscles) to 4 (=wheezing audible without
stethoscope and marked use of accessory respiratory muscles).
Pulmonary function tests
In 7 centres tidal breathing analysis (TBA) was performed, in 3 centres
interrupter resistance (Rint) measurement and in the academic centre also
impedance measurements with the impulse oscillation system (IOS) were
performed. When applicable the order of performance was TBA, followed
by IOS and finally Rint.
TBA was performed by a fully computerised TBA system (Master Screen
Paediatric, Erich Jaeger, Würzburg, Germany) with use of a mouth-
piece15,16. We used tPTEF/tE (time to peak tidal expiratory flow divided
by total expiratory time) and VPTEF/VE (expiratory volume to peak tidal
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expiratory flow divided by total expiratory volume) as measures of airway
obstruction.
Airway resistance was measured by the interrupter technique (Rint), using
a commercial device (MicroRint, MicroMedical Ltd, Rochester, UK) as
described previously17. Rint was calculated using the back extrapolation
technique to t = 0 ms after shutter closure during 100ms18.
Subjects were, if necessary, supported by parent or guardian. After explana-
tion of the technique at least one practice attempts was made before really
starting the procedure. They were instructed to breath quietly, sitting
upright with slightly extended neck and the chin and cheeks supported by
the investigator. A nose clip was used. After a period of quiet breathing in
response to a trigger during expiration at the peak tidal expiratory flow a
single shutter closed automatically within 10 ms and stayed closed for 100
ms. After 10 interruptions a minimal number of 5 correct tracings was
obtained. From these the median value was recorded. The logarithm of this
median value was used in the statistical analyses. Tracings were rejected in
case of tachypnoea, usage of vocal cords, irregular or forced breathing or
leakage.
The impedance of the total respiratory system was measured using a com-
mercially available oscillometry system (Masterlab-IOS, Erich Jaeger,
Germany), which has been described elsewhere19. In this study mean R
and X values were calculated over a measurement period of 60 sec in the
frequency range 5 - 35 Hz. We used only values measured at 5 Hz (R5 and
X5). During IOS measurement the children were sitting upright, their head
resting against the back of the chair. They were instructed to breath quietly
through the face mask. To reduce loss of energy in the upper airways their
cheeks and chin were supported by the hands of the investigator who was
standing behind the patient.
All lung function tests of a patient were performed on the same time of the
day and, if possible in these young children, all PFTs were repeated 15 min-
utes after administration of salbutamol 800 µg through pMDI and spacer.
Efficacy of salbutamol rescue medication
After the run-in period the parents were asked to judge the efficacy of the
salbutamol medication to treat the symptoms of their child, by using the
following questionnaire: “After the inhalation of the salbutamol rescue
medication the symptoms of my child have: 1 = strongly improved, 2 =
improved, 3 = unchanged, 4 = increased, 5 = strongly increased.
Salbutamol efficacy was also measured as bronchodilator response (BDR)
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using all three PFTs: BDR = Rintpre/Rintpost, tPTEF/tEpre - tPTEF/tEpost
and R5pre - R5post. 
Efficacy of salmeterol
During the run-in period and the salmeterol test period the parents record-
ed the symptoms and salbutamol use in the daily record card. The data
were averaged over the week before and the week during the salmeterol
test. The differences of the scores were investigated for their modifying
strength on the efficacy of fluticasone versus placebo. The efficacy of salme-
terol was also checked by parent global evaluation, asking the parents to
judge the clinical course at the end of the salmeterol test week, using the
same questionnaire as stated under Parent Global Evaluation.
Predictors of effect
Data for the following determinants were analysed for possible modification
of ICS effect:
1. Medical history: age category (1 to 2, 2 to 3, 3 to 4 yrs), sex
(male/female), height (cms), number of atopic subjects in first degree
relatives (0, 1, > 2), smoking history of the parents (0, 1 or 2 par-
ents), number of exacerbations in the past 12 months, living condi-
tions (pets, floor covers, humidity) (yes/no), reported other allergic
manifestations (yes/no), eczema (yes/no) frequent rhinitis (yes/no)
and frequency of symptoms (frequent = ≥ 75% of days, infrequent =
< 75% of days during run in).
2. Wheezing at physical examination at one or more visits (yes/no)
3. Laboratory tests: total IgE and RAST (positive versus negative).
4. Pulmonary function parameters (tPTEF/tE above median versus
under median, Rint above versus under median) and BDR at visit 2.
We did use neither R5 nor X5 under versus above median because
of the small numbers of children performing IOS.
5. Subjective evaluation of the effect of salbutamol rescue medication at
visit 1.
6. Parent global evaluation: perceived efficacy of rescue medication and
of 1 week treatment with salmeterol 50 µg bd via pMDI with
Babyhaler.
7. Change of symptoms (described in the daily record card) during
treatment with salmeterol, compared to the run in period.
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Data analysis
The symptoms and use of rescue medication were summarised daily as
symptom-free (yes/no) and rescue medication-free (yes/no). Within each
patient these daily scores constituted a series of repeated 0/1 data that were
analysed using a generalised linear model for repeated measurements with
model fitting based on Generalised Estimating Equations (GEE)20. Because
of the binary (0/1) outcome scores, the binomial distribution was assumed
with the dependency of the probability parameter on the explanatory vari-
ables modelled through a logistic function. The day to day correlation
structure of the outcome scores was assumed to be first order auto-regres-
sive (“AR(1)”). In the logistic model the treatment effect was represented
by an odds ratio (OR) (95% confidence interval (CI)) of active relative to
placebo treatment.
The percentage of symptom-free and rescue free days were calculated in
each child, during the last week before randomisation and during the 6-
weeks treatment period. Adjustment was made for the % symptom free (or
rescue medication free) days during the baseline period as continuous co-
variate and for time under treatment defined by three consecutive periods
of two weeks as a within patient factor; also the interaction between treat-
ment and time was tested. If this interaction turned out to be significant
with p < 0.10, then the treatment effect was presented per period. Else, one
overall treatment effect (assumed to be constant in time) was presented.
The change in the percentages of symptom free and rescue free days and
nights during the salmeterol test week were tested using the paired
Wilcoxon test.
PFTs were performed before (visit 2) and after the 6 weeks treatment peri-
od (visit 3). In an analysis of co-variance (ANCOVA) the values of each
PFT parameter after treatment was compared between the two treatment
groups, adjusted for baseline measurement of the outcome variable at hand.
Partial correlation analysis, adjusted for treatment group, was used to corre-
late changes in symptoms and salbutamol use with changes in PFT parame-
ters.
Initial patient characteristics were investigated for their possible modifying
role of therapy effect on the % symptom-free and rescue free days and on
the PFT variables. This was done by including and testing the interaction
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between the initial patient characteristics and treatment in the above-men-
tioned logistic regression and ANCOVA models. As there were many of
these patient characteristics available and the study was not specifically
powered to detect their interactions with treatment, these analyses were of
a more exploratory nature. In order not to rule out a priori the detection of
a potential effect modifying role, a p-value < 0.10 was considered signifi-
cant.
Results
131 subjects started the run in period, 32 subjects were excluded after this
run in period because of too little symptoms (n=29), parental unwillingness
to proceed the study (2) and salbutamol use >4 puffs per day during 10 of
14 days during run in (1). Patient characteristics are presented in Table 1.
There is a preponderance of males, but this inequality is equally distributed
in both treatment arms.
The effect of ICS
Improvements of subjective effect parameters were seen in both treatment
arms. In the total group of treated patients there were no significant differ-
ences between placebo and FP treated children for percentage of symptom
free days or nights and percentage of rescue free days or night (Figure 1).
Also changes in symptom scores did not show significant differences
between FP and placebo (Figure 2).
TBA measurements were performed in all 99 children and were possible in
43 of placebo and 42 of FP treated patients at visit 2. At visit 3 these figures
were 43 and 38 respectively. In 86 children Rint measurements were per-
formed. These were possible in 25 of placebo, 20 of FP at visit 2 and 24 and
25 respectively at visit 3. IOS was performed in 40 children and possible in
12 and 8, and 11 and 7 children respectively.
TBA parameters improved significantly in the FP treated children, com-
pared to placebo treated children (tPTEF/tE +4.61% versus -1.0%, p =
0.009 and VPTEF/VE +3.61% versus -0.17%, p = 0.003) (Figure 3).
Significant improvement was also seen for Rint (-0.18 kPa/L/s versus
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Table 1. Patient characteristics
fluticasone placebo total
propionate
no 48 51 131
sex M/F 36/12 38/13 98/33
height cm 91.4 ( 8.9) 90,6 (10.2) 90.7 (9.1)
weight kg 14.1 (2.2) 13,6 (2.9) 13.8 (2.6)
age yrs 1.9 (0.9) 1.8 (0.9) 1.9 (0.9)
birthweight kg 3.3 (0.7) 3.3 (0.8) 3.3 (0.7)
no of exacerbations during 7.8 (4.1) 6.6 (4.7) 6.6 (4.4)
last year
ATOPY
no of atopic 1st line relatives   0 13 12 42
1 16 13 35
>2 19 26 54
IgE U/ml 71.8 (140.0) 72.5 (109.8) 70.6 (124.1)
positive RAST Y/N 17/30 17/33
not measured
history of allergic disease Y/N 5/43 11/40 18/113
allergic rhinitis Y/N 15/33 19/32 48/83
eczema Y/N 11/37 10/41 26/105
ENVIRONMENTAL EXPOSURE
smoking mother Y/N 8/40 8/43 24/106
smoking father Y/N 18/30 14/37 42/88
smoking pregnancy Y/N 5/43 7/44 18/112
floor covers living room Y/N 3/44 8/43 25/106
floor covers sleeping room Y/N 14/34 15/36 37/94
humidity high living room Y/N 9/39 7/44 19/112
humidity high sleeping room Y/N 9/39 8/43 20/111
PETS
birds Y/N 4/44 1/50 8/123
dogs Y/N 10/38 10/41 25/106
cat Y/N 12/36 12/39 29/102
other Y/N 7/41 5/46 15/116
no pets Y/N 24/24 31/20 75/56
PHYSICAL EXAMINATION
wheezing at physical 
examination Y/N 8/40 10/41
Values are presented as means (SD) unless stated otherwise.
+0.16 kPa/L/s, p = 0.024) (Figure 4). Although there was improvement of
R5 and X5 this did not reach significance in this small group (p = 0.13 and
0.07 respectively).
Efficacy of salmeterol
During one week salmeterol treatment there were improvements in %
symptom free days (p = 0.004), % symptom free night (p = 0.06), rescue
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FP versus placebo
OR = 1.11, p=0.69
FP versus placebo
OR = 1.51, p=0.0932
% symptom free nights
p= 0.02
% symptom free days
free days (p <0.001) and rescue free nights (p =0.03), compared to the
week preceding salmeterol treatment.
Predictors of effect of ICS
The numbers of subjects with a positive family history, positive history of
allergy, eczema, allergic rhinitis, IgE levels, RAST positivity, and wheezing
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Figure 1. Changes in % of symptom free days, % of symptom free nights, % of rescue free days and % of res-
cue free nights, before, during and after treatment with study medication (SD).
FP versus placebo
OR = 0.57, p=0.05
FP versus placebo
OR = 0.87, p=0.67
% rescue free nights
% rescue free days
at physical examination are presented in Table 1. Neither these markers nor
bronchodilator response were significantly related to ICS effect. Also fre-
quency of symptoms during run in period and number of exacerbations
during the preceding 12 months were not related to ICS effect.
Improvements in % symptom free days during salmeterol therapy were
unrelated to improvements of both subjective and objective effect parame-
ters during ICS treatment.
Baseline pulmonary function was not significantly related to pulmonary
function improvement, but significant improvements of some subjective
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Figure 2. Changes in mean symptom scores, before, during and after treatment with study medication (SD).
FP versus placebo: no significant differences
FP versus placebo: no significant differences
baseline treatment 1 treatment 2 treatment 3 wash out 1 wash out 2
baseline treatment 1 treatment 2 treatment 3 wash out 1 wash out 2
symptom score day
symptom score night
disease markers were seen in children with decreased airway patency (high
Rint and low tPTEF/tE), with OR varying from 2.12 to 4.01 for Rint and
1.17 to 7.39 for tPTEF/tE (Table 2).
There were significant correlations between some markers of indoor envi-
ronment and ICS effect on some subjective markers. Especially patients liv-
ing in houses with carpets and biparental smoking showed significant
improvements in symptoms and use of rescue medication during ICS treat-
ment (Table 3). However, the presence of pets was correlated with less
improvement in % symptom free days and nights
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Figure 3. Changes in tPTEF/tE and VPTEF/VE during treatment with study medication (SD).
tPTEF/tE
visit 2 visit 3
visit 2 visit 3
VPTEF/VE
p=0.009
%
%
p=0.003
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Discussion
In the present study, evaluating the effects of ICS in pre-school children
with recurrent or chronic asthmatic symptoms we found beneficial effects
on pulmonary function parameters, not on subjective parameters. There
were no single predictors for pulmonary function improvement but subjec-
tive improvement was seen in patients with signs of airway obstruction on
pulmonary function measurement. Especially generally recognised indica-
tors of asthma such as bronchodilator response, atopy, positive family histo-
ry and wheezing were found to be unrelated to ICS effectiveness in this
study.
Both symptom scores and use of rescue medication are sensitive to placebo
effect. In younger children this effect is expected to exist too, also when
symptoms are interpreted and presented by parents or caregivers.
Therefore, a placebo controlled study design is necessary. We treated all
patients during the run in period with placebo via Babyhaler to minimise
placebo effects during the study period and to be sure that good inhalation
technique was practised.
Among others, the Dutch consensus on treatment of young children with
asthmatic symptoms21-23 suggest to test patients on their response to a short
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Figure 4. Changes in Rint during and after treatment with study medication (SD).
Rint (95% CI)
P=0.024
visit 2 visit 3
kP
a/
L/
s
acting bronchodilator as an indicator for asthma before starting ICS therapy.
However subjective evaluation of the effect of a short acting bronchodilator
is difficult, both for parents and doctors. That’s why we evaluated also the
response to a long acting bronchodilator as a test for bronchodilator
response. However no correlation with ICS efficacy was found.
The dose of ICS used in the present study was higher than the recom-
mended dose in daily practice to reach an all or not effect. The short period
of intervention decreased the chance for important side effects. However,
this relatively short period might also be a reason for not fully established
effects on individual effect parameters.
Bisgaard et al have shown that in pre-school children with asthmatic symp-
toms treatment with fluticasone propionate 100 and 200 µg daily via
Babyhaler is effective and safe. They found significant effects on symptoms,
use of rescue medication and exacerbation frequency. There was no dose
dependent effect11. In a retrospective analysis they pointed to the cost-
effectiveness of FP treatment in these children24. In children with recurrent
viral wheeze some authors found a beneficial effect of inhaled corticos-
teroids but in 1995 Wilson could not proof any prophylactic effect of ICS
in this patient group10.
The present study is a support to the use of objective effect parameters and
especially pulmonary function measurements to evaluate the effect of ICS
and other interventions. There are no earlier studies on the effect of ICS on
TBA parameters in younger children nor on the usability of TBA parame-
ters or Rint to predict the ICS effect. The only study that also used objec-
tive disease markers to evaluate the ICS effect in pre-school children was
performed by Nielsen and Bisgaard13. They found a significant improve-
ment of Rint, R5 and X5 after 8 weeks of 800 µg budesonide daily in 2-5
year old moderately asthmatic children, most of whom had been on ICS
treatment before the run in period13. Although in this study the symptom
severity was probably greater compared to the present study, results were
rather comparable and they also found effects on pulmonary function tests
to be more significant than effects on subjective parameters.
It seems reasonable that many pre-school children with recurrent asthmatic
symptoms are incorrectly treated when given inhaled steroids, because the
diagnosis can not adequately be made. Especially children who present with
recurrent or persistent cough, but without a history of wheeze are rarely
asthmatic25. This was recently confirmed in a study by McKenzie et al.
who showed that recurrent coughers without wheeze are rarely atopic
although they may show bronchodilator response26.
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Roorda et al. found that especially children with chronic persistent symp-
toms and a positive family history for asthma are the ones responding best
to treatment with fluticasone propionate12. Their findings were not con-
firmed in the present study. Few primary patient factors could predict a
positive ICS effect. The present study is the first that uses pulmonary func-
tion parameters to predict ICS efficacy. Only a subgroup with high Rint or
low tPTEF/tE showed significant correlation with a positive FP versus
placebo effect on subjective disease markers. Although this finding has to be
confirmed in future studies, it shows that pulmonary function tests using
recently developed pulmonary function techniques might offer a possibility
to determine a subgroup of pre school children with asthmatic symptoms
with optimal benefits from ICS treatment.
A remarkable finding was the beneficial effect in a subgroup of children
growing up in an unfavourable indoor environment (smoking, carpets).
This finding is difficult to interpret but might indicate that children living
under non-optimal environmental conditions have more pronounced
inflammation and therefore may be expected to show more beneficial
effects from ICS treatment. On the contrary, it could also mean that after
optimisation of the home situation an additive effect of ICS can not be
expected.
In general, this study shows that the effect of ICS in pre-school children
with asthmatic symptoms can not be derived from experiences in asthmatic
school children and adults. The international consensus to treat pre-school
children in a similar way as adults, i.e. based on the presence of atopy,
wheezing and a positive family history and effect of bronchodilators is not
supported by this study. Different “asthma phenotypes” with probably dif-
ferent inflammatory patterns27-29 might show different reactions to ICS
therapy. Predictors of asthma appear to be different from predictors of ICS
effect (e.g. worse pulmonary function, indoor environment) in young chil-
dren. It remains unclear if the improvement in pulmonary function in
young children is related to the presence of “real” asthma in this group. It
could also be that different asthma “phenotypes” show similar responses to
ICS treatment.
On the other hand, the present study indicates that objective parameters
such as pulmonary function results are more sensitive to ICS effects and
might be more useful parameters to use in population studies. Recently
performed studies in adults show that pulmonary function tests and espe-
cially bronchial hyperresponsiveness can be an additional guide of long
term asthma treatment30. These PFT results might also support the concept
194
to treat mild and uncertain asthma, as suggested in recent studies, indicating
that early start of ICS treatment for asthma can prevent the development of
irreversible, structural airway remodelling31,32.
Further studies should evaluate efficacy in different subgroups that only dif-
fer in asthma “phenotype”.
In conclusion, 6 weeks treatment with ICS in pre-school children with
recurrent asthmatic symptoms was effective in improvement in objective
effect parameters, but not of subjective markers. ICS effect on pulmonary
function could not be predicted from baseline pulmonary function testing,
but baseline pulmonary function predicted a beneficial subjective effect of
ICS. This study suggests that pulmonary function testing can and probably
should be implemented in efficacy studies in this age group.
The multi-centre study group consisted of the following physicians: Dr
JAAM van Diemen-Steenvoorde and Dr FB Plötz (St Antonius Hospital
Nieuwegein), EHG van Leer and FGA Versteegh (Groene Hart Hospital
Gouda), Dr PLP Brand and A Kamps (Isala Klinieken Zwolle), Dr GPJM
Gerrits (Canisius Wilhelmina Hospital Nijmegen), NJ van de Berg and KL
Tjia (Fleveo Hospital Almere), WA Verwijs (Hofpoort Hospital Woerden)
and Dr AAPH Vaessen-Verberne (De Baronie Hospital Breda), JH van der
Laag and Dr EEM van Essen-Zandvliet (University Medical Centre
Utrecht). 
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Concluding remarks
and suggestions for
further research
Introduction
The increasing incidence of respiratory disease in young children is a chal-
lenge to the clinician. Apart from medical history and physical examination
pulmonary function testing can be a valuable tool for diagnostic and thera-
peutic evaluation. However, it is important to realise the specific anatomic
and physiologic features of (the respiratory system in) the growing child.
These features have important implications for feasibility, applicability and
clinical importance of PFT results.
Only PFTs that have been standardised internationally should be used;
therefore working groups should be installed to provide guidelines for the
above mentioned aspects. Moreover, the widespread application of PFTs in
(young ) children is restricted to techniques that show as many as possible
specific characteristics as presented in Chapter 1, Table 2. Also reference
values from studies in healthy subjects should be available and they should
differentiate between healthy and diseased children.
The studies described in this thesis focus on several aspects of pulmonary
function testing in (young) children. Several questions on PFT and clinical
applicability have been evaluated in this thesis. However further research
should provide insight in unanswered or newly raised questions. Some of
the possible suggestions for future research will be discussed below.
Flow volume measurements in young children
Spirometry or flow volume measurements are considered the gold standard
of PFT especially when evaluating subjects with obstructive airway disease.
However, this method is supposed to be possible only in subjects that show
good co-ordination and co-operation in the performance of specific respi-
ratory techniques. Therefore in most children under the age of 6 years reli-
able FV measurements can not be assumed.
Standardisation of this technique has been performed and criteria for
acceptability and reproducibility of curves in individual subjects are avail-
able. However these standards are considered in adults and older children
and appear to be not applicable in younger age groups. Even many adoles-
200
cents who perform “technician accepted manoeuvres” fail to fulfil all crite-
ria. The increasing application of this technique (with or without using
computerised incentives) in children requires a reconsideration of these
standardisation guidelines in this age group. Specific attention should be
paid to equipment, environment, technician’s skills and procedures when
this technique is applied in children, as shown in Chapter 4.1. Many gene-
ral PFT laboratories and technicians might lack the specific requirements,
including dedication, for the performance of FEV1 in these children.
International reconsideration of standardisation of FV measurements,
specifically in young children should be performed. Young children show
shorter forced expiration times and it has been suggested that FEV0.5 might
be a better indicator of airway obstruction in this age group. Separate crite-
ria for different age groups should be set to enable widespread and well
founded application of this useful technique. A proposal for these adapta-
tions is presented in Chapter 4.2. Also specific education to and selection of
motivated pulmonary function technicians is necessary.
Last but not least the changing pattern of growth, weight and body compo-
sition of Western children, maybe even more specific Dutch children
strongly necessitates the development of new reference values (including
values for pre-school children) in the Netherlands and other western coun-
tries.
Interrupter technique
The recently (re)introduced interrupter technique for measurement of
resistance of the respiratory system (Rint) shows many characteristics as
mentioned in the introductory chapter. It is cheap, easily applicable and
well tolerated. Normal values are presented in Chapter 5.2. However there
are several disadvantages. Rint mirrors the resistance that is determined by
not only lower airways but also upper airways. This “contamination”
increases with age.
Although active co-operation and co-ordination are not required, the
applicability in pre-school children is restricted. Reproducibility is worse
than other techniques and there is a wide range of normal values. This
decreases the clinical relevance of single values in individual subjects to dis-
criminate between healthy and diseased. Also the sensitivity of changing
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airway obstruction appears to be less than with other techniques. Still it was
more sensitive to intervention with ICS than subjective disease markers.
Other authors confirmed these findings and also showed its power to dis-
tinguish groups of wheezers from both controls and coughers.
Several features of technical nature (e.g. the method of calculating post
occlusion pressure) should be standardised before studies can be compared.
After standardisation of this technique it seems to be promising for usage
e.g. in population studies. The applicability in the individual patient e.g. for
measurement of bronchodilator response might also be an important appli-
cation. Future studies should focus on these aspects to provide further
insights.
ICS effects in asthmatic children
The effect of ICS in children and adults with moderate to severe asthma is
undisputed and ICS are considered the treatment of choice in these
patients. During the last years treatment regimes have shifted to milder and
younger patients.
However the efficacy in mild to moderate asthma and in pre-school chil-
dren is less evidence based and hard to prove, because objective disease
markers are either within normal ranges (mild asthma) or not available (pre-
school children). The SJOKOLA studies show that both groups show an
objective improvement of pulmonary function parameters during treatment
with ICS. This effect is even more significant than the effect measured with
subjective parameters.
Although these findings support the concept to treat children with mild and
uncertain asthma, they do not support the recent national and international
consensus on treatment of pre-school asthmatic children with ICS. A treat-
ment based on subjective disease markers, subjective and objective bron-
chodilator response, presence of atopy, wheezing and a positive family
history is not supported by the findings in SJOKOLA 2. Predictors of asth-
ma (e.g. bronchodilator response, atopy) appear to be different from pre-
dictors of ICS effect (e.g. worse pulmonary function, indoor environment)
in young children. In this relatively small study especially wheezing, bron-
chodilator response and atopy appeared to be not useful for predicting ICS
effect.
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It remains unclear if the improvement in pulmonary function in young
children is related to the presence of “real” asthma in this group. It could
also be that different asthma “phenotypes” show similar responses to ICS
treatment.
Further studies should evaluate efficacy in different subgroups that only dif-
fer in asthma “phenotype”. The findings of SJOKOLA 2 show that also
indoor environment, pre-treatment pulmonary function and maybe other
factors influence the ICS effect. Therefore these factors can be important
confounders and impair the performance of such studies. Probably only
studies with large numbers of patients can correct for these confounders and
allow to draw some relevant conclusions. Although the SJOKOLA study
failed to show effect modification by specific disease or patient characteris-
tics further studies on possible predictors of ICS effectiveness (e.g. inflam-
mation markers, NO, specific symptoms (wheeze versus cough?)) are
needed. Therefore international (multi-centre) trials on this subject are
required. Only these studies might provide further insights in this important
issue.
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samenvatting
Summary
Many (pre-)school children with acute or chronic respiratory problems are
seen every day by physicians, both in primary care and in hospitals. In these
children, apart from upper and lower airway infections especially recurrent
wheezing and asthma are important differential diagnoses. The incidence of
asthma and asthma-like diseases is increasing, especially in young children.
Although in many children these respiratory symptoms are self-limiting, it
is important to recognise early in the course of the disease those children
that are at risk to suffer from persistent respiratory diseases and to develop
pulmonary function abnormalities and chronic airway remodelling. Only in
this way adequate treatment (e.g. inhaled corticosteroids and antibiotics)
and prophylaxis (e.g. smoking prevention and adaptation of indoor envi-
ronment) might prevent long term morbidity and possibly mortality.
In most children diagnosis and treatment of respiratory disease are mainly
based on medical history and physical examination. However, the evalua-
tion of objective disease markers, e.g. pulmonary function could be helpful
for the assessment of functional abnormalities. Although lung function
studies are increasingly used for the diagnosis and assessment of severity and
follow up, objective pulmonary function testing is often only possible for
older children. Especially in pre-school children respiratory function
parameters are rarely available.
Pulmonary function tests can be used to detect and quantify different kinds
of pulmonary functional abnormalities, to measure the effect of interven-
tion, to follow the time course of disease and to enable prognosis of disease
and disability.
The most often used parameter in subjects with obstructive lung disease is
the forced expiratory volume in 1 second (FEV1), obtained from a maximal
expiratory flow volume curve (MEFV). The technique, necessary to per-
form this manoeuvre requires optimal co-ordination and co-operation and
these premises impair the applicability, especially in infants and pre school
children, but also in many geriatric patients, older children and even adults.
That’s why other lung function methods are needed. Although recently
several alternative methods have been developed, most have and can not be
implemented for use in daily clinical practice and are currently only avail-
able in specialised centres. Many of these tests require difficult technical
procedures, anaesthetic care or are even invasive.
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Clinical application of new or alternative pulmonary function tests in
young children is only possible for techniques that are easily performed in
children of all ages, do not require much time or sedation and show results
quickly. They should be reproducible, cheap, able to distinguish healthy
from diseased children, not invasive, applicable during spontaneous breath-
ing, responsive to intervention and useful for follow up. Promising tech-
niques that might fulfil (most of these) requirements are tidal breathing
analysis, interrupter resistance measurement and impulse oscillometry.
Adaptation of traditional techniques (MEFV) or standardisation of these
newer techniques and availability of reference values might enable more
widespread use of these techniques in daily practice. The studies described
in this thesis addressed several aspects of pulmonary function testing in pre-
school and school children.
In Chapter 2 an overview of literature on general principles of pulmonary
and especially airway anatomy, followed by an overview of currently avail-
able methods to measure airway mechanics in non-sedated, spontaneously
breathing children is presented. Although the functional evaluation of
patients with lower airway obstruction is probably best performed using
FEV1, resistance measurement, using the interrupter technique or impulse
oscillation, can be applied when MEFV measurements are impossible.
Although several drawbacks of resistance measurements in young children
can be mentioned, there are several aspects that make resistance measure-
ments preferable.
Interrupter and oscillation technique, applied during spontaneous tidal
breathing, are not very burdensome, are simple, do not require sedation,
are non-invasive and require only passive co-operation of the patient.
Therefore these techniques are suitable in both daily practice and in a labo-
ratory setting or for research purposes. Another theoretical advantages of
these techniques is that they might be more representative of normal
breathing, i.e. daily life situations, in contrast to parameters obtained from
forced manoeuvres. Also, during childhood the most important pulmonary
diseases have an obstructive character and especially peripheral airway
resistance is better mirrored by resistance measurements in children than in
adults. Last but not least, changes after intervention or in disease are at least
similarly reflected by these techniques compared to “gold standards”.
The availability of these techniques has come with devices, that are cur-
rently tested and presented by commercial manufacturers. Although this
does encourage more widespread use of these techniques, it does not imply
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that standardisation of these techniques has been performed and e.g. normal
values and a good relation to pathophysiology are available.
In Chapter 3 a short overview is presented of the tidal breathing analysis,
one of the pulmonary function techniques that has been subject of several
studies in the University Medical Centre Utrecht. The shape of flow pat-
tern during tidal expiration is influenced by peripheral airway obstruction.
The time from the start of expiration to peak expiratory flow (tPTEF)
divided by the total expiratory time (tE) is significantly decreased in chil-
dren with asthma. Experimental studies in the cat have shown that the
expiratory flow pattern is the result of mechanical properties of the respira-
tory system (resistance and compliance) and of post-inspiratory activity of
inspiratory muscles.
Chapter 4 is dedicated to the maximal expiratory flow volume (MEFV)
curve, considered the “gold standard” of pulmonary function testing at all
ages.
Even pre-school children are sometimes able to perform the maximal effort
breathing techniques, required for this pulmonary function test. However,
children are not small adults and a lot of child-specific items in the per-
formance and interpretation of flow-volume curves can be overlooked,
resulting in errors in diagnosis and treatment.
In Chapter 4.1 we report on the most important conditions for reliable
measurement of flow-volume curves at all ages. Especially testing atmos-
phere and equipment, pulmonary function technician requirements, testing
procedure, reliability criteria, report making and interpretation are dis-
cussed. For many children the first visit to a pulmonary function laboratory
can be considered as the beginning of a long (if not ever) lasting PFT career
and “well begun is half done”.
Prior to attempting to interpret any MEFV curve (or whatever other pul-
monary function test), the quality of the tests should be assessed. Patient
effort, co-ordination, co-operation, artefacts and reproducibility should be
evaluated and less than optimal procedures should be judged with caution.
The performance of a maximal effort expiratory manoeuvre is not easy, as
was discussed before. International criteria (ATS and ERS) for the accept-
ability and reproducibility of spirometry are available for adults but are lack-
ing for children. In a retrospective study flow volume curves, performed by
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children of all ages were evaluated for their capability to meet these criteria.
Results of this study are described in Chapter 4.2. Maximal expiratory
flow volume (MEFV) measurements of 446 school-age-children, experi-
enced in performing MEFV manoeuvres and considered acceptable by well
trained pulmonary function technicians were evaluated. These curves
showed a rapid rise to peak flow at the start and a subsequent gradual
decrease of flow during the rest of the maximally prolonged expiratory
manoeuvre. Even the curves of these experienced children appeared to be
unable to meet all international criteria, although most of their MEFV
curves were useful for interpretation. Based on the performance of these
children, we made a proposal for adaptation of international criteria for
MEFV measurements in children.
Recently an old technique, the interrupter technique, for assessment of air-
way resistance showed a revival after introduction of a small handheld
device, the MicroRint®. This technique is described in Chapter 5. The
basis of the interrupter technique is that, during transient interruption of
the tidal airflow, alveolar pressure and mouth pressure equilibrate within a
few milliseconds. The alveolar pressure can therefore be derived from the
measurement at the mouth immediately after interruption. If the flow is
measured immediately prior to interruption, the ratio of pressure to flow
gives the interrupter resistance (Rint).
Together with two students a study was performed to evaluate the applica-
bility of this simple device for measuring airway resistance, to derive normal
values and to compare values with maximal expiratory flow volume
(MEFV) parameters in asthmatic and healthy children. As described in
Chapter 5.1 the majority of children from the age of 3 years was able to
perform Rint measurements and repeatability was good. Applicability is
comparable in asthmatic and healthy children and appears to be age
dependent. Good correlation with age and height was found. Baseline val-
ues could not discriminate healthy from asthmatic children. A significant
inverse correlation was found between Rint and MEFV values. After bron-
chodilation in asthmatic patients there was a significant increase in FEV1
and decrease in Rint, but changes between the two parameters did not cor-
relate.
Reference values for pre-school children exist but are lacking for children
over the age of 7. The results of two comparable studies performed in 208
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3-13 year old healthy children in Utrecht and Rotterdam were combined
to find reference values for expiratory interrupter resistance (Rinte). A
curvilinear relationship between Rinte and height was observed, similar to
published airways resistance data measured plethysmographically. No signif-
icant differences in cross-sectional trend or level of Rint were observed
according to gender. Based on the reference equation: 10log (Rinte) =
0.645 - 0.00668 x (standing height(cm)) kPa/L/s and residual standard devi-
ation (0.093 kPa/L/s), Z-scores can be used to express individual Rint val-
ues and to describe intra- and inter-individual differences (Chapter 5.2).
Another method to measure resistance (and reactance) of the respiratory
system which is applicable in young children is the impulse oscillation tech-
nique (IOS).
A sinusoidal oscillatory pressure wave, composed of different frequencies is
superimposed on the tidal breathing flow pattern. Pressure waves result in
flow oscillations, the magnitude and phase of which are determined by the
resistive, elastic and inertial properties of the respiratory system. The pres-
sure and flow signals are recorded at the mouth. For each of these frequen-
cies, the ratio of pressure to flow can be considered (i.e. the impedance Z),
which is a complex number of the magnitude of pressure to flow and about
the phase shift between these signals. Most often this complex number is
represented by its real part, the respiratory resistance (Rrs) and its imaginary
part, the respiratory reactance (Xrs).
This technique provides an alternative method to assess airflow obstruction
in patients who are not able to perform forced breathing manoeuvres. The
sensitivity and specificity of IOS parameters to quantify changes in airflow
obstruction in comparison with FEV1 and PEF measurements were evalu-
ated in a study in school children (Chapter 6). Measurements of FEV1,
PEF and Resistance (R) and Reactance (X) at frequencies of 5 to 35 Hz
were performed in 19 children with asthma before, during and after metha-
choline challenge and subsequent bronchodilation.
All parameters changed significantly during the tests. Values of resistance
and reactance correlated with FEV1 and changes in resistance preceded
changes in PEF and FEV1 during methacholine challenge. Although PEF is
a frequently used surrogate measure for airway hyperresponsiveness, the
area under the ROC curve to predict a 15% fall in FEV1 showed better
sensitivity and specificity for resistance than for PEF.
We conclude that IOS parameters can be easily used as an indirect measure
of airflow obstruction. Although the parameters do not exactly reflect the
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‘gold standard’ FEV1, this technique might be helpful in patients who are
not able to perform forced breathing manoeuvres.
In Chapter 7 the effect of inhaled corticosteroids in young children with
asthmatic symptoms is evaluated using several of the previously described
pulmonary function techniques.
The maintenance treatment of asthmatic children with inhaled corticos-
teroids has evolved during the last decennia. There is a tendency to treat
not only severely affected, but also less affected children with less frequent
and (mild to) moderate symptoms and pre-school children with asthma-like
symptoms. In these children who show hardly any abnormalities in pul-
monary function or in whom objective parameters are hardly available,
objective measurement of the effect of inhaled corticosteroids (ICS) is diffi-
cult.
The effect of treatment with ICS was studied in two groups:
1. 5-10 year old children with mild asthma (SJOKOLA 1)
2. 1-4 year old children with asthma-like symptoms (SJOKOLA 2)
SJOKOLA is short for “Steroiden bij JOnge Kinderen als
OnderhoudsbehandeLing van Astma” (Steroids in young children as main-
tenance treatment of asthma).
In the first study 68 children were randomly assigned to either fluticasone
propionate (FP) 250 µg or placebo twice daily as pMDI via spacer during 12
weeks. FP treated versus placebo treated children showed significant
changes, not only in % symptom free days, morning and evening PEF and
wheezing, but also in FEV1%pred. The latter improvement was only small
but significant, especially when we consider that baseline FEV1%pred values
were high (>100% pred). This study therefore shows that normal lung
function in children with symptoms of asthma does not rule out airway
obstruction, improving after proper treatment. Although no significant
improvements were found for tidal breathing parameters these findings
show that ICS are effective in children with mild asthma. This beneficial
effect can be assessed by both objective and subjective parameters.
During early childhood as many as 40% of children experience recurrent
asthmatic symptoms such as wheezing, cough or breathlessness In more
than half of these children symptoms disappear around the age of 6 years.
These symptoms are thought to reflect congenitally narrow airways, which
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predispose to wheezing during viral infections. In other children symptoms
persist and the latter group is eventually labelled as asthma. Many of these
patients have a positive family history for atopy and personal skin prick test
positivity and increased levels of total and specific IgE.
As in older children and adults, there is a tendency to treat recurrent asth-
matic symptoms in the younger age group in a similar way, although there
is the above mentioned uncertainty about the diagnosis and thus uncertain-
ty about the best ways of treatment. There are few studies on the effect of
ICS in pre school children and no studies using tidal breathing parameters,
impulse oscillometry and interrupter resistance as effect parameters. In a
prospective study the effect of ICS in 1-4 year old children with asthmatic
symptoms was evaluated using both subjective and objective parameters
(Chapter 7.2). Although there are certain “predictors” of asthma in pre
school children, there is no readily available instrument to identify pre-
school children with recurrent asthmatic symptoms who will benefit from
ICS treatment. Therefore we also searched for the possibilities of several
subjective and objective parameters to predict a possible beneficial effect of
ICS.
99 children were randomly assigned to receive either fluticasone propionate
(FP) 250 µg or placebo twice daily during 6 weeks. We found beneficial
effects on pulmonary function parameters, not on subjective parameters.
There were no single predictors for pulmonary function improvement but
subjective improvement was seen in patients with signs of airway obstruc-
tion on pulmonary function measurement. Especially generally recognised
indicators of asthma such as bronchodilator response, atopy, positive family
history and wheezing were found to be unrelated to ICS effectiveness in
this study.
We conclude that the effect of 6 weeks treatment with ICS in pre-school
children with asthma-like symptoms is best demonstrated by PFT markers,
not by subjective markers. Decreased pulmonary function appears to pre-
dispose to a beneficial effect.
This study also shows that the effect of ICS in pre-school children with
asthmatic symptoms can not be derived from experiences in asthmatic
school children and adults. The international consensus to treat pre-school
children in a similar way as older children and adults, i.e. based on the pres-
ence of atopy, wheezing and a positive family history and effect of bron-
chodilators is not supported by this study. Predictors of asthma appear to be
different from predictors of ICS effect (e.g. worse pulmonary function,
indoor environment) in young children.
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In Chapter 8 conclusions from these studies and suggestions for further
research are presented.
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Samenvatting
Op het spreekuur van huisartsen en kinderartsen worden dagelijks veel kin-
deren met acute of chronische luchtwegklachten gezien. Naast luchtwegin-
fecties van de bovenste (keel, neus, oor) en onderste (bronchiën en longen)
luchtwegen betreft het vooral ook kinderen met recidiverend hoesten, pie-
pen en/of zagen, b.v. ten gevolge van astma. Het aantal kinderen met ast-
matische klachten neemt de laatste jaren toe, vooral bij peuters en kleuters.
Hoewel luchtwegklachten vaak vanzelf weer over gaan is het belangrijk die
kinderen eruit te pikken die risico lopen op chronische luchtwegproble-
men, en wellicht blijvende luchtweg- of longafwijkingen, die het dagelijks
leven negatief kunnen beïnvloeden. Door deze kinderen (tijdig) te onder-
kennen en te behandelen kan op korte termijn verbetering worden bereikt
en kunnen wellicht problemen in de toekomst worden voorkomen of ver-
minderd.
Bij de meeste kinderen is de diagnose en behandeling geheel gebaseerd op
anamnese en lichamelijk onderzoek. Met name de anamnese blijft natuur-
lijk erg subjectief en er is dan ook behoefte aan objectieve ziekteparameters
zoals longfunctieonderzoek. Hoewel longfunctieonderzoek in toenemende
mate wordt gebruikt bij schoolkinderen, ontbreekt het aan mogelijkheden
bij jongere kinderen.
Longfunctieonderzoek kan bij kinderen met (en zonder) luchtwegklachten
o.a. worden gebruikt om verschillende soorten longfunctieafwijkingen te
ontdekken en te kwantificeren, om het effect van interventie te meten, om
het beloop in de tijd te vervolgen en zo prognoses voor de toekomst te
geven.
De meest gebruikte longfunctieparameter is de FEV1. Dit is het volume
lucht dat iemand na maximale inademing tijdens een zo krachtig en lang
mogelijke uitademing kan uitblazen in de eerste seconde (forced expiratory
volume in 1 second). De techniek om deze manoeuvre goed uit te voeren
vraagt om optimale coördinatie en medewerking van de patiënt en derhalve
is dit onderzoek vrijwel onmogelijk bij (de meeste) peuters en kleuters.
Overigens blijkt dat ook oudere kinderen, vele volwassenen en geriatrische
patiënten vaak moeite hebben met deze techniek.
Daarom bestaat er behoefte aan alternatieve methoden. Hoewel recent
enkele nieuwe methoden zijn ontwikkeld zijn deze meestal niet geschikt
voor de dagelijkse praktijk, omdat b.v. verdoving gewenst is, apparatuur erg
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moeilijk te bedienen of erg duur is of omdat ze invasief zijn. Deze technie-
ken worden daarom vaak alleen bij onderzoek en in gespecialiseerde centra
gebruikt.
Klinische toepassing van nieuwe technieken is alleen mogelijk bij jonge
kinderen als de uitvoering makkelijk is, niet te lang duurt, reproduceerbaar,
niet invasief en niet te duur is. Ook moeten ze zonder verdoving toe te
passen zijn, tijdens spontane rustige ademhaling en onderscheid kunnen
maken tussen gezond en ziek. Het effect van interventie moet meetbaar
zijn en liefst moet dezelfde techniek op alle leeftijden mogelijk zijn zodat
follow-up kan plaatsvinden. Technieken die veelbelovend lijken zijn de
rustademhalingsanalyse, de interruptie methode en de impulsoscillometrie.
Door aanpassing van bestaande technieken (FEV1) of door standaardisatie
en verdere ontwikkeling van deze nieuwe technieken kunnen we in de
toekomst wellicht in de dagelijkse praktijk op een objectieve wijze kinde-
ren met luchtwegklachten in beeld brengen.
De studies beschreven in dit proefschrift hebben betrekking op verschillen-
de aspecten van longfunctieonderzoek bij jonge kinderen.
In Hoofdstuk 2 wordt een overzicht gegeven van de literatuur over (de
ontwikkeling van) anatomie en fysiologie van de luchtwegen en longen.
Vervolgens worden de verschillende beschikbare technieken voor long-
functieonderzoek bij spontaan ademende jonge kinderen besproken.
Hoewel longfunctieonderzoek waarschijnlijk vooralsnog het best kan
plaatsvinden met de FEV1 kunnen de boven genoemde nieuwe technieken
om weerstand te meten zoals de interrupter techniek en impulsoscillatie
worden toegepast als de FEV1 meting niet mogelijk is.
Verschillende technieken om weerstand te meten hebben betrekking op
verschillende aspecten van weerstand. Alleen met lichaamsplethysmografie
wordt zuiver de luchtwegweerstand gemeten. Deze techniek is echter
alleen toepasbaar bij oudere kinderen, volwassenen en (onder sedatie) bij
zuigelingen. De middels de interruptie techniek gemeten weerstand is
slechts een benadering van de weerstand van het gehele ademhalingsstelsel
(behalve luchtwegen ook longweefsel en borstkast). De methode is niet
gestandaardiseerd en mede ten gevolge daarvan bestaat er voorlopig nog
geen algemene acceptatie van deze techniek. Daar staat tegenover dat de
interrupter techniek en impulsoscillatie makkelijk uitvoerbaar zijn bij spon-
taan ademende kinderen en slechts passieve medewerking vragen van de
patiënt. Daardoor lijken deze technieken geschikt voor gebruik in de dage-
lijkse praktijk, maar ook voor onderzoek bij jonge kinderen. Bovendien
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komen steeds meer makkelijk bruikbare en kleinere apparaten ter beschik-
king, die door de verschillende industrieën worden aangeboden. Hoewel
dit een uitgebreidere toepassing van deze technieken zal bevorderen dient
verder onderzoek en standaardisatie plaats te vinden, inclusief het bepalen
van normaalwaarden, alvorens deze technieken geschikt zijn voor dagelijks
gebruik door de verschillende hulpverleners.
Daar staat tegenover dat deze technieken toepasbaar zijn bij spontaan ade-
mende patiënten, dus zonder moeilijke ademhalingsmanoeuvres en dus
wellicht meer correlatie hebben met het functioneren tijdens dagelijkse
bezigheden. Bovendien zijn de meeste longfunctieafwijkingen op jonge
leeftijd het gevolg van afwijkingen in de doorgankelijkheid van perifere
luchtwegen en betreft de middels deze technieken bepaalde weerstand met
name bij jonge kinderen (meer dan bij volwassenen) de perifere luchtweg-
weerstand. Tenslotte blijken de technieken effecten van interventie mini-
maal even goed weer te geven als de “gouden standaard” FEV1.
Binnen ons ziekenhuis heeft in de jaren 90 veel onderzoek plaatsgevonden
met de rustademhalingsanalyse. In Hoofdstuk 3 wordt een overzicht gege-
ven van deze techniek. Uit de grafiek die de luchtstroomsnelheid (flow) tij-
dens ademhaling beschrijft blijkt dat dit patroon bij patiënten met perifere
luchtwegobstructie anders is. Dit wordt weergegeven als de ratio van
tPTEF en tE. tPTEF is de tijd vanaf het begin van de uitademing tot aan de
maximale flow en tE de totale uitademingtijd. Deze ratio is duidelijk ver-
minderd bij kinderen met astma. Studies bij katten hebben aangetoond dat
dit flowpatroon vooral wordt bepaald door de mechanische eigenschappen
van het ademhalingsstelsel (weerstand en compliantie) en de activiteit van
inademingspieren tijdens het begin van de uitademing.
Hoofdstuk 4 is gewijd aan de maximale expiratoire flow volume (MEFV)
curve, die algemeen beschouwd wordt als de gouden standaard van long-
functieonderzoek op alle leeftijden. Veel kinderen, zelfs peuters en kleuters
zijn soms in staat tot de speciale manoeuvres nodig voor het blazen van
MEFV curven. Kinderen zijn echter geen kleine volwassenen en vele kind-
specifieke aspecten van uitvoering en interpretatie van dit onderzoek bij
(jonge) kinderen verdienen aandacht.
In Hoofdstuk 4.1 bespreken we de belangrijkste voorwaarden voor
betrouwbaar gebruik van MEFV onderzoek bij kinderen. Vooral de inrich-
ting van de longfunctieruimte, apparatuur, personeel, instructie van adem-
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halingstechniek, betrouwbaarheidscriteria, afdruktechnieken en inter- pre-
tatie worden besproken. Voor veel kinderen kan het eerste bezoek aan een
longfunctielaboratorium worden gezien als het begin van en langdurige
“longfunctiecarrière” en een goed begin is ook hier het halve werk!
Voorafgaande aan de interpretatie van de MEFV curve ( of om het even
elke andere longfunctiemeting) dient de kwaliteit van het onderzoek wor-
den beoordeeld. De mate waarin de patiënt zich inspant, meewerkt, de
geforceerde techniek goed uitvoert en de reproduceerbaarheid van deze
techniek dient optimaal te zijn alvorens het resultaat te beoordelen. Zoals
hierboven besproken is de uitvoering van dit onderzoek niet makkelijk.
Internationale criteria voor de goedkeuring en reproduceerbaarheid van
MEFV curven zijn opgesteld door internationale organisaties, de American
Thoracic Society (ATS) en de European Respiratory Society (ERS). Deze
criteria hebben betrekking op volwassenen en specifieke criteria voor kin-
deren ontbreken. Middels een retrospectieve studie hebben we de MEFV
curven van kinderen van verschillende leeftijden beoordeeld op de mate
waarin ze voldoen aan de criteria voor volwassenen. De resultaten worden
beschreven in Hoofdstuk 4.2. Hiervoor werden de meest recente MEFV
curven gebruikt van 446 kinderen, die ervaring hadden met de uitvoering
van dit onderzoek en die volgens onze ervaren kinderlongfunctie-assisten-
ten de techniek prima beheersten. Deze curven toonden een onmiddellijke
scherpe piekflow bij start van een maximaal volgehouden uitademingsma-
noeuvre. Toch bleken zelfs de curven van deze ervaren kinderen, die er dus
technisch prima uitzagen en goed konden worden geïnterpreteerd, niet te
voldoen aan alle criteria zoals die bestaan voor volwassenen. Gebaseerd op
de prestaties van deze kinderen werd een voorstel gedaan voor aanpassing
van de internationale criteria voor kinderen.
Recent werd een reeds langer bestaande longfunctietechniek, namelijk de
interruptie techniek, voor het meten van weerstand nieuw leven ingeblazen,
mede door het ter beschikking komen van een klein handzaam apparaatje,
de MicroRint®. Deze techniek wordt beschreven in Hoofdstuk 5. De basis
van deze techniek is gelegen in het feit dat gedurende kortdurende afsluiting
van de luchtstroom er een snelle equilibratie van de druk in de diepste long-
delen (het “alveolaire” compartiment) en de monddruk plaatsvindt. Zo kan
de alveolaire druk worden gemeten aan de mond. Als de flow kort voor
afsluiting bekend is kan uit de veranderingen van flow en druk de interrup-
tieweerstand (Rint) worden gemeten (weerstand = druk: flow).
9
C
H
A
P
TE
R
SUMMARY EN SAMENVATTING
217
Samen met twee medische studenten werd een onderzoek verricht naar de
toepasbaarheid van dit apparaatje. Bij gezonde kinderen (op scholen en kin-
derdagverblijven) en bij astmatische kinderen (op de polikliniek) werden de
toepasbaarheid en reproduceerbaarheid vergeleken. Ook werden normaal-
waarden verzameld en werd bij astmapatiënten de correlatie met FEV1
bekeken. Zoals beschreven in Hoofdstuk 5.1 kon bij het overgrote deel
van kinderen vanaf 3 jaar een meting plaatsvinden en de reproduceerbaar-
heid was goed. Toepasbaarheid was vergelijkbaar bij gezonde en astmati-
sche kinderen en blijkt leeftijdsafhankelijk. Er bestond een goede correlatie
met leeftijd en lengte. Rintwaarden bij gezonde en astmatische kinderen
waren niet significant verschillend. Bij astmapatiënten werd een significante
correlatie met MEFV waarden gevonden. Na inhalatie van een luchtweg-
verwijder was er een significante stijging van FEV1 en afname van Rint,
maar veranderingen van beide parameters correleerden niet.
Normaalwaarden van Rint zijn er wel voor jonge kinderen maar ontbreken
voor kinderen vanaf de leeftijd van 7 jaar. De resultaten van twee vergelijk-
bare onderzoeken, het hiervoor genoemde en een onderzoek in het Sophia
Kinderziekenhuis te Rotterdam, werden gecombineerd. Bij 208 3-13 jaar
oude gezonde kinderen werd Rint gemeten. Daarmee konden referentie-
vergelijkingen worden opgesteld die de correlatie van Rint met lengte
beschrijven. Er bleek een curvilineair verband tussen de expiratoire Rint en
de lengte te bestaan, vergelijkbaar met de referentiewaarden zoals die
bestaan voor de luchtwegweerstand gemeten middel lichaamsplethysmogra-
fie. Er bestonden geen significante verschillen tussen jongens en meisjes.
Gebaseerd op de referentievergelijking 10log (Rinte) = 0.645 - 0.00668 x
(lengte (cm)) kPa/L/s en een residuale standaard deviatie (0.093 kPa/L/s),
kunnen Z-scores worden gebruikt om de individuele Rint waarde uit te
drukken en om intra- en interindividuele verschillen te beschrijven
(Hoofdstuk 5.2).
Een ander methode om weerstand (en reactantie) van het ademhalingsstel-
sel te meten en die eveneens te gebruiken is bij jonge kinderen is de impul-
soscillatie techniek (IOS). Een sinusoidale drukgolf, samengesteld uit
verschillende frequenties wordt aangeboden boven op het spontane rustige
ademhalingspatroon. Deze drukgolven resulteren in flowschommelingen,
waarvan de grootte en fase (t.o.v. de drukgolf) worden bepaald door de
weerstand, elastische eigenschappen en traagheid van het ademhalingsstelsel.
De veranderingen van druk en flow kunnen worden gemeten bij de mond
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en hieruit kan voor elke frequentie de relatie van druk en flow, de zgn.
impedantie (Z) worden berekend. Dit is een complexe weergave van de
druk versus flow ratio en van de fase shift van deze signalen. Meestal wordt
dit complexe getal dan ook uitgesplitst in weerstandswaarde R en reactan-
tiewaarde X.
Deze techniek biedt een alternatieve methode om luchtwegobstructie te
kwantificeren bij patiënten die niet in staat zijn tot geforceerde ademma-
noeuvres. De sensitiviteit van deze techniek om veranderingen in lucht-
wegobstructie in vergelijking met FEV1 en piekflow (PEF) te meten werd
onderzocht (Hoofdstuk 6). FEV1, PEF, R en X (bij verschillende frequen-
ties) werden bepaald bij 19 astmatische schoolkinderen voor, gedurende en
na methacholine provocatie en vervolgens na luchtwegverwijding met sal-
butamol. Alle parameters veranderden significant gedurende deze procedu-
res. Beginwaarden van R en X correleerden met FEV1 en veranderingen
van R gingen vooraf aan veranderingen van PEF en FEV1 gedurende pro-
vocatie. Hoewel de PEF vaak wordt gebruikt als een surrogaatmarker voor
luchtweggevoeligheid bleken veranderingen in weerstand R beter te corre-
leren met de gouden standaard FEV1 dan de veranderingen van PEF. We
concluderen dan ook dat IOS parameters kunnen worden gebruikt als een
indirecte maat voor luchtwegobstructie. Hoewel ze niet hetzelfde mecha-
nisme als de “gouden standaard” FEV1 beschrijven, kunnen ze bij patiënten
die niet in staat zijn tot geforceerde ademhalingsmanoeuvres worden
gebruikt.
In Hoofdstuk 7 wordt het effect van inhalatiecorticosteroïden bij jonge
kinderen met astmatische klachten beschreven. Hierbij wordt naast subjec-
tieve effectparameters ook gebruik gemaakt van enkele hierboven bespro-
ken longfunctieparameters.
De onderhoudsbehandeling van astmatische kinderen met inhalatiecorti-
costeroïden (ICS, ontstekingsremmende medicijnen, ingenomen via specia-
le apparaatjes tijdens de inademing) heeft de laatste decennia een sterke
ontwikkeling doorgemaakt. Er bestaat een tendens om niet alleen patiënten
met ernstig astma, maar ook kinderen met minder frequente en minder
ernstige klachten te behandelen met ICS. Echter kinderen met mild astma
hebben vanzelfsprekend ook mindere afwijkingen van verschillende ziekte-
parameters (o.a. longfunctie). Dit maakt het ook moeilijker om een verbe-
tering te meten.
Het effect van ICS behandeling werd onderzocht bij twee groepen kinde-
ren:
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1. 5-10 jaar oude kinderen met mild astma (SJOKOLA 1)
2. 1-4 jaar oude kinderen met “astmatische klachten” (SJOKOLA 2)
SJOKOLA is een afkorting van “Steroiden bij JOnge Kinderen als
OnderhoudsbehandeLing van Astma”
In de eerste studie werden 68 kinderen behandeld met fluticason propio-
naat (FP, Flixotide®) 2x/dag 250 µg of placebo (nepmedicijn) via een voor-
zetkamer gedurende 12 weken. Uit het onderzoek bleek dat behandeling
met FP in vergelijking met placebo een significante vermindering gaf van
het % dagen met klachten, verbetering van ochtend- en avondpiekflow en
van piepende ademhaling. Ook de FEV1 als % van voorspeld verbeterde
significant (Hoofdstuk 7.1). De laatste verbetering was weliswaar klein
maar des te opvallender daar de uitgangswaarde binnen normale grenzen
viel. Desondanks werd de longfunctie dus “nog beter”. Deze studie toont
dus dat een “normale “longfunctie” bij kinderen met astmatische klachten
niet uitsluit dat er luchtwegvernauwing bestaat, die verbetert middels ade-
quate therapie. Hoewel geen significante verbetering werd gevonden van
rustademhalingsparameters toont deze studie dan ook niet alleen aan dat
kinderen met mild astma verbeteren onder invloed van ICS maar ook dat
dit effect zowel subjectief als objectief meetbaar is.
Een groot aantal jonge kinderen (tot 40%) heeft gedurende de peuter-kleu-
ter jaren astmatisch te duiden klachten als piepen, hoesten en benauwdheid.
Bij meer dan de helft van deze kinderen verdwijnen de klachten enkele
jaren later. Waarschijnlijk hebben de klachten dan meer te maken met aan-
geboren nauwere luchtwegen, die extra klachten geven bij b.v. luchtwegin-
fecties. Bij een substantieel deel van de kinderen persisteren klachten echter
ook op latere leeftijd. Met name bij deze kinderen wordt dan de diagnose
astma gesteld. Vaak is er dan sprake van een familiair voorkomen van aller-
gie, bestaan er positieve huidtesten op allergenen en verhoogde bloed-
waarden van totaal en specifiek IgE (maat voor allergie).
Er bestaat een tendens om peuters en kleuters te behandelen als astma (hoe-
wel dus het grootste deel uiteindelijk geen astma zal blijken te hebben!). Of
deze therapie effectief is, is nog onduidelijk en slechts weinig onderzoekers
hebben dit onderzocht. Hierbij is geen gebruik gemaakt van de longfunc-
tietechnieken zoals boven beschreven.
In de tweede SJOKOLA studie werd het effect van ICS onderzocht bij 1-4
jaar oude kinderen met chronische of frequente astmatische symptomen.
Daarbij werd zowel van subjectieve als objectieve effectparameters gebruik
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gemaakt (Hoofdstuk 7.2).
Hoewel er zoals boven beschreven bepaalde voorspellers van astma bestaan,
is onduidelijk welke jonge kinderen wel en welke niet baat hebben bij
behandeling met ICS. Daarom zochten we in deze studie ook naar eventu-
ele voorspellers van ICS effectiviteit.
In deze studie werden 99 kinderen behandeld met FP 2x/dag 250 µg of pla-
cebo via een voorzetkamer gedurende 6 weken. We vonden bij FP behan-
delde patiënten in vergelijking met placebo een verbetering van
verschillende longfunctieparameters, maar niet van symptomen of klachten.
Er waren geen duidelijke voorspellers van de verbetering van longfunctie
maar in een groep met slechtere longfunctie werd wel een significante ver-
betering van symptomen en klachten gevonden. Met name echter de
bekende voorspellers van astma (verbetering o.i.v. luchtwegverwijders,
allergie, positieve familieanamnese en piepen bij lichamelijk onderzoek)
waren geen voorspeller van ICS effectiviteit. Concluderend is het effect
van ICS bij 1-4 jaar oude kinderen wel met longfunctie, niet met subjectie-
ve parameters te meten. Wellicht hebben vooral kinderen met een slechte
longfunctie baat bij behandeling met ICS.
Deze studie toont ook aan dat het effect van ICS bij jonge kinderen met
astmatische klachten niet kan worden vergeleken met ervaringen bij oudere
kinderen met astma. De (inter)nationale consensus om deze kinderen te
behandelen met ICS indien er sprake is van b.v. allergie, piepen, positieve
familieanamnese of effect van luchtwegverwijders wordt door deze studie
niet ondersteund. Voorspellers van astma zijn anders dan voorspellers van
ICS effect.
In Hoofdstuk 8 tenslotte worden enkele conclusies uit deze studies getrok-
ken en worden enkele adviezen voor toekomstige studies gegeven.
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List of abbreviations
A age in years
alv alveolar
ANCOVA analysis of co-variance
ANOVA analysis of variance
ao airway opening
AR auto regressive
ATS American Thoracic Society
aw airway
awc central airway
awp peripheral airway
BDP beclomethasone dipropionate
BDR bronchodilator response
BHR bronchial hyperresponsiveness
box body plethysmograph
BTPS body temperature, ambient pressure, saturated with
water vapor
BTS British Thoracic
BUD budesonide
C compliance
CF cystic fibrosis
CI confidence interval
CV coefficient of variation
cw chestwall
dFEV1abs absolute difference between two highest FEV1s
dFEV1% percentual difference between two highest FEV1s
dFVCabs absolute difference between two highest FVCs
dFVC% percentual difference between two highest FVCs
DRC daily record card
E elastance
ECSC European Community for Steel and Coal
el elastic
EPP equal pressure point
ERS European Respiratory Society
ext extrathoracic
η viscosity of the gas
F female
FET forced expiratory time
FEV1 forced expiratory volume in 1 second
FEV1%FVC FEV1 as a percentage of FVC
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FEV1%pred FEV1 as a percentage of predicted
FEV0.5 forced expiratory volume in 0.5 second
FOT forced oscillation technique
FP fluticasone propionate
FRC functional residual capacity
F-V flow volume
FVC forced vital capacity
GEE generalised estimating equations
H standing height in cm
H* standing height in meters
Hz Herz
ICS inhaled corticosteroids
IgE immunoglobuline E
in inside
int interrupter
IOS impulse oscillation technique
ISAAC International Study of Asthma and Allergies in
Childhood
ith intrathoracic
kPa kilopascal
l length
L liter
L lung
M male
MEF75/50/25 maximal expiratory flow at 75/50/25 % of FVC
MEFV maximal expiratory flow volume 
mo mouth
msec milliseconds
occ occlusion
oes oesophagus
OR odds ratio
out outside
p p value
P pressure 
PEF peak expiratory flow
PFT pulmonary function testing
pl pleural
pMDI pressurised metered dose inhaler
PtcO2 transcutaneous oxygen tension
LIST OF ABBREVIATIONS
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R resistance
r radius
r correlation coefficient
RAST radio allergo sorbent test
RC reliability coefficient
REM rapid eye movement
Rint interrupter resistance
Rinte expiratory interrupter resistance
Rinti inspiratory interrupter resistance
rs respiratory system
RSD residual standard deviation
Rx resistance at x Hz
s second
S sitting height in cm
SD standard deviation
SE standard error
sGaw specific airway conductance
SI sensitivity index
SJOKOLA Steroiden bij Jonge Kinderen als Onderhouds-
behandeling van Astma (Steroids in young children as
maintainance treatment of asthma)
sRaw specific airway resistance
τ time constant
TBA tidal breathing analysis
TLC total lung capacity
PD20 provocative dose leading to a 20% fall in FEV1
ROC receiver operating characteristics
tm transmural
tot total respiratory system
tPEF time to peak expiratory flow (during MEFV measure-
ment
tPTEF time to peak tidal expiratory flow (during TBA)
tE total expiratory time
V volume
V’ flow
Vbe backward extrapolated volume
Vbe%FVC backward extrapolated volume as a percentage of FVC
VE total expiratory volume
VPTEF volume to peak tidal expiratory flow
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V’maxFRC maximal expiratory flow at FRC level
X reactance
Xx reactance at x Hz
yrs years
Z impedance
LIST OF ABBREVIATIONS
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Dankwoord
Velen hebben op allerlei wijze bijgedragen aan het tot stand komen van dit
proefschrift. Ik dank hen allen en ondanks het gevaar dat ik enkelen nu ver-
geet wil ik toch een aantal mensen in het bijzonder noemen.
Laat ik met de allerbelangrijkste beginnen ..............
Dr CK van der Ent, beste Kors, jij hebt de basis gelegd voor de onderzoe-
ken die nu tot “ons” boekje hebben geleid. Hoewel je niet mijn promotor
de juro bent, ben je de facto veel meer dan dat. Je hebt mij niet alleen tot
een betere dokter, maar ook tot een redelijke onderzoeker gemaakt. Het
goede gevoel dat ik aan onze eerste gesprekken op de “confer” in het oude
WKZ overhield is volledig terecht gebleken. Dank ook voor de opleiding
tot kinderarts-pulmonoloog. Samen met Hein durfde je in zee te gaan met
een totaal onervaren onderzoeker die ook nog zei “onderzoek niet leuk te
vinden”. Dank voor een “superbegeleiding” en de vele levenswijsheden die
je me tijdens onze vele gesprekken hebt meegegeven, puur door te zijn en
te doen zoals je bent! Ik ben er trots op verder met je samen te werken op
de afdeling kinderlongziekten, die inmiddels duidelijk jouw stempel heeft
gekregen. Ons onderzoek heeft enkele vragen beantwoord maar vele nieu-
we vragen opgeworpen. Een goede basis voor de toekomst.
Ik verkeerde in de gelukkige omstandigheid dat ik vrijwel geheel “in de
baas z’n tijd” onderzoek heb kunnen verrichten. De sfeer en de instelling
op onze afdeling hebben dit mogelijk gemaakt. Onderling respect, vriend-
schap en collegialiteit vormen niet alleen de hoeksteen, maar het totale fun-
dament van onze afdeling.
Dr HJL Brackel, beste Hein, ook jij hebt vanaf het begin een belangrijke
bijdrage geleverd aan alle studies. Vanaf 1990 heb jij in vele jaren de afde-
ling kinderlongziekten van een éénmansbedrijfje tot een bloeiende afdeling
gemaakt. Ondanks de drukte van je eigen promotietraject was er altijd een
warme belangstelling voor mijn “onderzoeksperikelen” en werd de per-
soonlijke kant zeker niet vergeten. Ik dank je hiervoor en met name ook
voor onze vriendschap die ondanks de voor jou zo moeilijke ontwikkelin-
gen op onze afdeling is blijven bestaan.
Drs J van der Laag, beste Han, zonder anderen tekort te doen ben met
name jij een collega pur sang en jouw bijdrage aan dit proefschrift is mini-
maal even groot als dat van de andere co-auteurs. De patiëntenzorg staat
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vooral dankzij jou op een hoog niveau en ik hoop nog vele jaren van je te
leren. Nooit was het opvullen van gaatjes in met name patiëntenzorg en
onderwijs voor jou een probleem. Soms schieten woorden te kort....
Dr EEM van Essen-Zandvliet en Drs WAF Balemans, beste Liesbeth en
Walter, ook jullie dank ik voor jullie steun en belangstelling en de vele
gezellige gesprekken op onze kamer.
De afdeling kinderlongziekten kan alleen functioneren als de sfeer goed is.
Deze wordt grotendeels bepaald door het ondersteunend personeel van
secretariaat, polikliniek en longfunktie. Myriam, Joke, Maltie, Sylvia en
Tineke, dank voor alle hulp en morele steun. Myriam, je warme persoon-
lijkheid, hulp en bereidheid tot af en toe een extra uurtje zijn bewonde-
renswaardig. Je verschafte me zo een soort overlevingspakket (en niet alleen
op de tennisbaan!). Sylvia, als spil van het CF centrum ben je van onschat-
bare waarde. Tineke, de patiënten komen graag ter controle en niet zozeer
voor de dokter....
Natuurlijk een speciaal woord van dank aan alle kinderen die tijdens de stu-
dies bereid waren hun best te doen bij het uitvoeren dan wel ondergaan
van longfunctieonderzoek. In totaal is dit proefschrift gebaseerd op de long-
functie van ruim 8000 kinderen. Met plezier denk ik terug aan alle
SJOKOLA patientjes en met name ook hun ouders neem ik mee in deze
dankzegging.
Het enthousiasme van ouders en kinderen om vaak vele malen te oefenen,
te herhalen en vooral hun uiterste best te doen was alleen mogelijk door de
toegewijde begeleiding en aansporing door goede longfunctieassistenten.
Behalve de longfunctieassistenten in Nijmegen, Breda en Zwolle noem ik
met name Wilma Baars-de Gier, Moniek Diederik-Zwijnenburg, Wim
Klein Nagelvoort, Mariska Stehouwer- De Gooijer, Bianca van Dijk,
Corrie de Lange en last but not least Joyce Tersmette en Ingeborg Prins.
Jullie zijn toppers!
Ook de studenten Geraldine Vink, Madelon Brouha en Annemieke Siero
hebben vele kinderen gemeten met IOS en MicroRint. Jullie zijn goede
onderzoekers in spé en hebben je onderscheiden van de gemiddelde stu-
denten. Ik wens jullie veel succes in jullie verdere carrière.
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Dank aan allen die in algemene ziekenhuizen patienten hebben begeleid tij-
dens de bezoeken in verband met de SJOKOLA studies. Met name wil ik
noemen Arvid Kamps, Ruurd Jan Roorda, Paul Brand, Peter Gerrits,
Ronnie van Diemen en Frans Plötz, Ed van Leer, Florens Versteegh, Rinse
Oosterkamp, Wim Verwijs, Norbert van de Berg en Anja Vaessen-
Verberne.
Prof Dr JLL Kimpen, beste Jan, dank voor je bereidheid op het einde van
de rit het promotorschap op je te nemen. Binnen korte tijd heb je je de
inhoud van het proefschrift eigen gemaakt. Ik bewonder je manier van
werken, gestructureerd en efficiënt. Dank ook voor je steun aan onze afde-
ling en de samenwerkingsverbanden die steeds meer vorm krijgen.
Prof Dr JM Bogaard, beste Jan, jij bent vanaf het begin betrokken geweest
bij vele onderzoeken binnen onze afdeling. Dank voor je meedenken,
adviseren en corrigeren bij al mijn onderzoekswerk. Onze gezamenlijke
treinreisjes waren bijzonder. Je hebt en houdt een speciale band met onze
afdeling.
Ook de overige leden van de beoordelingscommissie, Prof Dr PJM
Helders, Prof Dr AJ van Vught, Prof Dr WMC van Aalderen en Prof Dr J
Raaijmakers. Beste Paul, Hans, Wim en Jan, dank voor de kritische beoor-
deling van het manuscript.
Niek Vermue en Paul Mulder, beste Niek, dank voor je hulp bij de juiste
uitvoering (volgens Helsinki!) van de SJOKOLA studies. Je was meer dan
zomaar een farmaceutisch begeleider van onderzoek en was steeds goed op
de hoogte van alle ins en outs op het terrein van ons onderzoek. Paul, Kors
sprak ooit over een Pentium brein, inmiddels is dit een te zwakke weergave
van je capaciteiten. Je wist zelfs voor mij de statistiek enigszins begrijpelijk
te maken.
Via jullie twee, Peter van Wingerden en Peter Jagt dank ik natuurlijk ook
de firma GLAXO (later Glaxo Wellcome en inmiddels GSK). Jullie hebben
niet alleen mijn maar ook inmiddels andere fellowships kinderlongziekten
gefinancierd en daarmee aanzienlijk bijgedragen aan de ontwikkeling van
de kinderlongziekten in Nederland. Dank voor de financiering van het
SJOKOLA-onderzoek, die mijn promotie mede heeft mogelijk gemaakt.
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De firma Micro Medical Limited dank ik voor het ter beschikking stellen
van de MicroRint. Mr Ian Shuttlewood, dear Ian, your generous disposal
of the MicroRint enabled us to study the applicability of this promising
new method and to find normal values. Results are encouraging! Thank
you very much.
Peter Merkus, beste Peter, dank voor de samenwerking bij het verzamelen
van normaalwaarden van de interruptieweerstand. Het heeft tot een mooie
publicatie geleid! Onze speleologietocht door Bob Woods apenheul was
erg gezellig!
Prof. RH Kuijten, Prof CE Blanco en Dr PMVM Theunissen dank ik voor
de opleiding tot kinderarts. Dr JJE Hendriks, beste Han, jij hebt me
enthousiast gemaakt voor de kinderlongziekten. Dank hiervoor en voor
een goede vriendschap. We zullen elkaar blijven tegenkomen.
Mijn paranimfen, vriend Henk Jan Nijenhuis en broer Sjef, dank voor jullie
bereidheid om mij vandaag bij te staan. Henk-Jan, wat de vriendschap tus-
sen onze gezinnen betekent is moeilijk te beschrijven, maar we hebben het
vaak genoeg besproken. Begonnen op de Aegeische Zee in 1989 heeft het
begrip vriendschap door jou en Monique vele extra dimensies gekregen.
We gaan nog vele jaren zo door, samen met de kinderen!
Sjef, dank voor onze gezamenlijke jeugd, gekenmerkt door alles wat broers
tot broers maakt. Hoewel we elkaar te weinig zien staan onze deuren altijd
voor elkaar open. Dank voor de goede relatie die we nog steeds hebben,
ook met “kleine zusje” Hannie en onze respectievelijke partners.
Hannie, ik ben blij en trots dat ook jij de medische wereld als speelplaats
hebt gekozen. Of ik er aan heb bijgedragen weet ik niet, maar je bent er
helemaal geschikt voor.
Papa en mama, hoewel nu pas genoemd (dat schijnt zo te horen) begon het
lieve leventje natuurlijk bij jullie! Nog steeds slagen jullie erin het “Arets
nest” tot een warm nest te maken waar we als kinderen, partners en klein-
kinderen graag komen. Dank voor een fantastische jeugd en opvoeding
waarin de werkelijke waarden van het leven voorop stonden. Dank ook
voor de mogelijkheid te studeren als voorbereiding op een mooi beroep
waarvan ik nog dagelijks geniet. Dit proefschrift draag ik dan ook aan jullie
op en ook jullie promoveren vandaag een beetje mee. Ondanks de afstand
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heb ik jullie altijd dichtbij geweten. Dank voor de vele momenten van
steun en hulp. Jullie zijn een geweldig stel ouders en grootouders !!
Pa en ma van Geel, ook jullie dank ik voor jullie warme belangstelling en
belangeloze bijdrage aan het levensgeluk van Ingrid, Kors, Amber en
mezelf. Nooit kloppen we aan een gesloten deur en de afstand van
Roosendaal naar Montfoort lijkt af en toe korter dan omgekeerd. Kors en
Amber varen er wel bij!
Last but not least bedank ik jou Ingrid. Je bent in de loop der tijd van een
geweldige vriendin mijn beste maatje geworden en bent nu inmiddels een
onvergelijkbare moeder. Samen hebben we vele prachtige herinneringen
en de geboortes van onze kinderen bewijzen dat een promotie slechts een
“minor life event” is. Hoewel ik praktisch gezien weinig tijd thuis heb hoe-
ven besteden aan mijn onderzoek was ik wellicht in gedachten ook thuis te
vaak met mijn proefschrift bezig. Dat laatste gaat nu in elk geval veranderen
en ik verheug me op de komende tijd met jou en de kinderen.
Lieve Kors en Amber, jullie zijn papa’s grote trots. Later zal ik jullie wel
eens uitlegggen wat ik allemaal heb gedaan de afgelopen jaren. Kors, mor-
gen gaan we gewoon weer naar het zwembad en de ballenbak. Amber, je
betoverende glimlach zie ik dagelijks vele malen voor me. Kanjers, geniet
ook een beetje van deze dag en ik zal nog vaak voor jullie ons liedje zin-
gen:
“Lieve Kors en Amber, papa is weer hier
we gaan nu samen spelen en hebben veel plezier
Lieve Kors en Amber, lieve Kors en Amber,
Lieve Kors en Amber, papa is weer hier”
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Curriculum vitae
Bert Arets werd geboren op 4 mei 1965 te Beek (L). In 1983 werd het
VWO diploma behaald aan de “Serviam Scholengemeenschap” te Sittard.
Hetzelfde jaar startte hij de studie geneeskunde aan de Universiteit van
Maastricht, waar hij in 1990 het artsexamen behaalde. Na een kort verblijf
op de kinderafdeling van het “Mangochi District Hospital” te Malawi ver-
vulde hij zijn militaire dienstplicht in het Militair Hospitaal 
Dr. A. Matthijsen te Utrecht als assistent interne geneeskunde (Hoofd afde-
ling kolonel-arts Dr M van Zoeren). Vanaf mei 1991 was hij werkzaam in
het De Wever Ziekenhuis (tegenwoordig Atrium Medisch Centrum) te
Heerlen op de afdeling kindergeneeskunde, eerst als AGNIO en vanaf 1
mei 1992 als AGIO (opleider Dr PMVM Theunissen). De opleiding werd
in 1993 voortgezet in het Academisch Ziekenhuis Maastricht (opleiders
Prof Dr RH Kuijten en Prof Dr CE Blanco). In februari 1997 werd hij
geregistreerd als kinderarts. Gedurende 6 maanden was hij als kinderarts
algemene kindergeneeskunde werkzaam op de kinderafdeling met specifie-
ke aandacht voor kinderlongziekten (i.s.m. JJE Hendriks). Vervolgens was
hij vanaf 1 september 1997 werkzaam in het Wilhelmina Kinderziekenhuis
te Utrecht. Als voorbereiding op de opleiding tot kinderarts-pulmonoloog
was hij de eerste 3 maanden werkzaam als kinderarts-fellow op de afdeling
intensive care (hoofd Prof. Dr. AJ van Vught). In december 1997 startte hij
met de opleiding tot kinderarts-pulmonoloog (hoofd HJL Brackel, later Dr.
CK van der Ent). In deze periode werd ook gestart met het onderzoek, dat
de basis vormde voor dit proefschrift. Sinds december 2000 is hij staflid op
de afdeling kinderlongziekten van het UMC Utrecht.
Bert is getrouwd met Ingrid van Geel. Samen hebben zij twee kinderen:
Kors (2000) en Amber (2002).
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